<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="review-article" dtd-version="1.0" xml:lang="hr" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">LV</journal-id>
<journal-id journal-id-type="nlm-ta">Lijec Vjesn</journal-id>
<journal-title-group>
<journal-title>Lijecnicki Vjesnik</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Lijec. Vjesn.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">0024-3477</issn>
<issn pub-type="epub">1849-2177</issn>
<publisher><publisher-name>Croatian Medical Association</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">LV-147-317</article-id>
<article-id pub-id-type="doi">10.26800/LV-147-9-10-1</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Guidelines</subject></subj-group>
</article-categories>
<title-group>
<article-title>Klasifikacija, dijagnosti&#x010D;ki postupnik i mjere ishoda u bolesnika s kri&#x017E;oboljom: smjernice Hrvatskoga vertebrolo&#x0161;kog dru&#x0161;tva</article-title>
<trans-title-group xml:lang="en">
<trans-title>Classification, diagnostic pathway, and outcome measures in patients with low back pain: Guidelines of the Croatian Society of Vertebrology</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3407-0317</contrib-id><name><surname>Grazio</surname><given-names>Simeon</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lovren&#x010D;i&#x0107;-Huzjan</surname><given-names>Arijana</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ivica</surname><given-names>Marija</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vukojevi&#x0107;</surname><given-names>Rudolf</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kraja&#x010D;-&#x010C;upi&#x0107;</surname><given-names>Alemka</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Grubi&#x0161;i&#x0107;</surname><given-names>Frane</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Houra</surname><given-names>Karlo</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lakta&#x0161;i&#x0107; &#x017D;erjavi&#x0107;</surname><given-names>Nadic</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nikoli&#x0107;</surname><given-names>Tatjana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Peri&#x0107;</surname><given-names>Porin</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Perovi&#x0107;</surname><given-names>Darko</given-names></name><xref ref-type="aff" rid="aff9"><sup>9</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schnurrer Luke Vrbani&#x0107;</surname><given-names>Tea</given-names></name><xref ref-type="aff" rid="aff10"><sup>10</sup></xref><xref ref-type="aff" rid="aff11"><sup>11</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vlak</surname><given-names>Tonko</given-names></name><xref ref-type="aff" rid="aff12"><sup>12</sup></xref><xref ref-type="aff" rid="aff13"><sup>13</sup></xref></contrib><contrib contrib-type="author"><name><surname>Markulin</surname><given-names>Helena</given-names></name><xref ref-type="aff" rid="aff14"><sup>14</sup></xref></contrib><contrib contrib-type="author"><name><surname>&#x0160;kori&#x0107;</surname><given-names>Lea</given-names></name><xref ref-type="aff" rid="aff14"><sup>14</sup></xref></contrib><contrib contrib-type="author"><name><surname>Trkulja</surname><given-names>Vladimir</given-names></name><xref ref-type="aff" rid="aff15"><sup>15</sup></xref></contrib><contrib contrib-type="author"><collab>uime radne skupine za smjernice Hrvatskoga vertebrolo&#x0161;kog dru&#x0161;tva HLZ-a<xref ref-type="fn" rid="afn1">*</xref></collab></contrib>
<aff id="aff1"><label>1</label><institution>Klinika za reumatologiju, fizikalnu medicinu i rehabilitaciju, Klini&#x010D;ki bolni&#x010D;ki centar Sestre milosrdnice</institution>, <addr-line>Zagreb</addr-line></aff>
<aff id="aff2"><label>2</label><institution>Medicinski fakultet Sveu&#x010D;ili&#x0161;ta u Zagrebu</institution>, <addr-line>Zagreb</addr-line></aff>
<aff id="aff3"><label>3</label><institution>Klinika za neurologiju, Klini&#x010D;ki bolni&#x010D;ki centar Sestre milosrdnice</institution>, <addr-line>Zagreb</addr-line></aff>
<aff id="aff4"><label>4</label><institution>Stomatolo&#x0161;ki fakultet Sveu&#x010D;ili&#x0161;ta u Zagrebu</institution>, <addr-line>Zagreb</addr-line></aff>
<aff id="aff5"><label>5</label><institution>Klini&#x010D;ki zavod za dijagnosti&#x010D;ku i intervencijsku radiologiju, Klini&#x010D;ki bolni&#x010D;ki centar Sestre milosrdnice</institution>, <addr-line>Zagreb</addr-line></aff>
<aff id="aff6"><label>6</label><institution>Dom zdravlja Zagreb &#x2013; Centar</institution>, <addr-line>Zagreb</addr-line></aff>
<aff id="aff7"><label>7</label>Specijalna bolnica &#x201E;Aksis&#x201C;, <addr-line>Zagreb</addr-line></aff>
<aff id="aff8"><label>8</label><institution>Klinika za reumatske bolesti i rehabilitaciju, Klini&#x010D;ki bolni&#x010D;ki centar Zagreb</institution>, <addr-line>Zagreb</addr-line></aff>
<aff id="aff9"><label>9</label><institution>Klinika za kirurgiju, Klini&#x010D;ka bolnica Dubrava</institution>, <addr-line>Zagreb</addr-line></aff>
<aff id="aff10"><label>10</label><institution>Zavod za fizikalnu i rehabiitacijsku medicinu, Klini&#x010D;ki bolni&#x010D;ki centar Rijeka</institution>, <addr-line>Rijeka</addr-line></aff>
<aff id="aff11"><label>11</label><institution>Medicinski fakultet Sveu&#x010D;ili&#x0161;ta u Rijeci</institution>, <addr-line>Rijeka</addr-line></aff>
<aff id="aff12"><label>12</label><institution>Zavod za fizikalnu medicinu i rehabilitaciju s reumatologijom, Klini&#x010D;ki bolni&#x010D;ki centar Split</institution>, <addr-line>Split</addr-line></aff>
<aff id="aff13"><label>13</label><institution>Medicinski fakultet Sveu&#x010D;ili&#x0161;ta u Splitu</institution>, <addr-line>Split</addr-line></aff>
<aff id="aff14"><label>14</label><institution>Sredi&#x0161;nja medicinska knji&#x017E;nica, Medicinski fakultet Sveu&#x010D;ili&#x0161;ta u Zagrebu</institution>, <addr-line>Zagreb</addr-line></aff>
<aff id="aff15"><label>15</label><institution>Zavod za temeljnu i klini&#x010D;ku farmakologiju, Medicinski fakultet Sveu&#x010D;ili&#x0161;ta u Zagrebu</institution>, <addr-line>Zagreb</addr-line></aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Adresa za dopisivanje: Prof. prim. dr. sc. Simeon Grazio, dr. med., <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0003-3407-0317">https://orcid.org/0000-0003-3407-0317</ext-link>, Klinika za reumatologiju, fizikalnu medicinu i rehabilitaciju Medicinskog fakulteta Sveu&#x010D;ili&#x0161;ta u Zagrebu, Klini&#x010D;ki bolni&#x010D;ki centar Sestre milosrdnice, Vinogradska 29, 10&#x2005;000 Zagreb, e-po&#x0161;ta: <email xlink:href="simeon.grazio@kbcsm.hr">simeon.grazio@kbcsm.hr</email></corresp>
<fn id="afn1"><label>*</label><p>&#x010C;lanovi radne skupine: Branka Aukst Margeti&#x0107;; Diana Balen; Vide Bili&#x0107;; Dubravka Bobek; Boris Bo&#x017E;i&#x0107;; Vedran Brni&#x0107;; Stipe &#x0106;orluka; Stjepan Dokuzovi&#x0107;; Simeon Grazio; Frane Grubi&#x0161;i&#x0107;; Karlo Houra; Marija Ivica; Dalibor Karlovi&#x0107;; Petra Kova&#x010D;evi&#x0107;-Toti&#x0107;; Alemka Kraja&#x010D;-&#x010C;upi&#x0107;; Dra&#x017E;en Kvesi&#x0107;; Nadica Lakta&#x0161;i&#x0107; &#x017D;erjavi&#x0107;; Arijana Lovren&#x010D;i&#x0107;-Huzjan; Tomislav Nem&#x010D;i&#x0107;; Tatjana Nikoli&#x0107;; Helena Markulin; Dubravka Sajkovi&#x0107;; Dubravka &#x0160;ali&#x0107; Herjavec; Lea &#x0160;kori&#x0107;; Porin Peri&#x0107;; Darko Perovi&#x0107;; Ivan Rado&#x0161;; Dominik Romi&#x0107;; Tea Schnurrer Luke Vrbani&#x0107;; Vladimir Trkulja; Tonko Vlak; Rudolf Vukojevi&#x0107;</p></fn>
<fn id="afn2"><p>Konzervativno lije&#x010D;enje: Branka Aukst Margeti&#x0107;; Diana Balen; Dubravka Bobek; Vedran Brni&#x0107;; Frane Grubi&#x0161;i&#x0107;; Petra Kova&#x010D;evi&#x0107; Toti&#x0107;; Alemka Kraja&#x010D;-&#x010C;upi&#x0107;; Nadica Lak-ta&#x0161;i&#x0107; &#x017D;erjavi&#x0107;; Arijana Lovre&#x010D;i&#x0107;-Huzjan; Tomislav Nem&#x010D;i&#x0107;; Tatjana Nikoli&#x0107;; Porin Peri&#x0107;; Dubravka Sajkovi&#x0107;; Tea Schnurrer Luke Vrbani&#x0107;; Dubravka &#x0160;ali&#x0107; Herjavec; Tonko Vlak; Darko Perovi&#x0107;</p></fn>
<fn fn-type="con">
<p content-type="fn-title">DOPRINOS AUTORA</p>
<p>K<sc>oncepcija</sc> <sc>ili</sc> <sc>nacrt</sc> <sc>rada</sc>: SG, HM, VT, L&#x0160;</p>
<p>P<sc>rikupljanje</sc>, <sc>analiza</sc> <sc>i</sc> <sc>interpretacija</sc> <sc>podataka</sc>: SG, ALH, MI, RV, AK&#x010C;, FG, KH, NL&#x017D;, TN, PP, DP, TSLV, TV, HM, VT, L&#x0160;</p>
<p>P<sc>isanje</sc> <sc>prve</sc> <sc>verzije</sc> <sc>rada</sc>: SG</p>
<p>K<sc>riti&#x010D;ka</sc> <sc>revizija</sc>: SG, ALH, MI, RV, AK&#x010C;, FG, KH, NL&#x017D;, TN, PP, DP, TSLV, TV, HM, VT, L&#x0160;</p>
</fn>
</author-notes>
<pub-date date-type="pub" publication-format="electronic"><month>11</month><year>2025</year></pub-date>
<pub-date date-type="pub" publication-format="print"><month>11</month><year>2025</year></pub-date>
<volume>147</volume>
<issue>9-10</issue>
<fpage>317</fpage>
<lpage>337</lpage>
<permissions>
<copyright-statement>Croatian Medical Association</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Croatian Medical Association</copyright-holder>
<license xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" specific-use="CC BY-NC-ND 4.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.</license-p></license>
</permissions>
<abstract>
<title>SA&#x017D;ETAK</title>
<sec><title>Cilj</title><p>Izraditi nacionalne smjernice za klasifikaciju, dijagnostiku i mjere ishoda u kri&#x017E;obolji.</p></sec>
<sec><title>Metode</title><p>Sustavni pregled literature i evaluacija multidisciplinarnog panela te formulacija preporuka prema metodi GRADE, procesom glasanja i konsenzusa.</p></sec>
<sec><title>Rezultati</title><p>Definirane su 23 preporuke, od kojih se 14 sna&#x017E;no, a 9 uvjetno preporu&#x010D;uje. Sna&#x017E;ne preporuke odnose se na standardnu definiciju kri&#x017E;obolje, klasifikaciju kri&#x017E;obolje prema trajanju na akutnu (&lt;6 tj.), subakutnu (6&#x2013;12 tj.) i kroni&#x010D;nu kri&#x017E;obolju (&gt;12 tj.), s dodatnim izrazom &#x201E;probijaju&#x0107;a bol / akutno pogor&#x0161;anje kroni&#x010D;ne kri&#x017E;obolje&#x201C;, etiolo&#x0161;ku podjelu na nespecifi&#x010D;nu kri&#x017E;obolju i specifi&#x010D;nu kri&#x017E;obolju (uklju&#x010D;uju&#x0107;i onu povezanu s ozbiljnim stanjima), te kri&#x017E;obolju s radikulopatijom, pri &#x010D;emu se mo&#x017E;e koristiti i termin &#x201E;lumboishijalgija&#x201C;. Anamneza i klini&#x010D;ka procjena temelj su utvr&#x0111;ivanja po&#x010D;etne dijagnoze i pristupu lije&#x010D;enju, pri &#x010D;emu se u akutnoj i subakutnoj fazi kri&#x017E;obolje treba uzeti u obzir znakove upozorenja ozbiljne patologije. Sna&#x017E;no se preporu&#x010D;uju i: nekorisnost laboratorijskih pretraga za procjenu nespecifi&#x010D;ne kri&#x017E;obolje (iako mogu biti korisne u diferencijalnoj dijagnozi), nepostojanje indikacije za primjenu slikovne dijagnostike kod akutne kri&#x017E;obolje i odsutnosti tzv. &#x201E;crvenih zastava&#x201C;, preporuka za slikovne metode kod sumnje na ozbiljnu patologiju u sklopu specifi&#x010D;nih uzroka kri&#x017E;obolje, primjena magnetske rezonancije (MR) ili kompjuterizirane tomografije (ako je MR kontraindicirana) ako se razmatra invazivni/kirur&#x0161;ki zahvat, a slikovna dijagnostika se mo&#x017E;e razmotriti u slu&#x010D;aju zna&#x010D;ajnog nesposobnosti zbog kroni&#x010D;ne kri&#x017E;obolje (nakon tri mjeseca), dok nema indikacije za njezino ponavljanje ako nema promjene simptoma. Elektromiografija (EMG) se ne preporu&#x010D;uje kod akutne kri&#x017E;obolje, a mo&#x017E;e se u&#x010D;initi u slu&#x010D;aju dugotrajne i izra&#x017E;ene subakutne/kroni&#x010D;ne kri&#x017E;obolje s radikulopatijom. Tako&#x0111;er, sna&#x017E;no se preporu&#x010D;uje da mjere ishoda, a posebno ishodi o kojima izvje&#x0161;tavaju bolesnici, trebaju biti standardna klini&#x010D;ka praksa, pri &#x010D;emu su preporu&#x010D;eni instrumenti za procjenu intenziteta boli vizualna analogna ljestvica (VAS) i numeri&#x010D;ka ljestvica boli (NRS).</p></sec>
<sec><title>Zaklju&#x010D;ak</title><p>Definirane su sna&#x017E;ne i uvjetne preporuke o klasifikaciji, va&#x017E;nosti dijagnosti&#x010D;kih postupaka i mjera ishoda u bolesnika s kri&#x017E;oboljom.</p></sec>
</abstract>
<trans-abstract xml:lang="en">
<title>SUMMARY</title>
<sec><title>Objective</title><p>To develop national guidelines for classification, diagnosis and outcome measures in low back pain.</p></sec>
<sec><title>Methods</title><p>A systematic literature review and evaluation by a multidisciplinary panel, and recommendations formulated using the GRADE method, a voting and consensus process.</p></sec>
<sec><title>Results</title><p>Twenty three recommendations were defined, of which 14 are strongly recommended and nine are conditionally recommended. Strong recommendations relate to the standard definition of low back pain, classification of low back pain according to duration into acute (&lt;6 weeks), subacute (6&#x2013;12 weeks), and chronic low back pain (&gt;12 weeks), with the additional term &#x201C;breaking pain / acute exacerbation of chronic low back pain&#x201D;, etiological classification into non-specific low back pain and specific low back pain (including that associated with serious conditions), and low back pain with radiculopathy, where the term &#x201C;lumboischialgia&#x201D; can also be used, history and clinical assessment as the basis for establishing the initial diagnosis and treatment approach, warning signs of serious pathology being taken into account in the acute and subacute phases of low back pain. Also strongly recommended are: the uselessness of laboratory tests for the evaluation of non-specific low back pain (although they may be useful in differential diagnosis), the absence of an indication for the use of imaging diagnostics in acute low back pain, and the absence of &#x201C;red flags&#x201D;, recommendation for imaging methods in case of suspicion of serious pathology within the specific causes of low back pain, use of magnetic resonance imaging (MRI) or computed tomography (if MRI is contraindicated) if invasive/surgical intervention is being considered, and imaging diagnostics may be regarded as in the case of significant disability due to chronic low back pain (after three months), while there is no indication for its repeating if there is no change in symptoms. Electromyography (EMG) is not recommended in acute low back pain, but can be done in the case of long-term and pronounced subacute/chronic low back pain with radiculopathy. It is also strongly recommended that outcome measures, especially patient-reported outcomes, should be standard clinical practice. The instruments for assessing pain intensity are the visual analogue scale (VAS) and the numerical pain scale (NRS).</p></sec>
<sec><title>Conclusion</title><p>Strong and conditional recommendations have been defined on the classification, importance of diagnostic procedures, and outcome measures in patients with low back pain.</p></sec>
</trans-abstract>
<kwd-group kwd-group-type="author"><kwd>Deskriptori KRI&#x017D;OBOLJA &#x2013; dijagnoza, etiologija, klasifikacija</kwd><kwd>MJERE ISHODA ZDRAVSTVENE SKRBI &#x2013; metode</kwd><kwd>PROCJENA BOLI</kwd><kwd>PROCJENA INVALIDNOSTI</kwd><kwd>KVALITETA &#x017D;IVOTA</kwd><kwd>UPITNICI</kwd><kwd>SMJERNICE</kwd><kwd>HRVATSKA</kwd></kwd-group>
<kwd-group kwd-group-type="translator" xml:lang="en"><title>Descriptors </title><kwd>LOW BACK PAIN &#x2013; classification, diagnosis, etiology</kwd><kwd>OUTCOME ASSESMENT, HEALTH CARE &#x2013; methods</kwd><kwd>PAIN MEASUREMENT</kwd><kwd>DISABILITY EVALUATION</kwd><kwd>QUALITY OF LIFE</kwd><kwd>SURVEYS AND QUESTIONNAIRES</kwd><kwd>PRACTICE GUIDELINES AS TOPIC</kwd><kwd>CROATIA</kwd></kwd-group>
</article-meta>
</front>
<body>
<p>Kri&#x017E;obolja je po svojoj u&#x010D;estalosti, utjecaju na kvalitetu &#x017E;ivota, radnu sposobnost te direktne i indirektne tro&#x0161;kove jedno od najva&#x017E;nijih medicinskih stanja uop&#x0107;e. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>) Ona je vode&#x0107;i uzrok godina &#x017E;ivota s nesposobno&#x0161;&#x0107;u (engl. <italic>years lived with disability, skr. YLDs</italic>) za oba spola. (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>) Ovisno o populaciji i definiciji, prevalencija kri&#x017E;obolje kre&#x0107;e se izme&#x0111;u 22% i 48%. &#x0160;to se ti&#x010D;e vremenskih trendova, u sustavnoj analizi podataka u studiji globalnog tereta bolesti (2019.) utvr&#x0111;eno je da se od 1990. do 2019. godine dobno standardizirana stopa prevalencije i incidencije kri&#x017E;obolje te broj godina pro&#x017E;ivljenih s nesposobnosti (YLDs) u kri&#x017E;obolji blago smanjuje, ali je apsolutni broj prevalentnih i incidentnih slu&#x010D;ajeva te YLD-ova zna&#x010D;ajno porastao. Broj prevalentnih slu&#x010D;ajeva pove&#x0107;avao se s dobi i dosegao vrhunac u dobi od 45 do 54 godine za oba spola, a globalna stopa prevalencije bila je vi&#x0161;a u &#x017E;ena nego u mu&#x0161;karaca i rasla je s godinama, dosegnuv&#x0161;i vrhunac u dobnoj skupini od 80 do 84 godine, u oba spola. &#x0160;to se ti&#x010D;e globalne prevalencije hospitalizacije zbog kri&#x017E;obolje ona je, prema sustavnom pregledu iz 2023. godine iznosila 159,1 (IQR 82,6-313,8) na 100.000 stanovnika. Medijan postotka svih prijama u bolnicu zbog kri&#x017E;obolje je 0,9% (IQR 0,6-1,5; 30 zemalja), dok je prosje&#x010D;na duljina boravka u bolnici prema podatcima iz 39 zemalja 6,2 dana za &#x201E;bol u le&#x0111;ima&#x201C; (IQR 4,4-8,6) i 5,4 dana za &#x201E;poreme&#x0107;aje intervertebralnog diska&#x201C; (IQR 4,1-8,4). (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>) Bolesnici s akutnom nespecifi&#x010D;nom kri&#x017E;oboljom koji se javljaju na hitne prijme prijavljuju vi&#x0161;e razine boli i invaliditeta od onih koji se vide u op&#x0107;oj medicinskoj praksi. (<xref ref-type="bibr" rid="r4"><italic>4</italic></xref>)</p>
<p>Lije&#x010D;enje kri&#x017E;obolje u svijetu je razli&#x010D;ito, a adherencija uz pobolj&#x0161;anje ishoda lije&#x010D;enja i kvalitete &#x017E;ivota mo&#x017E;e smanjiti direktne i indirektne tro&#x0161;kove. Kako bi se sprije&#x010D;ila epidemija kri&#x017E;obolje promovira se potreba primjene medicine temeljene na dokazima, pri &#x010D;emu va&#x017E;nu ulogu imaju smjernice za dijagnostiku i lije&#x010D;enje kri&#x017E;obolje, a sve u cilju pobolj&#x0161;anja ishoda. (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>)</p>
<p>Hrvatsko vertebrolo&#x0161;ko dru&#x0161;tvo (HVD) Hrvatskoga lije&#x010D;ni&#x010D;kog zbora objavilo je 2012. i 2013. godine hrvatske smjernice za dijagnostiku, konzervativno lije&#x010D;enje te intervencijsko i invazivno lije&#x010D;enje bolesnika s kri&#x017E;oboljom. (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>, <xref ref-type="bibr" rid="r6"><italic>6</italic></xref>) S obzirom na protok vremena, u okviru HVD-a pokrenuta je inicijativa za a&#x017E;uriranje i izradu novih smjernica. One se odnose na terminologiju, klasifikaciju, mjere ishoda i dijagnosti&#x010D;ki postupnik te na konzervativno lije&#x010D;enje i invazivno/kirur&#x0161;ko lije&#x010D;enje. U ovom radu iznosimo smjernice za prve &#x010D;etiri teme sa svrhom da na temelju relevantne literature preporu&#x010D;imo definiciju i terminologiju kri&#x017E;obolje, klini&#x010D;ku evaluaciju, razvrstavanje bolesnika s kri&#x017E;oboljom, s posebnim naglaskom na ocjenu rizika za kroni&#x010D;nost, dijagnosti&#x010D;ku va&#x017E;nost pojedinih pretraga (laboratorijskih pretraga, slikovnih metoda i elektromiografije), izbor mjera ishoda i mjera ocjene fizi&#x010D;ke funkcije te postavljanje okvirnih uputa (<italic>framework</italic>) o op&#x0107;em dijagnosti&#x010D;kom putu bolesnika s kri&#x017E;oboljom (s radikulopatijom ili bez nje). Pritom smo uzeli u obzir i klini&#x010D;ku praksu skrbi za te bolesnike u Hrvatskoj, iako smjernice mogu biti polazi&#x0161;na to&#x010D;ka i za druge sredine, napose one koje imaju sli&#x010D;no organizirano zdravstvo i sli&#x010D;ne resurse. Ciljna su skupina smjernica svi lije&#x010D;nici koji skrbe za bolesnike s kri&#x017E;oboljom (lije&#x010D;nici obiteljske medicine ili drugih specijalnosti). Smjernice mogu biti korisne, iako nisu primarno namijenjene donositeljima zdravstvenih politika ili osiguravateljima, u vezi strate&#x0161;kih i/ili poslovnih odluka, ali i ostalim zdravstvenim radnicima (<italic>allied health professionals</italic>). Smjernice nisu namijenjene bolesnicima.</p>
<sec sec-type="other1">
<title>Metode</title>
<p>Radna skupina multidisciplinarnog panela stru&#x010D;njaka odabrana je na temelju dogovora u sklopu Upravnog odbora HVD-a, na poziv voditelja smjernica (SG). Sastojala se od: specijalista fizikalne medicine i rehabilitacije (SG, FG, DB, VB, TSLV, TN, DB, TN, TV, DS, PK, PP, D&#x0160;H, NL&#x017D;), spinalnih kirurga (DP, DK, VB, S&#x0106;, SD), neurokirurga (KH, BB, DR), neurologa (ALH, MI), anesteziologa i reanimatologa (IR), psihijatara (BAM, DK) i lije&#x010D;nika obiteljske medicine (AK&#x010C;). Radna skupina se prvi put sastala u o&#x017E;ujku 2022. pod pokroviteljstvom Hrvatskoga vertebrolo&#x0161;kog dru&#x0161;tva. Nakon inicijalnog sastanka o svrsi i okvirima smjernica zapo&#x010D;eo je rad na metodologiji, odabiru pojedinih tema i prijedlozima &#x010D;lanova radnih skupina po temama, pri &#x010D;emu su u radnu skupinu pozvane i knji&#x017E;ni&#x010D;arske savjetnice iz Sredi&#x0161;nje medicinske knji&#x017E;nice Medicinskog fakulteta u Zagrebu (HM, L&#x0160;), kao i lije&#x010D;nik, stru&#x010D;njak za metodologiju znanstvenih istra&#x017E;ivanja (VT).</p>
<p>Odabrani su oni uzroci i vrste kri&#x017E;obolje u odraslih koji su &#x010D;esti u klini&#x010D;koj praksi i imaju neka zajedni&#x010D;ka obilje&#x017E;ja. U tom su smislu uklju&#x010D;ni kriteriji bili: dob &#x2013; stariji od 18 godina, kri&#x017E;obolja, bol u le&#x0111;ima, akutna kri&#x017E;obolja, subakutna kri&#x017E;obolja, kroni&#x010D;na kri&#x017E;obolja, nespecifi&#x010D;na kri&#x017E;obolja, degenerativna bolest kralje&#x017E;nice, hernija intervertebralnog (i. v.) diska, osteoartritis, ishijalgija/radikulopatija, fasetni zglobni sindrom, spinalna stenoza, degenerativna spondilolisteza i bol iz sakroilijakalnog zgloba degenerativne etiologije.</p>
<p>Iz smjernica su isklju&#x010D;ena stanja od kojih se ve&#x0107;ina mo&#x017E;e svrstati u ozbiljne i potencijalno opasne uzroke kri&#x017E;obolje (tzv. crvene zastave). Specifi&#x010D;no, isklju&#x010D;ni kriteriji bili su: skolioza, upalne reumatske bolesti, infekcija, tumori/neoplazme, sindrom ravnih le&#x0111;a, sindrom susjednog segmenta, trauma, trudno&#x0107;a i stanja nakon operacija kralje&#x017E;nice.</p>
<p>S obzirom na &#x010D;injenicu da se kri&#x017E;oboljom sustavno bave razna strukovna dru&#x0161;tva i a&#x017E;uriraju svoje stavove i preporuke, u izradi ovih smjernica, a s ciljem smanjenja potrebnog broja dokaza, odnosno opsega obrazlo&#x017E;enja i u&#x0161;tede prostora za publikaciju, odredili smo nekoliko etabliranih me&#x0111;unarodnih smjernica kao polazi&#x0161;ne to&#x010D;ke u odnosu na koje bi se u ove smjernice unijele mogu&#x0107;e prilagodbe/dodatne informacije: a) francuske smjernice za kri&#x017E;obolju iz 2021. (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>); b) smjernice <italic>National Institute for Health and Care Excellence</italic> (NICE) dodatno a&#x017E;urirane literaturom o farmakoterapiji do 2020. (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>) i a&#x017E;urirani pregled temeljen na dokazima o intervencijskim metodama iz 2019. godine (<xref ref-type="bibr" rid="r9"><italic>9</italic></xref>). Neki od pojmova od interesa ve&#x0107; su bili obuhva&#x0107;eni navedenim smjernicama. Neovisno od toga provedeno je pretra&#x017E;ivanje literature, pri &#x010D;emu smo se odlu&#x010D;ili za sljede&#x0107;e literaturne izvore i selekciju preferiranog tipa publikacija: a) sekundarne/tercijarne publikacije &#x2013; sustavni pregledi literature, metaanalize, &#x201E;<italic>scoping</italic>&#x201C; pregledni tekstovi, smjernice; b) primarne publikacije &#x2013; randomizirane klini&#x010D;ke studije i nerandomizirane kontrolirane studije (za postupke/procedure koje nisu obuhva&#x0107;ene sekundarnim/tercijarnim publikacijama). Razdoblje pretra&#x017E;ivanja bilo je inicijalno od 1. sije&#x010D;nja 2011. do 31. o&#x017E;ujka 2022., uz naknadno a&#x017E;uriranje do 31. prosinca 2024.</p>
<p>Sukladno prethodno navedenim polazi&#x0161;nim to&#x010D;kama, pretra&#x017E;ivanje literature za ovaj dio smjernica odnosilo se na sljede&#x0107;e: definiciju kri&#x017E;obolje, vrste kri&#x017E;obolje prema trajanju i uzrocima, ocjenu rizika za kronicitet, klini&#x010D;ku ocjenu bolesnika s kri&#x017E;oboljom, ulogu laboratorijskih pretraga, slikovnih metoda i elektromiografije, mjere ishoda, mjere fizi&#x010D;ke (tjelesne) funkcije i op&#x0107;i dijagnosti&#x010D;ki put/postupnik za bolesnike s kri&#x017E;oboljom. Glede ishoda od interesa uklju&#x010D;ili smo one koji su klini&#x010D;ki va&#x017E;ni i vezani za bolesnika, kao &#x0161;to su bol, funkcionalna sposobnost i kvaliteta &#x017E;ivota povezana sa zdravljem (engl. skr. HR-QoL). Zbog slo&#x017E;enosti i nedostatne validiranosti uzro&#x010D;no-posljedi&#x010D;nih povezanosti u na&#x0161;im uvjetima u ishode nismo uvrstili ili smo tek usputno spomenuli neke indirektne pokazatelje tereta bolesti kao &#x0161;to su izostanak s posla i/ili (direktni/indirektni) tro&#x0161;kovi.</p>
<p>S obzirom na (o&#x010D;ekivanu) veliku koli&#x010D;inu literaturnih izvora s izvjesno mogu&#x0107;im preklapanjem sadr&#x017E;aja/informacija u odnosu na me&#x0111;unarodne smjernice koje su definirane kao orijentirne to&#x010D;ke, uspostavljen je hodogram:</p>
<list id="L1" list-type="simple"><list-item><p>po&#x010D;etna identifikacija potencijalno va&#x017E;nih izvora (pretra&#x017E;ivanja literaturnih baza &#x2013; Sredi&#x0161;nja medicinska knji&#x017E;nica (SMK), Medicinski fakultet Zagreb);</p></list-item>
<list-item><p>po&#x010D;etni probir na temelju sukladnosti tema/podru&#x010D;ja i vremenskog okvira (na temelju sa&#x017E;etaka);</p></list-item>
<list-item><p>&#x201E;revizija&#x201C; po&#x010D;etnog probira;</p></list-item>
<list-item><p>popis probranih sa&#x017E;etaka upu&#x0107;en radnim skupinama na daljnju ocjenu sukladnosti sadr&#x017E;aja/relevantnosti i probir izvora koje treba evaluirati u cjelovitom tekstu.</p></list-item></list>
<p>Pretra&#x017E;ivanje je provela specijalistica za pretra&#x017E;ivanje iz Sredi&#x0161;nje medicinske knji&#x017E;nice (HM), a zbog koli&#x010D;ine publikacija i u cilju dobivanja &#x0161;to pouzdanijih podataka ograni&#x010D;ili smo se na sistematske preglede, metaanalize i kontrolirane studije. Razvijena je detaljna strategija pretra&#x017E;ivanja, temeljena na strategiji za MEDLINE (upotrebljavaju&#x0107;i MeSH termine i tekstualne klju&#x010D;ne rije&#x010D;i), ali revidirano sukladno svakom od izvora. Pretra&#x017E;ene su sljede&#x0107;e baze podataka: <italic>Cochrane Central Register of Controlled Trials</italic> (Cochrane Library; via Ovid), <italic>Cochrane Database of Systematic Reviews</italic> (Cochrane Library; via Ovid), <italic>MEDLINE</italic> (via Ovid), <italic>Scopus</italic>, <italic>Web of Science Core Collection</italic> (via <italic>Web of Science</italic>) i <italic>Current Contents</italic> (via <italic>Web of Science</italic>). Koristili smo engleski jezik za pretra&#x017E;ivanje svih baza podataka, a u obzir su uzete publikacije na engleskom jeziku. Svi rezultati pretra&#x017E;ivanja uvezeni su u <italic>EndNote citation softver</italic> (EndNote, Clarivate, Philadephia, PA, USA). Duplikati su uklonjeni putem softvera. Inicijalno pretra&#x017E;ivanje bilo je dovr&#x0161;eno 12. travnja 2022., s tim da je 2. sije&#x010D;nja 2025. dovr&#x0161;eno dodatno a&#x017E;uriranje literature do 31. prosinca 2024.</p>
<p>Od po&#x010D;etnog 3.391 zapisa nakon uklanjanja duplikata ostalo je 1.865 radova. Prije daljnjeg &#x201E;ru&#x010D;nog&#x201C; probira dvoje koautora (VT i SG) odr&#x017E;ali su sastanak s &#x010D;etvero &#x010D;lanova radne skupine, dvoje specijalista fizikalne medicine i rehabilitacije, jednim vertebralnim kirurgom i jednim neurokirurgom (VB, PKT, SD, DR), s ciljem uputa u vezi ru&#x010D;nog probira, koji su i u&#x010D;inili. Nakon prvoga ru&#x010D;nog probira uslijedio je jo&#x0161; jedan ru&#x010D;ni probir (VT i SG), a nakon toga su &#x010D;lanovi radnih skupina po temama, uklju&#x010D;ivo i ove koje ovdje obra&#x0111;ujemo, u&#x010D;inili izbor onih od u&#x017E;eg interesa za tra&#x017E;enje referencija <italic>in extenso</italic>, koje su dodatno pregledane. U kona&#x010D;nici, u&#x010D;injen je zavr&#x0161;ni izbor publikacija. Osim ovoga sistematskog pretra&#x017E;ivanja, dodatno je ru&#x010D;no provedeno pretra&#x017E;ivanje, prvenstveno za one teme koje nisu bile primarni interes ovih smjernica, ali su va&#x017E;ne za razumijevanje konteksta kri&#x017E;obolje, te u cilju diferencijalne dijagnoze unutar entiteta kri&#x017E;obolje. Op&#x0107;enito, pri odabiru literaturnih informacija koje bi podr&#x017E;ale na&#x0161;e smjernice postojala je okvirna preporuka da se prvenstveno u obzir uzme &#x0161;to recentnija literatura, uz to da je glavno obilje&#x017E;je za odabir njihova kvaliteta u stru&#x010D;nom/metodolo&#x0161;kom smislu. U kona&#x010D;nici su odabrana 254 rada iz 248 studija. Formalna analiza u smislu metaanalize i odre&#x0111;ivanja snage dokaza za publikacije unutar pojedine teme nije provedena.</p>
<p>Na <xref ref-type="fig" rid="f1">Figure 1</xref> prikazan je tijek pretra&#x017E;ivanja u obliku postupnika prema na&#x010D;elima grupe PRISMA. (<xref ref-type="bibr" rid="r10"><italic>10</italic></xref>)</p>
<fig id="f1" position="float" fig-type="figure"><label>Figure 1</label><caption><p>Flow diagram of literature search according to PRISMA 2020 for systematic reviews of databases and registers only (ref. no. 10)</p></caption><graphic xlink:href="LV-147-317-f1"></graphic></fig>
<p>Pojedine teme smjernica, uklju&#x010D;uju&#x0107;i i one koje se ovdje prikazuju, izlo&#x017E;ene su na zajedni&#x010D;kom sastanku, Godi&#x0161;njem simpoziju Hrvatskoga vertebrolo&#x0161;kog dru&#x0161;tva, koji je odr&#x017E;an 11. listopada 2022. pod pokroviteljstvom Razreda za medicinske znanosti Hrvatske akademije znanosti i umjetnosti. Na sastanku su sudjelovala ukupno 124 lije&#x010D;nika razli&#x010D;itih specijalnosti (fizijatrija, neurologija, radiologija, ortopedija, neurokirurgija, kirurgija-traumatologija, obiteljska medicina). Predstavnici pojedinih radnih skupina izlo&#x017E;ili su rezultate pregleda odabrane literature te se na samom sastanku odr&#x017E;ala rasprava i glasanje u vezi pojedinih preporuka ovog dijela smjernica.Te su preporuke donesene konsenzusom. One se odnose na: definiciju kri&#x017E;obolje, pojmove za klasifikaciju i definiciju pojedinih tipova kri&#x017E;obolje prema trajanju i uzroku, trija&#x017E;u, dijagnozu i ocjenu kri&#x017E;obolje, uklju&#x010D;ivo ocjenu rizika kroniciteta, relevantnost laboratorijskih, slikovnih i elektrofiziolo&#x0161;kih metoda, mjere ishoda, mjere fizi&#x010D;ke (tjelesne) funkcije te op&#x0107;i put bolesnika u dijagnostici kri&#x017E;obolje. Snaga preporuke je mogla biti &#x201E;sna&#x017E;na&#x201C; ili &#x201E;slaba&#x201C; prema metodi GRADE. (<xref ref-type="bibr" rid="r11"><italic>11</italic></xref>) Snaga preporuke se temeljila na vi&#x0161;e &#x010D;imbenika, a na prvom mjestu na ocjeni kvalitete dokaza iz literature. Donja granica konsenzusa definirana je s najmanje 75% slaganja svih stru&#x010D;njaka, s tim da se o pojedinoj preporuci trebalo slo&#x017E;iti najmanje 50% stru&#x010D;njaka odre&#x0111;ene specijalnosti.</p>
<p>Prvi autor je napisao prvu ina&#x010D;icu rukopisa, koji je poslan cijeloj radnoj skupini na kona&#x010D;no odobrenje. Nakon manjih modifikacija smjernice su dobile jednoglasnu podr&#x0161;ku radne skupine.</p>
<p>Za ovaj projekt nije bilo potrebno eti&#x010D;ko odobrenje. Tako&#x0111;er, nije bio potreban ni informirani pristanak. Naime, svi postupci provedeni od strane autora odnose se na analizu prethodno objavljenih publikacija, te su u skladu s eti&#x010D;kim standardima Helsin&#x0161;ke deklaracije iz 1964. i njezinih kasnijih nadopuna.</p>
<p>Izrada smjernica nije bila financijski ili na drugi na&#x010D;in potpomognuta od bilo koje farmaceutske ili druge tvrtke.</p>
</sec>
<sec sec-type="other2">
<title>Definicija kri&#x017E;obolje</title>
<p>Kri&#x017E;obolja se definira kao bol i nelagoda, lokalizirana ispod ruba rebara i iznad donjih glutealnih nabora, s boli u nozi ili bez nje. <italic>STUPANJ PREPORUKE: SNA&#x017D;NO SE PREPORU&#x010C;UJE.</italic></p>
<p>Kri&#x017E;obolja je bol u donjem dijelu le&#x0111;a, uklju&#x010D;uju&#x0107;i i stra&#x017E;nju regiju zdjelice, ponekad pra&#x0107;ena radikularnom boli lokaliziranom u jednoj ili obje noge (prema dermatomskoj distribuciji). Radna skupina se slo&#x017E;ila oko definicije kri&#x017E;obolje kako ju je predlo&#x017E;ila Europska radna skupina za smjernice za kroni&#x010D;nu bol u donjem dijelu le&#x0111;a. (<xref ref-type="bibr" rid="r12"><italic>12</italic></xref>) Mora se imati na umu da postoje i neke druge definicije kri&#x017E;obolje, npr. Kinkade navodi da je to &#x201E;bol koja se javlja posteriorno u regiji izme&#x0111;u donjeg ruba rebara i proksimalnih bedara&#x201C;. (<xref ref-type="bibr" rid="r13"><italic>13</italic></xref>) Me&#x0111;utim, ta je definicija vrlo sli&#x010D;na onoj naj&#x010D;e&#x0161;&#x0107;e citiranoj iz europskih smjernica pa se u potpunosti podudara s gore navedenom definicijom.</p>
</sec>
<sec sec-type="other3">
<title>Klasifikacija kri&#x017E;obolje</title>
<sec>
<title>Klasifikacija kri&#x017E;obolje prema trajanju</title>
<p>Prema trajanju kri&#x017E;obolja mo&#x017E;e biti: akutna, subakutna i kroni&#x010D;na. Akutna kri&#x017E;obolja je epizoda koja traje manje od &#x0161;est tjedana, subakutna traje izme&#x0111;u &#x0161;est i dvanaest tjedana, a kroni&#x010D;na kri&#x017E;obolja traje dulje od dvanaest tjedana. Dodatni izraz unutar trajanja je &#x201E;probijaju&#x0107;a bol / akutno pogor&#x0161;anje kroni&#x010D;ne kri&#x017E;obolje&#x201C;. <italic>STUPANJ PREPORUKE: SNA&#x017D;NO SE PREPORU&#x010C;UJE.</italic></p>
<p>Kri&#x017E;obolja se mo&#x017E;e klasificirati na nekoliko na&#x010D;ina, a najkorisniji za odabir odgovaraju&#x0107;e strategije daljnje obrade (dijagnostike) i lije&#x010D;enja su oni prema trajanju, uzrocima i riziku kroni&#x010D;nosti.</p>
<p>Iako je op&#x0107;enito prihva&#x0107;ena, kategorizacija kri&#x017E;obolje prema trajanju na akutnu, subakutnu i kroni&#x010D;nu donekle je proizvoljna. Ve&#x0107;ina pacijenata ima putanju boli koja varira u vremenu, s epizodama relapsa i remisije, s pozadinskom/probijaju&#x0107;om boli ili bez nje. (<xref ref-type="bibr" rid="r13"><italic>13</italic></xref>) Prema Van Korffu kri&#x017E;obolja se klasificira na &#x201E;prolaznu&#x201C;, koja traje manje od tri mjeseca u slijedu te se ne ponavlja u periodu od dvanaest mjeseci; &#x201E;ponavljaju&#x0107;u&#x201C; s nastupom od vi&#x0161;e epizoda u manje od polovine dana unutar dvanaest mjeseci; &#x201E;kroni&#x010D;nu&#x201C; koja zahva&#x0107;a barem polovinu dana unutar dvanaest mjeseci u jednoj ili vi&#x0161;e epizoda. Nadalje, &#x201E;akutna kri&#x017E;obolja&#x201C; je brzog i nedavnog nastupa; &#x201E;prva epizoda&#x201C; odnosi se na prvu pojavu kri&#x017E;obolje u &#x017E;ivotu, te naposljetku &#x201E;pogor&#x0161;anje&#x201C; se odnosi na razdoblja kada je kri&#x017E;obolja ja&#x010D;eg intenziteta nego ina&#x010D;e, s ispunjenim kriterijima za ponavljaju&#x0107;u ili kroni&#x010D;nu kri&#x017E;obolju i bolesnik to&#x010D;no zna identificirati po&#x010D;etak nastupa kri&#x017E;obolje koja je ja&#x010D;eg intenziteta. (<xref ref-type="bibr" rid="r14"><italic>14</italic></xref>)</p>
<p>Akutnom kri&#x017E;oboljom se uobi&#x010D;ajeno smatra ona trajanja kra&#x0107;eg od &#x0161;est tjedana. Ona je dobro lokalizirana i ovisi o ja&#x010D;ini podra&#x017E;aja, a naj&#x010D;e&#x0161;&#x0107;e je samoograni&#x010D;avaju&#x0107;a. (<xref ref-type="bibr" rid="r13"><italic>13</italic></xref>) Kako ti bolesnici imaju povoljnu prognozu, akutnoj kri&#x017E;obolji se na&#x010D;elno posve&#x0107;uje manja pozornost. (<xref ref-type="bibr" rid="r15"><italic>15</italic></xref>, <xref ref-type="bibr" rid="r16"><italic>16</italic></xref>) Me&#x0111;utim, podatci iz klini&#x010D;kih studija pra&#x0107;enja pokazuju da oko 2/3 bolesnika do&#x017E;ivi relaps kri&#x017E;obolje u roku od jedne godine nakon ozdravljenja, dok neki podatci ukazuju da &#x0107;e ne&#x0161;to manje od tre&#x0107;ine ljudi koji imaju kri&#x017E;obolju imati barem umjerenu bol jednu godinu nakon akutne epizode. (<xref ref-type="bibr" rid="r17"><italic>17</italic></xref>, <xref ref-type="bibr" rid="r18"><italic>18</italic></xref>) Kako epizode kri&#x017E;obolje imaju tendenciju ponavljanja, radna je skupina tako&#x0111;er raspravljala o kori&#x0161;tenju izraza &#x201E;ponavljaju&#x0107;a kri&#x017E;obolja&#x201C;. Taj je termin uveden u francuskim smjernicama kao kri&#x017E;obolja koja se ponavlja u roku od dvanaest mjeseci, a &#x010D;imbenik je rizika za kronicitet. (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) Me&#x0111;utim, zbog nepostojanja jednoglasnog dogovora o u&#x010D;estalosti takvih epizoda unutar odre&#x0111;enoga vremenskog okvira, trajanju, te&#x017E;ini i razvoju, zaklju&#x010D;eno je da se ovaj pojam ne uvodi u na&#x0161;e preporuke.</p>
<p>Subakutna kri&#x017E;obolja je ona trajanja izme&#x0111;u &#x0161;est i dvanaest tjedana. Neki stru&#x010D;njaci smatraju da u akutnu kri&#x017E;obolju ulazi i cijelo razdoblje od po&#x010D;etka do dvanaest tjedana, me&#x0111;utim, podjela na akutnu i subakutnu kri&#x017E;obolju korisna je jer je potonja va&#x017E;no razdoblje za eventualnu odgovaraju&#x0107;u dodatnu obradu i lije&#x010D;enje, s ciljem neprelaska u kroni&#x010D;nu kri&#x017E;obolju. (<xref ref-type="bibr" rid="r19"><italic>19</italic></xref>) Naime, ako se ne pristupi pravovremenom i pravovaljanom lije&#x010D;enju za neke oblike kri&#x017E;obolje postoji rizik prelaska u kroni&#x010D;nu, pri &#x010D;emu je napose va&#x017E;no ocijeniti rizik za takav prijelaz.</p>
<p>Kroni&#x010D;na kri&#x017E;obolja se naj&#x010D;e&#x0161;&#x0107;e definira kao ona trajanja duljeg od dvanaest tjedana. Definiranje kroni&#x010D;ne kri&#x017E;obolje je dogovorni koncept klasificiranja heterogene populacije sa simptomima kri&#x017E;obolje. U kroni&#x010D;noj kri&#x017E;obolji bol je na&#x010D;elno slabo lokalizirana i slabo korelira s ja&#x010D;inom podra&#x017E;aja. Osim naj&#x010D;e&#x0161;&#x0107;e definicije kroni&#x010D;ne kri&#x017E;obolje postoje i neke druge, kao &#x0161;to je ona Ameri&#x010D;kog dru&#x0161;tva lije&#x010D;nika za intervencijsku bol (<italic>American Society of Interventional Pain Physicians</italic>, ASIPP), gdje je grani&#x010D;no vrijeme za kroni&#x010D;nu kri&#x017E;obolju odre&#x0111;eno na &#x0161;est mjeseci. (<xref ref-type="bibr" rid="r20"><italic>20</italic></xref>)</p>
<p>Podatci iz longitudinalnih studija ukazuju na to da bolesnici s dugotrajnim tegobama mogu razviti epizode boli pra&#x0107;ene razdobljima kontinuirane boli blagog intenziteta s neznatnim utjecajem na aktivnosti, ili pak razdoblja boli ja&#x010D;eg intenziteta s velikim utjecajem na njihove svakodnevne aktivnosti. Takvo pogor&#x0161;anje kri&#x017E;obolje naziva se probijaju&#x0107;om boli ili akutnim pogor&#x0161;anjem kroni&#x010D;ne kri&#x017E;obolje. (<xref ref-type="bibr" rid="r21"><italic>21</italic></xref>) Kroni&#x010D;na kri&#x017E;obolja povezana je s brojnim komorbiditetima, kao &#x0161;to su simptomi depresivnog poreme&#x0107;aja, naru&#x0161;ena kvaliteta sna, osje&#x0107;aj op&#x0107;e slabosti, smanjenje koncentracije, smanjenje ili pove&#x0107;anje apetita i gubitak interesa za spolne aktivnosti. Ona je odgovorna za ve&#x0107;inu tereta glede kvalitete &#x017E;ivota, kao i za vi&#x0161;e od 80% tro&#x0161;kova kri&#x017E;obolje uop&#x0107;e. (<xref ref-type="bibr" rid="r19"><italic>19</italic></xref>)</p>
<p>Osim ranije spomenutih definicija trajanja kri&#x017E;obolje neki autori imaju ne&#x0161;to druga&#x010D;ije klasifikacije, pa smatraju da je akutna kri&#x017E;obolja trajanja kra&#x0107;eg od dva do &#x010D;etiri tjedna, subakutna izme&#x0111;u &#x010D;etiri i dvanaest tjedana, a kroni&#x010D;na trajanja vi&#x0161;e od dvanaest tjedana. (<xref ref-type="bibr" rid="r22"><italic>22</italic></xref>)</p>
<p>O tijeku akutne, subakutne i kroni&#x010D;ne kri&#x017E;obolje ogledan je sistematski pregled i metaanaliza Wallworka i suradnika, koji su na&#x0161;li da je procijenjeni srednji rezultat intenziteta boli na ljestvici 0 &#x2013; 100 za kohortu akutne boli po&#x010D;etno bio 56, nakon &#x0161;est tjedana 26, nakon 26 tjedana 22 i nakon 52 tjedna 21 (dokazi umjerene sigurnosti), za kohortu subakutne boli 63, 29, 29, odnosno 31 (umjereno pouzdani dokazi), a za kohortu s trajnom boli te su vrijednosti 56, 48, 43 i 40 (dokazi vrlo niske sigurnosti). (<xref ref-type="bibr" rid="r23"><italic>23</italic></xref>) U usporedbi s klini&#x010D;kim tijekom boli, klini&#x010D;ki tijek nesposobnosti bio je malo povoljniji. Bolesnici s akutnom i subakutnom kri&#x017E;oboljom imali su zna&#x010D;ajna pobolj&#x0161;anja u razinama boli i nesposobnosti unutar prvih &#x0161;est tjedana (dokazi umjerene sigurnosti), dok su bolesnici s dugotrajnom kri&#x017E;oboljom imali visoku razinu boli i nesposobnosti s minimalnim pobolj&#x0161;anjima tijekom vremena (dokazi s vrlo niskom sigurno&#x0161;&#x0107;u). Stoga bi prepoznavanje i intenziviranje skrbi za osobe sa subakutnom kri&#x017E;oboljom sa sporim oporavkom moglo biti sredi&#x0161;te intervencija s ciljem smanjenja vjerojatnosti prijelaza u kroni&#x010D;nu kri&#x017E;obolju.</p>
</sec>
<sec>
<title>Klasifikacija kri&#x017E;obolje prema uzroku</title>
<p>Prema etiologiji korisna je klasifikacija kri&#x017E;obolje na nespecifi&#x010D;nu i specifi&#x010D;nu (uklju&#x010D;uju&#x0107;i onu povezanu s ozbiljnim stanjima), te kri&#x017E;obolju s radikulopatijom, pri &#x010D;emu se mo&#x017E;e koristiti i pojam &#x201E;lumboishijalgija&#x201C;. <italic>STUPANJ PREPORUKE: SNA&#x017D;NO SE PREPORU&#x010C;UJE.</italic></p>
<p>Prema uzrocima, kri&#x017E;obolja se klasificira na &#x201E;nespecifi&#x010D;nu&#x201C; ili &#x201E;specifi&#x010D;nu&#x201C;. Izraz &#x201E;nespecifi&#x010D;na kri&#x017E;obolja&#x201C; skovan je na temelju studije iz 1966., koja je zaklju&#x010D;ila da se izvor kroni&#x010D;ne kri&#x017E;obolje ne mo&#x017E;e identificirati u 79% mu&#x0161;karaca i 89% &#x017E;ena u okru&#x017E;enju primarne zdravstvene skrbi. (<xref ref-type="bibr" rid="r24"><italic>24</italic></xref>) Iako su se dijagnosti&#x010D;ke mogu&#x0107;nosti da se to&#x010D;no identificiraju uzroci kri&#x017E;obolje u me&#x0111;uvremenu nedvojbeno pobolj&#x0161;ale, utvr&#x0111;ivanje to&#x010D;ne dijagnoze i dalje je izazovno. &#x010C;ak i danas, u klini&#x010D;koj praksi 80&#x2013;90% pacijenata s kri&#x017E;oboljom spada u kategoriju nespecifi&#x010D;ne kri&#x017E;obolje, koja se ne pripisuje poznatoj specifi&#x010D;noj patologiji. (<xref ref-type="bibr" rid="r25"><italic>25</italic></xref>, <xref ref-type="bibr" rid="r26"><italic>26</italic></xref>) Iako se ne mo&#x017E;e pripisati odre&#x0111;enom nociceptivnom uzroku, op&#x0107;enito se vjeruje da se nespecifi&#x010D;na kri&#x017E;obolja temelji na povezanosti s &#x010D;imbenicima biomehani&#x010D;kog i funkcionalnog podrijetla, kao &#x0161;to su mi&#x0161;i&#x0107;i, naprezanje i preoptere&#x0107;enje dinami&#x010D;kog segmenta kralje&#x017E;aka, odnosno zbog postupnog mikroo&#x0161;te&#x0107;enja struktura aksijalnog skeleta uslijed kumulativnog optere&#x0107;enja tijekom toga dugotrajnog procesa. (<xref ref-type="bibr" rid="r27"><italic>27</italic></xref>) &#x0160;tovi&#x0161;e, termin mehani&#x010D;ka kri&#x017E;obolja nerijetko se upotrebljava kao sinonim za nespecifi&#x010D;nu kri&#x017E;obolju. (<xref ref-type="bibr" rid="r28"><italic>28</italic></xref>) Iako strukture kao &#x0161;to su mi&#x0161;i&#x0107;i, fasetni zglobovi ili intervertebralni (skr. i. v.) diskovi (ili njihova kombinacija) mogu uzrokovati bol, nije jednostavno identificirati konkretno ishodi&#x0161;te uzimanjem anamneze i fizikalnim pregledom. (<xref ref-type="bibr" rid="r29"><italic>29</italic></xref>) Osim toga, poznato je da osim strukturalnih lezija kralje&#x017E;nice (npr. degeneracija i. v. diska), i &#x010D;imbenici &#x017E;iv&#x010D;anog sustava (dijagnosticirani npr. kvantitativnim senzornim testovima, strukturnim i funkcionalnim mjerama), te posebno psihosocijalni &#x010D;imbenici (npr. depresija) doprinose nespecifi&#x010D;noj kri&#x017E;obolji. (<xref ref-type="bibr" rid="r30"><italic>30</italic></xref>) Ti me&#x0111;uodnosi ovise o tome je li bol akutna ili kroni&#x010D;na, a potonja je vi&#x0161;e povezana s psiholo&#x0161;kim &#x010D;imbenicima.</p>
<p>Tako&#x0111;er, termin &#x201E;nespecifi&#x010D;an&#x201C; je pomalo zbunjuju&#x0107;i prvenstveno za bolesnike, jer oni obi&#x010D;no vjeruju da ako uzrok nije to&#x010D;no identificiran, njihove mogu&#x0107;nosti lije&#x010D;enja i prognoza tako&#x0111;er nisu poznate. (<xref ref-type="bibr" rid="r31"><italic>31</italic></xref>) Stoga neke smjernice, uklju&#x010D;uju&#x0107;i francuske, preferiraju izraz &#x201E;uobi&#x010D;ajena&#x201C; kri&#x017E;obolja umjesto &#x201E;nespecifi&#x010D;na&#x201C; kri&#x017E;obolja. Uobi&#x010D;ajena kri&#x017E;obolja definirana je kao ona bez znakova upozorenja na ozbiljne uzroke, tzv. &#x201E;crvene zastave&#x201C;. (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>)</p>
<p>Unato&#x010D; ovim dvojbama, radna skupina je smatrala da je u slu&#x010D;aju kada se ne mo&#x017E;e odrediti to&#x010D;an uzrok kri&#x017E;obolje preferirani termin &#x201E;nespecifi&#x010D;an&#x201C;, kao onaj koji je op&#x0107;enito prihva&#x0107;en, s potrebom da se bolesnicima bolje objasni priroda i relativna bezopasnost njihovog stanja.</p>
<p>Kri&#x017E;obolja se smatra &#x201E;specifi&#x010D;nom&#x201C; kad postoji jasan poznat razlog koji se mo&#x017E;e povezati sa znakovima i simptomima bolesti. To je obi&#x010D;no povezano s degenerativnim promjenama intervertebralnog diska, fasetnih zglobova i ligamentarnim promjenama koje se mogu identificirati. Me&#x0111;utim, u nekim slu&#x010D;ajevima u svakodnevnoj klini&#x010D;koj praksi te&#x0161;ko je odrediti jesu li oni izvori&#x0161;te boli. Na primjer, za razliku od osteoartritisa perifernih zglobova, ne postoje dijagnosti&#x010D;ki kriteriji za osteoartritis malih zglobova kralje&#x017E;nice i potrebne su dodatne pretrage za postavljanje dijagnoze i lije&#x010D;enje. (<xref ref-type="bibr" rid="r29"><italic>29</italic></xref>) Specifi&#x010D;na kri&#x017E;obolja pra&#x0107;ena radikularnom simptomatologijom zbog zahva&#x0107;enosti korijena &#x017E;ivca ima ve&#x0107;u prevalenciju (5&#x2013;10%) od ostalih poznatih uzroka kri&#x017E;obolje. Dva naj&#x010D;e&#x0161;&#x0107;a takva uzroka kri&#x017E;obolje jesu hernijacija i. v. diska i spinalna stenoza. (<xref ref-type="bibr" rid="r32"><italic>32</italic></xref>) Kri&#x017E;obolja mo&#x017E;e uklju&#x010D;ivati bol koja se &#x0161;iri du&#x017E; jednog ili vi&#x0161;e dermatoma distribucije &#x017E;ivaca formiranih od spinalnih korijena lumbosakralne regije u jednoj ili obje noge. U ve&#x0107;ini slu&#x010D;ajeva to je uzrokovano kompromitacijom korijenova spinalnih &#x017E;ivaca od L4 do S1. Stanje se obi&#x010D;no naziva <italic>ischialgia</italic> ili i&#x0161;ijas. Ne postoji op&#x0107;eprihva&#x0107;ena nomenklatura za takvo stanje, jer se naziva i radikulopatija, radikulalgija itd. (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) Tako&#x0111;er, naziv mo&#x017E;e ovisiti o tome &#x0161;iri li se bol u le&#x0111;a ili noge iznad ili ispod koljena. Dijagnoza se mo&#x017E;e postaviti klini&#x010D;kim pregledom, no ako stanje potraje, a osobito ako postoji motori&#x010D;ki deficit, potrebna je dodatna obrada kako bi se utvrdilo to&#x010D;no podrijetlo boli. Uzimaju&#x0107;i u obzir na&#x0161;u tradicionalnu nomenklaturu, radna skupina je odabrala i pojam &#x201E;lumboishijalgija&#x201C; sa slikovnom ili neurofiziolo&#x0161;kom potvrdom ili bez nje. Potkategorija nedegenerativne specifi&#x010D;ne kri&#x017E;obolje jest ona s ozbiljnim uzrocima, koji zahtijevaju &#x017E;urnu dijagnosti&#x010D;ku obradu i specifi&#x010D;no lije&#x010D;enje (molim vidjeti dalje).</p>
</sec>
<sec>
<title>Kri&#x017E;obolja s rizikom od kroni&#x010D;nosti</title>
<p>Kategorija &#x201E;kri&#x017E;obolja s rizikom od kroni&#x010D;nosti&#x201C; koristan je termin za ozna&#x010D;avanje kri&#x017E;obolje koja traje kra&#x0107;e od tri mjeseca i s visokim rizikom kroni&#x010D;nosti prema prisutnosti psihosocijalnih &#x010D;imbenika. <italic>STUPANJ PREPORUKE: UVJETNO SE PREPORU&#x010C;UJE.</italic></p>
<p>Negdje u sredini &#x2013; s obzirom na trajanje i etiologiju, kao i prognozu, budu&#x0107;i da je povezana sa svim tim zna&#x010D;ajkama &#x2013; nalazi se &#x201E;kri&#x017E;obolja s rizikom od kroni&#x010D;nosti&#x201C;. Radna skupina se zala&#x017E;e za ovaj termin, jer mo&#x017E;e biti razuman pokazatelj nu&#x017E;nosti ranog intenzivnijeg, eventualno i multidisciplinarnog pristupa, s ciljem sprje&#x010D;avanja razvoja kri&#x017E;obolje u kroni&#x010D;nu fazu. (<xref ref-type="bibr" rid="r18"><italic>18</italic></xref>) Napominjemo da je sli&#x010D;an koncept ve&#x0107; bio prepoznat i predlo&#x017E;en u prvim hrvatskim smjernicama. (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>) Kri&#x017E;obolja s rizikom od kroni&#x010D;nosti definira se s obzirom na trajanje i rizike. To je bol koja traje kra&#x0107;e od tri mjeseca i s visokim je rizikom kroni&#x010D;nosti prema prisutnosti psihosocijalnih &#x010D;imbenika, tzv. &#x201E;&#x017E;utih zastava&#x201C; (molim vidjeti dalje). Ovo je definicija sastavljena iz razli&#x010D;itih izvora, ali u prvom redu temeljena na definiciji francuskih preporuka. (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>)</p>
</sec>
<sec>
<title>&#x010C;imbenici rizika kri&#x017E;obolje</title>
<p>&#x010C;imbenike rizika za kri&#x017E;obolju trebalo bi uzeti u obzir u pogledu dijagnoze i prevencije. <italic>STUPANJ PREPORUKE: UVJETNO SE PREPORU&#x010C;UJE.</italic></p>
<p>Iako svrha ovih smjernica nije detaljno istra&#x017E;iti &#x010D;imbenike rizika, treba imati na umu mogu&#x0107;e &#x010D;imbenike rizika povezane s kri&#x017E;oboljom, u okviru mogu&#x0107;e dijagnosti&#x010D;ke obrade. Tako&#x0111;er, neki od &#x010D;imbenika rizika mogu se mijenjati, &#x0161;to ukazuje na potencijalne koristi za primarnu i sekundarnu prevenciju. &#x0160;to se ti&#x010D;e prve epizode kri&#x017E;obolje, predlo&#x017E;eni su brojni i razli&#x010D;iti &#x010D;imbenici rizika. Me&#x0111;utim, u svom sustavnom pregledu i metaanalizama Taylor i suradnici nisu prona&#x0161;li ni jedan dosljedan &#x010D;imbenik rizika, fizi&#x010D;ki ili psihosocijalni, povezan s prvom epizodom kri&#x017E;obolje, s izuzetkom prethodne epizode kri&#x017E;obolje. (<xref ref-type="bibr" rid="r33"><italic>33</italic></xref>) &#x0160;to se ti&#x010D;e prevencije u ovom kontekstu, neke prethodne studije zaklju&#x010D;ile su da je jedina preventivna intervencija (primarna ili sekundarna) koja se dosljedno pokazala u&#x010D;inkovitom vje&#x017E;banje. (<xref ref-type="bibr" rid="r34"><italic>34</italic></xref>) Me&#x0111;utim, isti autori su doveli u pitanje izvedivost sveobuhvatnog pristupa kao sna&#x017E;nog cilja prevencije kri&#x017E;obolje, jer rezultati njihovog rada sugeriraju da nema razloga za ulaganje zna&#x010D;ajnih resursa u preventivne prakse, ve&#x0107; sugeriraju da je resurse isplativije koristiti za u&#x010D;inkovitu sekundarnu prevenciju. (<xref ref-type="bibr" rid="r33"><italic>33</italic></xref>)</p>
</sec>
<sec>
<title>Anamneza i klini&#x010D;ka slika i inicijalna klasifikacija bolesnika s kri&#x017E;oboljom</title>
<p>Anamneza i klini&#x010D;ka procjena temelj su utvr&#x0111;ivanja po&#x010D;etne dijagnoze i pristupa lije&#x010D;enju bolesnika s kri&#x017E;oboljom. <italic>STUPANJ PREPORUKE: SNA&#x017D;NO SE PREPORU&#x010C;UJE.</italic></p>
<p>Inicijalna razdioba bolesnika s kri&#x017E;oboljom u tri &#x0161;iroke kategorije: nespecifi&#x010D;na kri&#x017E;obolja, radikularni sindromi i specifi&#x010D;na ozbiljna patologija kralje&#x017E;nice koristan je pristup, prije svega u primarnoj zdravstvenoj za&#x0161;titi. <italic>STUPANJ PREPORUKE: UVJETNO SE PREPORU&#x010C;UJE.</italic></p>
<p>Osnovu klini&#x010D;ke dijagnoze kri&#x017E;obolje &#x010D;ine usmjerena anamneza i klini&#x010D;ki pregled, &#x0161;to su dva po&#x010D;etna klju&#x010D;na koraka za odre&#x0111;ivanje pristupa lije&#x010D;enju, dijagnosti&#x010D;ku obradu i upu&#x0107;ivanje lije&#x010D;niku specijalistu. Tijekom uzimanja anamneze i klini&#x010D;kog pregleda lije&#x010D;nik mora posti&#x0107;i dobar odnos s bolesnikom: treba biti pozoran, zainteresiran, shvatiti problem te odrediti sustav bolesnikovih uvjerenja glede kri&#x017E;obolje, utvrditi ili isklju&#x010D;iti uzro&#x010D;no-posljedi&#x010D;nu vezu s potencijalnim uzrokom, a napose onu s radnim mjestom, po mogu&#x0107;nosti utvrditi strukturalnu dijagnozu, a isklju&#x010D;iti ozbiljnu bolest te identificirati zna&#x010D;ajne ekstrinzi&#x010D;ke ili psihosocijalne &#x010D;imbenike. (<xref ref-type="bibr" rid="r12"><italic>12</italic></xref>)</p>
<p>Dijagnosti&#x010D;ka diferencijacija, odnosno trija&#x017E;a kri&#x017E;obolje u primarnoj zdravstvenoj za&#x0161;titi temeljna je to&#x010D;ka za postavljanje dijagnoze. Njezin cilj je isklju&#x010D;iti nespinalne uzroke kri&#x017E;obolje, a ako se radi o prenesenoj boli, na&#x010D;elno, ona se ne&#x0107;e poja&#x010D;avati prilikom optere&#x0107;enja ili pokreta u kralje&#x017E;nici. Nakon toga, s prakti&#x010D;nog gledi&#x0161;ta korisno je podijeliti bolesnike s kri&#x017E;oboljom u tri kategorije: nespecifi&#x010D;na kri&#x017E;obolja, radikularni sindromi i specifi&#x010D;na spinalna patologija s ozbiljnom patologijom, tzv. &#x201E;crvene zastave&#x201C; (molimo vidjeti dalje). (<xref ref-type="bibr" rid="r26"><italic>26</italic></xref>) Sukladno tomu, s prakti&#x010D;nog gledi&#x0161;ta, nespecifi&#x010D;na kri&#x017E;obolja pretpostavljala bi isklju&#x010D;ivanje zahva&#x0107;enosti korijena &#x017E;ivca ili specifi&#x010D;ne ozbiljne patologije.</p>
<p>S obzirom na anamnezu i klini&#x010D;ki pregled neki od parametara koje treba uzeti u obzir jesu: prethodne bolesti i stanja, obiteljska anamneza, na&#x010D;in nastanka boli, mogu&#x0107;i neposredni &#x010D;imbenici rizika i uzroci, vrijeme boli ili njezinog poja&#x010D;anja, karakter boli, lokalizacija boli, &#x0161;irenje boli, trajanje boli, pote&#x0161;ko&#x0107;e s mokrenjem i/ili defekacijom, smanjenje ili gubitak osjeta, slabost mi&#x0161;i&#x0107;a, dr&#x017E;anje, krivulje kralje&#x017E;nice, palpacija i perkusija kralje&#x017E;nice i paraspinalne regije, ispitivanje opsega pokreta, specifi&#x010D;ni klini&#x010D;ki testovi i klini&#x010D;ko testiranje osjeta i mi&#x0161;i&#x0107;a. Neki od primjera specifi&#x010D;nih obilje&#x017E;ja anamnesti&#x010D;kih podataka koji mogu pomo&#x0107;i u otkrivanju uzroka kri&#x017E;obolje jesu le&#x017E;anje mirno, odnosno izbjegavanje provociraju&#x0107;ih pokreta u bolesnika s kri&#x017E;oboljom, uvjetno re&#x010D;eno mehani&#x010D;kih uzroka. S druge strane, bolesnici s upalnom kri&#x017E;oboljom preferiraju razgibavanje, jer se time bol smanjuje, dok se mirovanjem ona pogor&#x0161;ava. Bolesnici s vaskularnim ili visceralnim uzrocima kri&#x017E;obolje &#x010D;esto se previjaju od bolova i ne mogu na&#x0107;i ugodan polo&#x017E;aj. Nadalje, osobitosti mehani&#x010D;ke kri&#x017E;obolje, diskogene i vertebrogene jesu: poja&#x010D;anje boli prilikom stati&#x010D;kog optere&#x0107;enja (npr. sjedenje), pokreta (npr. pretklon u trupu, rotacija), no&#x0161;enja tereta ispred trupa ili rad s podignutim rukama i udaljenima od tijela (npr. usisavanje) i/ili du&#x017E;eg stajanja, dok se smanjuje kad vi&#x0161;eusmjerene sile uravnote&#x017E;uju kralje&#x017E;nicu (npr. hodanje), napose kod hoda niz strminu. Poja&#x010D;anje bolova kod napinjanja (npr. ka&#x0161;ljanje, kihanje, defekacija) karakteristi&#x010D;no je za diskogenu bol, ali ne i za bol s izvori&#x0161;tem iz zigoapofizealnih zglobova. (<xref ref-type="bibr" rid="r35"><italic>35</italic></xref>, <xref ref-type="bibr" rid="r36"><italic>36</italic></xref>) Budu&#x0107;i da se bolna artropatija fasetnog zgloba mo&#x017E;e pojaviti sli&#x010D;no osteoartritisu na drugim mjestima na tijelu, bolesnici imaju smanjenu pokretljivost, uko&#x010D;enost donjeg dijela le&#x0111;a (osobito ujutro, trajanja kra&#x0107;eg od od 30 minuta) i mehani&#x010D;ku bol koja je ja&#x010D;a s aktivno&#x0161;&#x0107;u i ponavljaju&#x0107;im pokretima slabinske kralje&#x017E;nice. (<xref ref-type="bibr" rid="r37"><italic>37</italic></xref>) Kod sindroma lumbalnoga fasetnog zgloba bol u donjem dijelu le&#x0111;a mo&#x017E;e iradirati prema gluteusima, bo&#x010D;nim stranama bedara ili u prepone, ali se tipi&#x010D;no ne prote&#x017E;e ni&#x017E;e od koljena. (<xref ref-type="bibr" rid="r38"><italic>38</italic></xref>) Radikularna bol mo&#x017E;e biti pra&#x0107;ena trncima, utrnulo&#x0161;&#x0107;u, ispadima osjeta ili motori&#x010D;ke funkcije u odre&#x0111;enom dermatomskom i/ili miotomskom podru&#x010D;ju &#x017E;ivca, a posljedica je kompresije &#x017E;ivca naj&#x010D;e&#x0161;&#x0107;e u lateralnom recesusu ili neuralnom foramenu. Nalaz mi&#x0161;i&#x0107;ne slabosti u nogama mo&#x017E;e pomo&#x0107;i u lokalizaciji mjesta neurolo&#x0161;ke disfunkcije. Zna&#x010D;ajna jednostrana slabost mi&#x0161;i&#x0107;a natkoljenice i potkoljenice ukazuje na zahva&#x0107;enost vi&#x0161;e &#x017E;iv&#x010D;anih korjenova, a dok je o&#x0161;te&#x0107;enje perifernih &#x017E;ivaca, koje tako&#x0111;er mo&#x017E;e biti uzrok takve slabosti, u praksi relativno rijetko. &#x201E;Sedlasta&#x201C; anestezija, bol u nogama, slabost mi&#x0161;i&#x0107;a, a kod duljeg trajanja i njihova atrofija, ponekad pra&#x0107;ena ote&#x017E;anim ili nemogu&#x0107;im izmokravanjem i pra&#x017E;njenjem crijeva ili zadr&#x017E;avanjem mokra&#x0107;e i/ili stolice, upu&#x0107;uje na sindrom kaude ekvine, &#x0161;to zahtijeva promptnu obradu i intervenciju. (<xref ref-type="bibr" rid="r39"><italic>39</italic></xref>-<xref ref-type="bibr" rid="r41"><italic>41</italic></xref>) Radna skupina obratila je posebnu pozornost na neke elemente fizikalnog pregleda koji bi mogli ukazivati na zahva&#x0107;enost korijena &#x017E;ivca, &#x0161;to rezultira simptomima povezanima s lumboishijalgijom. U tom pogledu jedan od naj&#x010D;e&#x0161;&#x0107;e kori&#x0161;tenih klini&#x010D;kih testova za lumboishijalgiju jest Lasegueov test ili, kako se navodi u literaturi na engleskom jeziku, &#x201E;test ispru&#x017E;ene noge&#x201C; (engl. <italic>straight leg test</italic>, skr. SLT), kad se fleksijom u kuku ispru&#x017E;ene noge izme&#x0111;u 30 i 70 stupnjeva izaziva bol uzdu&#x017E; noge (ispod koljena), zbog pritiska na korjenove &#x010D;etvrtoga lumbalnog, petoga lumbalnog i prvoga sakralnog spinalnog &#x017E;ivca. (<xref ref-type="bibr" rid="r42"><italic>42</italic></xref>) Bol pri fleksiji kuka pod kutem ve&#x0107;im od 70 stupnjeva mo&#x017E;e ukazivati na skra&#x0107;enje i zatezanje tetiva mi&#x0161;i&#x0107;a stra&#x017E;nje strane natkoljenice ili patologiju zglobne &#x010D;ahure ili samog zgloba kuka ili ishodi&#x0161;te u sakroilijakalnim zglobovima, kao i u slu&#x010D;aju ako se bol ne &#x0161;iri ispod koljena. Istra&#x017E;ivanja su pokazala zna&#x010D;ajnu varijabilnost u mogu&#x0107;nostima toga klini&#x010D;kog testa za dijagnosticiranje radikulopatije, s uglavnom relativno visokom osjetljivo&#x0161;&#x0107;u i niskom specifi&#x010D;no&#x0161;&#x0107;u. (<xref ref-type="bibr" rid="r43"><italic>43</italic></xref>, <xref ref-type="bibr" rid="r44"><italic>44</italic></xref>) U svom recentnom sustavnom pregledu s metaanalizom Nee i suradnici pokazali su najmanje dobru podudarnost me&#x0111;u ocjenjiva&#x010D;ima kada je prilikom izvo&#x0111;enja Lasegueov test izazvao bol u donjim ekstremitetima. Tako&#x0111;er, njegova podudarnost bila je barem umjerena kada je testiranje uklju&#x010D;ivalo strukturnu diferencijaciju primjenom modifikacije istodobnom dorzalnom fleksijom gle&#x017E;nja. Ta modifikacija Lasegueovog testa po autoru se naziva i Bragardov test, a njime se smanjuje kut pri kojem je test pozitivan i mo&#x017E;e se koristiti za razlikovanje neuralnih simptoma od onih mi&#x0161;i&#x0107;no-ko&#x0161;tanih. (<xref ref-type="bibr" rid="r45"><italic>45</italic></xref>) Ukri&#x017E;ni Lasegueov test, kad se bol uzdu&#x017E; noge provocira podizanjem kontralateralne noge, ima nisku prevalenciju i posljedi&#x010D;no &#x0161;iroku procjenu podudarnosti. Vrijednosti najmanje uo&#x010D;ljive razlike (engl. <italic>smallest detectable difference</italic>, skr. SDD (<xref ref-type="bibr" rid="r95"><italic>95</italic></xref>)) za razli&#x010D;ite ocjenjiva&#x010D;e prilikom izvo&#x0111;enja Lasegueovog testa koji su mjerili raspon kretnji u tom klini&#x010D;kom testu kretale su se od 13&#x00B0; do 20&#x00B0;. Dakle, pogre&#x0161;ka mjerenja vjerojatno ne dopu&#x0161;ta kori&#x0161;tenje raspona pokreta Lasegueovog testa za pouzdano dono&#x0161;enje klini&#x010D;kih odluka. Osim toga, ne postoji jasna proceduralna definicija i nejasno je primjenjuje li se Lasegueov test iznad 70 stupnjeva. Budu&#x0107;i da niska specifi&#x010D;nost Lasegueovog testa mo&#x017E;e biti povezana s heterogeno&#x0161;&#x0107;u u njegovom tuma&#x010D;enju, Pesonen i suradnici su evaluirali od ranije poznati klini&#x010D;ki test koji uz podizanje ispru&#x017E;ene noge uklju&#x010D;uje dorzifleksiju stopala i njegovu unutarnju rotaciju, te su ga nazvali pro&#x0161;ireni SLR (engl. skr. ESLR) za dijagnosticiranje lumboishijalgije. Ova modifikacija ima prednost, jer mo&#x017E;e pomicati &#x017E;ivce bez pomicanja mi&#x0161;i&#x0107;no-ko&#x0161;tanih struktura na mjestu gdje su simptomi izazvani. Autori su zaklju&#x010D;ili da je takva varijanta dodatkom strukturne diferencijacije specifi&#x010D;ne za lokaciju pouzdan i ponovljiv alat u razlikovanju neuralnih simptoma od mi&#x0161;i&#x0107;no-ko&#x0161;tanih u bolesnika s radijantnom boli u donjem dijelu le&#x0111;a. (<xref ref-type="bibr" rid="r46"><italic>46</italic></xref>)</p>
<p>Op&#x0107;enito, klini&#x010D;ki testovi su pouzdaniji u akutnim nego u kroni&#x010D;nim stanjima. Jedan od razloga mogao bi biti taj &#x0161;to kod kroni&#x010D;ne nespecifi&#x010D;ne kri&#x017E;obolje bolesnici pokazuju odre&#x0111;enu varijabilnost pokreta. Me&#x0111;utim, ove varijabilnosti nisu dosljedne kroz studije i stoga nemaju dovoljno osjetljivosti i specifi&#x010D;nosti da bi se pouzdano koristile u klini&#x010D;koj praksi. (<xref ref-type="bibr" rid="r47"><italic>47</italic></xref>)</p>
<p>Naj&#x010D;e&#x0161;&#x0107;i muskuloskeletni uzrok koji se prezentira kri&#x017E;oboljom, a ne proizlazi iz promjena u podru&#x010D;ju kralje&#x017E;nice, jest bol iz podru&#x010D;ja kuka i iz sakroilijakalnih zglobova. Bol u kuku je naj&#x010D;e&#x0161;&#x0107;e posljedica osteoartritisa. Kako kuk inerviraju ogranci triju velikih &#x017E;ivaca, n. ishijadikusa, n. femoralisa i n. obturatoriusa, njegova afekcija se, osim boli u preponi, koja je najkarakteristi&#x010D;nija, mo&#x017E;e manifestirati posteriornom boli, odnosno kri&#x017E;oboljom i boli u natkoljenici i to prednjom medijalnom stranom, do razine koljena. Bol s izvori&#x0161;tem iz kuka naj&#x010D;e&#x0161;&#x0107;e je posljedica osteoartritisa, obi&#x010D;no ima postupni tijek, a naj&#x010D;e&#x0161;&#x0107;e zapo&#x010D;inje kod dugotrajnog sjedenja ili du&#x017E;eg hodanja, a karakterizirana je antalgi&#x010D;nim hodom te ograni&#x010D;enim i bolnim kretnjama, najprije unutarnjom rotacijom. (<xref ref-type="bibr" rid="r48"><italic>48</italic></xref>) Bol iz sakroilijakalnih zglobova u mla&#x0111;ih je osoba &#x010D;e&#x0161;&#x0107;e upalne geneze (npr. aksijalni spondiloartritis), a u starijih osoba degenerativne geneze. Za prepoznavanje tog sijela kri&#x017E;obolje u praksi korisni su anamnesti&#x010D;ki podatci o postupnom tijeku kri&#x017E;obolje, kri&#x017E;obolje koja se pogor&#x0161;ava mirovanjem, a pobolj&#x0161;ava razgibavanjem, &#x010D;esto budi bolesnika no&#x0107;u i pra&#x0107;ena je produ&#x017E;enom jutarnjom zako&#x010D;eno&#x0161;&#x0107;u. (<xref ref-type="bibr" rid="r49"><italic>49</italic></xref>, <xref ref-type="bibr" rid="r50"><italic>50</italic></xref>) Sakroilijakalni zglobovi imaju inervaciju koja rezultira nespecifi&#x010D;nijim simptomima, a u klini&#x010D;kom pregledu koriste se brojni testovi, op&#x0107;enito, s niskom specifi&#x010D;no&#x0161;&#x0107;u. Telli i suradnici su evaluirali valjanost i pouzdanost nekoliko provokacijskih testova, a me&#x0111;u njima je onaj vanjske rotacije fleksije s abdukcijom (engl. skr. FABER) imao najve&#x0107;u osjetljivost (91,4%), s tim da je kod pregleda istog klini&#x010D;ara u dva razli&#x010D;ita vremena taj test pokazao dobro slaganje s kappa koeficijentom (0,78) i koeficijentom PABAK (0,92). (<xref ref-type="bibr" rid="r51"><italic>51</italic></xref>) Glede broja pozitivnih klini&#x010D;kih testova njihovo pove&#x0107;anje ne pobolj&#x0161;ava bitno dijagnosti&#x010D;ku snagu, a najbolji omjer vjerojatnosti bio je 1,26 za &#x2265;5 pozitivnih testova, s tim da pove&#x0107;anje broja testova ne povisuje vjerojatnost za suprotno. (<xref ref-type="bibr" rid="r52"><italic>52</italic></xref>) Sustavni pregled i metaanaliza procijenili su grupiranje testova vi&#x0161;estruke provokacije boli s jednom ili dvostrukom intraartikularnom injekcijom anestetika u sakroilijakalne zglobove kao referentnim standardom. Autori su zaklju&#x010D;ili da pozitivna skupina provokacijskih klini&#x010D;kih testova mo&#x017E;e klini&#x010D;aru dati 35% sigurnosti u identificiranju boli s izvori&#x0161;tem iz sakroilijakalnog zgloba. Klini&#x010D;ka korisnost samoga fizikalnog pregleda mo&#x017E;e biti relevantnija za isklju&#x010D;ivanje boli iz sakroilijakalnog zgloba, budu&#x0107;i da se uz njihov negativan nalaz mo&#x017E;e zaklju&#x010D;iti s 92-postotnom sigurno&#x0161;&#x0107;u da je negativan rezultat klini&#x010D;kog testiranja to&#x010D;an. (<xref ref-type="bibr" rid="r53"><italic>53</italic></xref>)</p>
</sec>
<sec>
<title>Ozbiljna patologija kao uzrok kri&#x017E;obolje</title>
<p>Procjena u akutnoj i subakutnoj fazi kri&#x017E;obolje treba uklju&#x010D;ivati znakove upozorenja ozbiljne patologije. <italic>STUPANJ PREPORUKE: SNA&#x017D;NO SE PREPORU&#x010C;UJE.</italic></p>
<p>Razli&#x010D;iti znakovi upozorenja koji upu&#x0107;uju na ozbiljnu patologiju mogu se prona&#x0107;i u procjeni pacijenata s bolovima u kri&#x017E;ima. To su tzv. &#x201E;crvene zastave&#x201C;, koje zahtijevaju hitno i/ili specifi&#x010D;no upravljanje stanjem. (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) Neke &#x201E;crvene zastave&#x201C; trebale bi potaknuti promptno upu&#x0107;ivanje stru&#x010D;njaku, dijagnosti&#x010D;ku obradu i agresivno lije&#x010D;enje, dok su druge manje zabrinjavaju&#x0107;e. Treba ih tra&#x017E;iti posebno kod bilo kakve nedavne kri&#x017E;obolje, kod pogor&#x0161;anja simptoma ili u slu&#x010D;aju pojave novih simptoma. Ozbiljne &#x201E;crvene zastave&#x201C; uklju&#x010D;uju (ali nisu ograni&#x010D;ene na): bol progresivnog pogor&#x0161;anja, bol u mirovanju i osobito tijekom no&#x0107;i, velike, ekstenzivne i/ili progresivne neurolo&#x0161;ke simptome (nedostatak kontrole mjehura ili analnog sfinktera, motori&#x010D;ko o&#x0161;te&#x0107;enje u nogama, sindrom kaude ekvine), traumu (velika trauma i manji pad ili dizanje te&#x0161;kog tereta u bolesnika s osteoporozom ili mogu&#x0107;om osteoporozom), zna&#x010D;ajna strukturalna deformacija kralje&#x017E;nice, povijest maligne bolesti (osobito metastatske u kostima), vru&#x0107;icu, neobja&#x0161;njiv gubitak na tjelesnoj te&#x017E;ini, promjene op&#x0107;eg stanja, sumnju na infekciju kralje&#x017E;nice, intravensku uporabu droga, produljenu uporabu glukokortikoida te dob po&#x010D;etka bolesti manju od 20 godina ili vi&#x0161;e od 55 godina. (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>, <xref ref-type="bibr" rid="r54"><italic>54</italic></xref>) U sveobuhvatnom pregledu 16 preporuka za kri&#x017E;obolju naj&#x010D;e&#x0161;&#x0107;e spominjane patologije za koje &#x201E;crvene zastave&#x201C; mogu biti indikativne uklju&#x010D;uju: maligne bolesti, prijelome, infekcije i sindrom <italic>caude equine</italic> (CES), uz neke druge kao &#x0161;to su ankilozantni spondilitis, aneurizma i mijelopatija. (<xref ref-type="bibr" rid="r55"><italic>55</italic></xref>) Jo&#x0161; uvijek nije jasno kako bi se &#x201E;crvene zastave&#x201C; trebale primijeniti u praksi, jer njihovo razmatranje kao izoliranih znakova upozorenja ima ograni&#x010D;enu specifi&#x010D;nost. (<xref ref-type="bibr" rid="r56"><italic>56</italic></xref>) S druge strane, kombinacija znakova upozorenja trebala bi privu&#x0107;i pozornost i dovesti do sumnje na patologiju koja zahtijeva daljnju specifi&#x010D;nu dijagnostiku i lije&#x010D;enje, &#x0161;to potvr&#x0111;uju i poneki primjeri za pojedina patolo&#x0161;ka stanja. (<xref ref-type="bibr" rid="r57"><italic>57</italic></xref>-<xref ref-type="bibr" rid="r59"><italic>59</italic></xref>)</p>
<p>Moramo imati na umu da je prevalencija ozbiljne spinalne patologije ve&#x0107;a na hitnom prijmu nego u primarnoj zdravstvenoj za&#x0161;titi. U analizi 22 studije (prospektivne i retrospektivne) s ukupno 41.320 bolesnika primljenih na hitni prijam, u prospektivnim studijama prevalencija bilo koje ozbiljne patologije kralje&#x017E;nice koja zahtijeva trenutno ili hitno lije&#x010D;enje bila je 2,5&#x2013;5,1%, a u retrospektivnim studijama 0,7&#x2013;7,4%. (<xref ref-type="bibr" rid="r60"><italic>60</italic></xref>)</p>
</sec>
<sec>
<title>Algoritam dijagnosti&#x010D;ke trija&#x017E;e bolesnika s kri&#x017E;oboljom</title>
<p>Uzimaju&#x0107;i u obzir sve navedeno radna skupina je raspravljala i predlo&#x017E;ila dijagnosti&#x010D;ku trija&#x017E;u kri&#x017E;obolje uklju&#x010D;uju&#x0107;i ishijalgiju, kako je prikazano na <xref ref-type="fig" rid="f2">Figure 2</xref>. Namijenjena je prvenstveno primjeni u primarnoj zdravstvenoj za&#x0161;titi, ali se mo&#x017E;e koristiti i u sekundarnoj i tercijarnoj zdravstvenoj za&#x0161;titi.</p>
<fig id="f2" position="float" fig-type="figure"><label>Figure 2</label><caption><p>Basic classification diagnostic triage algorithm for patients with low back pain</p></caption><graphic xlink:href="LV-147-317-f2"></graphic></fig>
</sec>
<sec>
<title>Procjena rizika od kroni&#x010D;nosti kri&#x017E;obolje</title>
<p>U akutnoj i subakutnoj fazi kri&#x017E;obolje preporu&#x010D;uje se procijeniti bolesnike na rizik od kroni&#x010D;nosti, &#x0161;to uklju&#x010D;uje somatske i psihosocijalne komponente. <italic>STUPANJ PREPORUKE: UVJETNO SE PREPORU&#x010C;UJE.</italic></p>
<p>U akutnoj, a posebno u subakutnoj fazi kri&#x017E;obolje (trajanje do dvanaest tjedana) va&#x017E;no je identificirati &#x010D;imbenike rizika za kroni&#x010D;nost i predlo&#x017E;iti odgovaraju&#x0107;u terapiju prema stupnju rizika, odnosno slo&#x017E;eniju i intenzivniju terapiju, uklju&#x010D;uju&#x0107;i i multidisciplinarno lije&#x010D;enje za bolesnike s povi&#x0161;enim rizikom za kroni&#x010D;nost.</p>
<p>Mora se imati na umu da su rezultati pregleda glede &#x010D;imbenika rizika za kroni&#x010D;nost pokazali znatnu raznolikost. U sustavnom pregledu Nieminena i suradnici identificirali su nekoliko prognosti&#x010D;kih &#x010D;imbenika za kroni&#x010D;nost kri&#x017E;obolje, s biomehani&#x010D;kog, psiholo&#x0161;kog i psihosocijalnog gledi&#x0161;ta. (<xref ref-type="bibr" rid="r61"><italic>61</italic></xref>) Naj&#x010D;e&#x0161;&#x0107;i rizi&#x010D;ni &#x010D;imbenici u tom smislu bili su: vi&#x0161;i intenzitet boli, ve&#x0107;a tjelesna te&#x017E;ina, no&#x0161;enje te&#x0161;kih tereta na radnom mjestu, nefiziolo&#x0161;ki polo&#x017E;aji pri obavljanju posla i depresija. Tako&#x0111;er, neprilago&#x0111;ene strategije pona&#x0161;anja, anksioznost, funkcionalna ograni&#x010D;enja tijekom epizode kri&#x017E;obolje, pu&#x0161;enje, a posebno te&#x017E;i fizi&#x010D;ki rad bili su jasni &#x010D;imbenici rizika za kroni&#x010D;nost. (<xref ref-type="bibr" rid="r61"><italic>61</italic></xref>) U drugom sustavnom pregledu promjenjivih prognosti&#x010D;kih &#x010D;imbenika povezanih s na&#x010D;inom &#x017E;ivota i &#x010D;imbenicima rizika za kroni&#x010D;nu kri&#x017E;obolju na&#x0111;ena je umjerena povezanost s prekomjernom tjelesnom te&#x017E;inom i opsegom struka i bokova, dok su dokazi bili proturje&#x010D;ni za visok indeks tjelesne mase (engl. <italic>body mass index</italic>, skr BMI), pu&#x0161;enje i tjelesnu aktivnost. (<xref ref-type="bibr" rid="r62"><italic>62</italic></xref>) U vezi budu&#x0107;ih ishoda u tzv. krovnom (engl. <italic>umbrella</italic>) pregledu, Mansell i suradnici prona&#x0161;li su sedam &#x010D;imbenika rizika koji imaju umjerenu pouzdanost u pogledu postojanosti: nesposobnost/ograni&#x010D;enje tjelesne aktivnosti, mentalno zdravlje, intenzitet boli, ozbiljnost boli, suo&#x010D;avanje; o&#x010D;ekivanje ishoda/oporavka i izbjegavanje straha. (<xref ref-type="bibr" rid="r63"><italic>63</italic></xref>) Glede istra&#x017E;ivanja bolesnika s kri&#x017E;oboljom u primarnoj zdravstvenoj za&#x0161;titi, studija Cruza i suradnika pokazala je da su prognosti&#x010D;ki pokazatelji lo&#x0161;ijih ishoda, kao &#x0161;to su nesposobnost, bol i op&#x0107;a percepcija tjelesne promjene ili bolesti, nakon uskla&#x0111;ivanja za demografske i klini&#x010D;ke karakteristike bili: epizoda kri&#x017E;obolje dulja od dvanaest tjedana i maladaptivni psihosocijalni &#x010D;imbenici, dok zaposlenost smanjuje &#x0161;anse za lo&#x0161;e ishode nesposobnosti. (<xref ref-type="bibr" rid="r64"><italic>64</italic></xref>) Dakle, autori su izdvojili psihosocijalne &#x010D;imbenike i nezaposlenost kao one koji zna&#x010D;ajno povisuju rizik od lo&#x0161;ijih ishoda, te bi trebalo staviti naglasak na njihovu &#x0161;to raniju identifikaciju i lije&#x010D;enje, s ciljem sprje&#x010D;avanja prijelaza u kroni&#x010D;nu i onesposobljavaju&#x0107;u kri&#x017E;obolju. Kad se govori o zaposlenim osobama u longitudinalnoj njema&#x010D;koj studiji 1.208 osoba s jakom kri&#x017E;oboljom, 48% je stagniralo na toj razini boli nakon dvije godine. Prediktori uporne i jake boli u le&#x0111;ima bili su: starija dob, lo&#x0161;ije op&#x0107;e zdravstveno stanje, vi&#x0161;e dodatnih stanja koja onesposobljavaju, vi&#x0161;e depresivnih simptoma, teret skrbi, manja samou&#x010D;inkovitost povezana s boli i vi&#x0161;e uvjerenja o izbjegavanju straha. (<xref ref-type="bibr" rid="r65"><italic>65</italic></xref>)</p>
<p>U akutnoj, a posebno subakutnoj fazi kri&#x017E;obolje me&#x0111;u razli&#x010D;itim prognosti&#x010D;kim &#x010D;imbenicima za prijelaz u kroni&#x010D;nu fazu posebnu pozornost treba posvetiti psihosocijalnim &#x010D;imbenicima rizika (tzv. &#x201E;&#x017E;ute zastave&#x201C;). U tom smislu radna skupina preporu&#x010D;uje kori&#x0161;tenje upitnika STarT Back i upitnika &#x00D6;rebro. <italic>STUPANJ PREPORUKE: UVJETNO SE PREPORU&#x010C;UJE.</italic></p>
<p>Istra&#x017E;ivanja pokazuju da su me&#x0111;u &#x010D;imbenicima rizika za prijelaz iz akutne u kroni&#x010D;nu kri&#x017E;obolju najva&#x017E;nije &#x201E;&#x017E;ute zastave&#x201C;. (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) One uklju&#x010D;uju, ali nisu ograni&#x010D;ene na sljede&#x0107;e psihosocijalne zna&#x010D;ajke: depresiju, anksioznost, stres, sklonost depresivnom raspolo&#x017E;enju i povla&#x010D;enju iz dru&#x0161;tvenih aktivnosti, alternativne stavove i predod&#x017E;be da je bol opasna ili da bi mogla dovesti do te&#x0161;kog invaliditeta, pasivan stav da su rje&#x0161;enja postavljena u lije&#x010D;enju, a ne aktivno osobno sudjelovanje, izbjegavanje ili smanjenje aktivnosti koje su u nesrazmjeru sa stvarnim somatskim simptomima, probleme povezane s poslom (npr. nezadovoljstvo poslom, podr&#x0161;ka, kontrola, zahtjevi posla), kao i probleme povezane s kompenzacijom (invalidska mirovina itd.). (<xref ref-type="bibr" rid="r66"><italic>66</italic></xref>, <xref ref-type="bibr" rid="r67"><italic>67</italic></xref>)</p>
<p>Publikacije o perspektivama bolesnika i lije&#x010D;nika sugeriraju da osobni &#x010D;imbenici i dru&#x0161;tvene komponente imaju podcijenjenu ulogu u do&#x017E;ivljaju i lije&#x010D;enju kri&#x017E;obolje. (<xref ref-type="bibr" rid="r68"><italic>68</italic></xref>, <xref ref-type="bibr" rid="r69"><italic>69</italic></xref>) Zbog heterogenosti studija smjernice o kri&#x017E;obolji &#x010D;esto ne navode precizne upute o tome kako uklju&#x010D;iti psihosocijalne &#x010D;imbenike u svakodnevnu praksu. (<xref ref-type="bibr" rid="r59"><italic>59</italic></xref>)</p>
<p>Stalni su napori usmjereni na usvajanje standardne metodologije kako bi se pobolj&#x0161;ala mogu&#x0107;nost generalizacije rezultata i implementacija sveobuhvatnog i izvedivog okvira procjene s ciljem olak&#x0161;anja implementacije precizne medicine. Najva&#x017E;niji po&#x010D;etni korak u sklopu toga jest usvajanje sveobuhvatnog i izvedivog okvira za procjenu svih, pa tako i psihosocijalnih &#x010D;imbenika.</p>
<p>Za procjenu psihosocijalnih &#x010D;imbenika rizika kod pacijenata s kri&#x017E;oboljom predlo&#x017E;eno je nekoliko upitnika, kao &#x0161;to su: alat za probir <italic>STarT Back</italic> (engl. <italic>STarT Back screening tool</italic>), upitnik <italic>&#x00D6;rebro</italic> (engl. <italic>&#x00D6;rebro Musculoskeletal Pain Screening Questionnaire,</italic> skr. OMPSQ), upitnik o izbjegavanju straha u kri&#x017E;obolji (engl. <italic>Fear-Avoidance Back Questionnaire</italic>) ili upitnik o bolni&#x010D;koj anksioznosti i depresiji (engl. <italic>Hospital Anxiety and Depression</italic>), pri &#x010D;emu su zadnja dva vi&#x0161;e usmjerena na neka specifi&#x010D;na podru&#x010D;ja ili okru&#x017E;enja. (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) Svi prethodno navedeni upitnici preporu&#x010D;eni su u francuskim smjernicama (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>), dok su alat probira <italic>STarT Back</italic> ili upitnik <italic>&#x00D6;rebro</italic> predlo&#x017E;eni od strane Belgijskoga vertebrolo&#x0161;kog dru&#x0161;tva (<italic>Belgian Spine Society</italic>), kao i od strane britanskih preporuka NICE-a (<italic>National Institute for Health and Care Excellence</italic>). (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>, <xref ref-type="bibr" rid="r70"><italic>70</italic></xref>)</p>
<p>U recentnom sistematskom pregledu prognosti&#x010D;kih modela za kroni&#x010D;nu kri&#x017E;obolju, a s obzirom na visok rizik od pristranosti i nedostatak vanjske validacije, autori nisu mogli preporu&#x010D;iti ni jedan upitnik za primjenu u primarnoj zdravstvenoj za&#x0161;titi. (<xref ref-type="bibr" rid="r71"><italic>71</italic></xref>)</p>
<p>Dva najvi&#x0161;e prou&#x010D;avana i najva&#x017E;nija upitnika primarno namijenjena probiru u primarnoj zdravstvenoj za&#x0161;titi jesu <italic>STarT Back</italic> i <italic>&#x00D6;rebro</italic>. (<xref ref-type="bibr" rid="r72"><italic>72</italic></xref>) Detalji upitnika <italic>STarT Back</italic> i <italic>&#x00D6;rebro</italic> &#x0161;ire su obja&#x0161;njeni u drugim publikacijama i izvan su okvira ovih smjernica. (<xref ref-type="bibr" rid="r73"><italic>73</italic></xref>, <xref ref-type="bibr" rid="r74"><italic>74</italic></xref>) Op&#x0107;enito je upitnik <italic>STarT Back</italic> brz i jednostavan te je ne&#x0161;to prakti&#x010D;niji za kori&#x0161;tenje u klini&#x010D;koj praksi nego upitnik <italic>&#x00D6;rebro</italic>. <italic>STarT Back</italic> je utemeljen i validiran u okru&#x017E;enju primarne zdravstvene za&#x0161;tite i pokazao je pozitivne rezultate u korist stratificirane skrbi za neke va&#x017E;ne ishode kao &#x0161;to je funkcija. (<xref ref-type="bibr" rid="r72"><italic>72</italic></xref>)</p>
<p>U metaanalizi Bastosa i suradnika, u koju su bile uklju&#x010D;ene 23 studije, pristup klasifikacije temeljene na planiranom lije&#x010D;enju (engl. <italic>treatment based classification,</italic> skr. TBC) &#x010D;ini se korisnim za bolesnike s akutnom kri&#x017E;oboljom, ishijalgijom i spinalnom stenozom (niska sigurnost dokaza za ve&#x0107;inu usporedbi). (<xref ref-type="bibr" rid="r75"><italic>75</italic></xref>) S druge strane, u sistematskom pregledu i metaanalizi Tagliaferrija i suradnika, s uklju&#x010D;ene 24 studije, na&#x0111;ena je niska sigurnost malog u&#x010D;inka na kraju intervencije za intenzitet kri&#x017E;obolje i invalidnost, favoriziraju&#x0107;i klasificirane tretmane u usporedbi s generaliziranim intervencijama, ali ne i za intenzitet boli u nogama. (<xref ref-type="bibr" rid="r76"><italic>76</italic></xref>) Stoga su autori zaklju&#x010D;ili da za intenzitet boli i stupanj nesposobnosti nema dovoljno dokaza koji podupiru upotrebu sustava klasifikacije u odnosu na generalizirane intervencije u lije&#x010D;enju bolesnika s kri&#x017E;oboljom.</p>
<p>Tako&#x0111;er, u recentnom sistematskom pregledu i metaanalizi Chioda i suradnika s pet uklju&#x010D;enih studija bolesnika s kri&#x017E;oboljom trajanja kra&#x0107;eg od tri mjeseca koji su stratificirani prema njihovoj razini rizika za lo&#x0161; funkcionalni ishod i kojima je pru&#x017E;en tretman uskla&#x0111;en s njihovom razinom rizika, na&#x0111;eni su dokazi vrlo niske sigurnosti da uporaba pristupa stratifikacije rizika s odgovaraju&#x0107;im lije&#x010D;enjem mo&#x017E;e dovesti do vrlo malog smanjenja razine boli nakon tri do &#x0161;est mjeseci u usporedbi s uobi&#x010D;ajenom skrbi, dok glede nesposobnosti nije na&#x0111;ena razlika za kori&#x0161;tenje stratifikacije rizika u usporedbi s uobi&#x010D;ajenom skrbi. (<xref ref-type="bibr" rid="r77"><italic>77</italic></xref>)</p>
<p>Tako&#x0111;er, zbog svojih psihometrijskih zna&#x010D;ajki i specifi&#x010D;nog okru&#x017E;enja u kojem lije&#x010D;nici u Hrvatskoj obavljaju svoju praksu, u tom su smislu preferirani klini&#x010D;ki alati &#x2013; upitnik <italic>STarTBack</italic> ili upitnik <italic>&#x00D6;rebro</italic> &#x2013; korisni prije svega u primarnoj zdravstvenoj za&#x0161;titi.</p>
</sec>
</sec>
<sec sec-type="other4">
<title>Dijagnosti&#x010D;ke pretrage</title>
<sec>
<title>Laboratorijske pretrage</title>
<p>Laboratorijske pretrage nisu korisne za procjenu nespecifi&#x010D;ne kri&#x017E;obolje, ali mogu biti korisne u diferencijalnoj dijagnozi. <italic>PREPORUKA: SNA&#x017D;NO SE PREPORU&#x010C;UJE.</italic></p>
<p>U sistematskom pregledu literature Pinta i suradnika pokazana je povi&#x0161;ena razina proupalnih biomarkera CRP, interleukina-6 (IL-6) i faktora nekroze tumora-alfa (TNF-alfa) i smanjena razina protuupalnog biomarkera interleukina-10 (IL-10) u bolesnika s kri&#x017E;oboljom, dok visoko osjetljivi C-reaktivni protein (hs-CRP) nije bio u korelaciji s kri&#x017E;oboljom, te nije na&#x0111;eno dovoljno dokaza koji bi povezali te nalaze sa stupnjem intenziteta boli ili statusom boli tijekom vremena. (<xref ref-type="bibr" rid="r78"><italic>78</italic></xref>) Glede intenziteta boli, drugi je sistematski pregled pokazao da su tri proupalna biljega povezana s intenzitetom boli kod odraslih bolesnika s aksijalnom kri&#x017E;oboljom: CRP, TNF-alfa i IL-6, te da bi mogli poslu&#x017E;iti kao kompozitni biomarkeri za bol, povezane simptome, pa i komorbiditete. (<xref ref-type="bibr" rid="r79"><italic>79</italic></xref>) Iako je u nekim studijama procjenjivana povezanost izme&#x0111;u proupalnih citokina i simptoma depresije, nitko nije istra&#x017E;ivao povezanost proupalnih citokina s umorom, tjeskobom, poreme&#x0107;ajem spavanja ili komorbiditetima (npr. dijabetes, sr&#x010D;ane bolesti ili malignomi). (<xref ref-type="bibr" rid="r79"><italic>79</italic></xref>)</p>
<p>Potrebna su daljnja istra&#x017E;ivanja s ciljem boljeg razumijevanja patogeneze kri&#x017E;obolje u kojima bi se procjenjivala povezanost upalnih parametara, boli, bihevioralnih simptoma i komorbiditeta, &#x0161;to bi potencijalno bilo od pomo&#x0107;i u dijagnostici i u ciljanom lije&#x010D;enju.</p>
<p>U klini&#x010D;koj praksi laboratorijski testovi u velikoj ve&#x0107;ini slu&#x010D;ajeva nisu potrebni u po&#x010D;etnoj procjeni akutne kri&#x017E;obolje. Ako se sumnja na tumor ili infekciju, potrebno je napraviti kompletnu krvnu sliku i sedimentaciju eritrocita/CRP. Dodatni laboratorijski testovi, kao &#x0161;to su testiranje na antigen HLA-B27 (prisutan kod spondiloartritisa), elektroforeza serumskih proteina (za detekciju multiplog mijeloma) ili analiza urina, trebaju biti prilago&#x0111;eni mogu&#x0107;im dijagnozama koje sugeriraju anamneza i fizikalni nalazi. Ostale laboratorijske pretrage ne preporu&#x010D;uju se, osim ako nisu klini&#x010D;ki opravdane.</p>
</sec>
<sec>
<title>Slikovne metode</title>
<p>Kod akutne kri&#x017E;obolje i odsutnosti &#x201E;crvenih zastava&#x201C; postoji indikacija za primjenu slikovnih metoda. <italic>STUPANJ PREPORUKE: SNA&#x017D;NO SE NE PREPORU&#x010C;UJE.</italic></p>
<p>MR ili CT su metode izbora ako se prema klini&#x010D;kom nalazu sumnja na ozbiljnu patologiju u sklopu specifi&#x010D;nih uzroka kri&#x017E;obolje. <italic>STUPANJ PREPORUKE: SNA&#x017D;NO SE PREPORU&#x010C;UJE.</italic></p>
<p>U nedostatku &#x201E;crvenih zastava&#x201C; mo&#x017E;e se razmotriti slikovna dijagnostika u slu&#x010D;aju zna&#x010D;ajne nesposobnosti zbog kroni&#x010D;ne kri&#x017E;obolje (nakon tri mjeseca). <italic>STUPANJ PREPORUKE: SNA&#x017D;NO SE PREPORU&#x010C;UJE.</italic></p>
<p>MR ili CT (ako je MR kontraindicirana) preporu&#x010D;uje se ako se razmatra invazivni/kirur&#x0161;ki zahvat (npr. epiduralna infiltracija ili operacija kralje&#x017E;nice). <italic>STUPANJ PREPORUKE: SNA&#x017D;NO SE PREPORU&#x010C;UJE.</italic></p>
<p>Ponavljanje snimanja ako nema promjene simptoma. <italic>STUPANJ PREPORUKE: SNA&#x017D;NO SE NE PREPORU&#x010C;UJE.</italic></p>
<p>Slikovne metode obi&#x010D;no su dio dijagnosti&#x010D;ke obrade u bolesnika s kri&#x017E;oboljom, iako za veliku ve&#x0107;inu bolesnika nisu korisne. (<xref ref-type="bibr" rid="r80"><italic>80</italic></xref>, <xref ref-type="bibr" rid="r81"><italic>81</italic></xref>) Vrijednost nativnog radiograma vrlo je dvojbena, jer se degenerativne i posturalne promjene &#x010D;esto na&#x0111;u u osoba bez kri&#x017E;obolje, dok slikovni nalazi slabo koreliraju sa simptomima i op&#x0107;enito nisu povezani s budu&#x0107;om kri&#x017E;oboljom. (<xref ref-type="bibr" rid="r82"><italic>82</italic></xref>, <xref ref-type="bibr" rid="r83"><italic>83</italic></xref>) Unato&#x010D; tim &#x010D;injenicama, stope naru&#x010D;ivanja slikovnih pretraga u bolesnika s kri&#x017E;oboljom i dalje su visoke. (<xref ref-type="bibr" rid="r84"><italic>84</italic></xref>) U svom sustavnom pregledu i metaanalizi Downie i suradnici na&#x0161;li su da se zahtjevi za slikovnom dijagnostikom (jednostavnom ili slo&#x017E;enom) za bolesnike s kri&#x017E;oboljom koji posje&#x0107;uju primarnu zdravstvenu za&#x0161;titu pove&#x0107;avaju, kao i za one na odjelu hitne medicinske skrbi, &#x0161;to je utvr&#x0111;eno u vremenskom okviru od 21 godine. (<xref ref-type="bibr" rid="r85"><italic>85</italic></xref>) Sustavni pregled Lemmersa i suradnika pokazao je da primjena slikovnih dijagnosti&#x010D;kih metoda u kri&#x017E;obolji mo&#x017E;e biti povezana s vi&#x0161;im medicinskim tro&#x0161;kovima, pove&#x0107;anom upotrebom zdravstvene skrbi i pove&#x0107;anjem izostanka s posla. (<xref ref-type="bibr" rid="r86"><italic>86</italic></xref>) S druge strane, smanjenjem broja primjena magnetske rezonancije (MR) ukupni godi&#x0161;nji tro&#x0161;kovi snimanja povezanih s kri&#x017E;oboljom zna&#x010D;ajno se smanjuju. (<xref ref-type="bibr" rid="r87"><italic>87</italic></xref>) Nejasno je koji su razlozi zbog kojih lije&#x010D;nici obiteljske medicine upu&#x0107;uju bolesnike na slikovnu dijagnostiku. (<xref ref-type="bibr" rid="r88"><italic>88</italic></xref>) To mo&#x017E;e biti zato &#x0161;to se lije&#x010D;nici boje da &#x0107;e propustiti &#x201E;crvenu zastavu&#x201C;, da &#x0107;e biti podvrgnuti sudskom sporu ili zbog financijskih razloga. Tako&#x0111;er, op&#x0107;enito govore&#x0107;i, lije&#x010D;nici &#x010D;esto imaju obrazovanje usmjereno na slikovne metode kao glavne alate koji mogu razrije&#x0161;iti razli&#x010D;ite klini&#x010D;ke nedoumice. Nedostatak komunikacije izme&#x0111;u lije&#x010D;nika i bolesnika, pritisak bolesnika da se uvjere u svoje stanje i mi&#x0161;ljenje da im takvo snimanje na neki na&#x010D;in mo&#x017E;e pomo&#x0107;i u ubla&#x017E;avanju boli i/ili nedostatak komunikacije izme&#x0111;u stru&#x010D;njaka tako&#x0111;er mogu biti razlozi za umno&#x017E;avanje pretraga, ponajvi&#x0161;e onih slikovnih. (<xref ref-type="bibr" rid="r89"><italic>89</italic></xref>, <xref ref-type="bibr" rid="r90"><italic>90</italic></xref>) Recentni pregled 35 klini&#x010D;kih studija dodatno je ukazao na slo&#x017E;ena me&#x0111;udjelovanja izme&#x0111;u klini&#x010D;kih obilje&#x017E;ja, drugih obilje&#x017E;ja bolesnika i klini&#x010D;ara, uvjerenja i okolinskih &#x010D;imbenika koji utje&#x010D;u na dono&#x0161;enje odluka o primjeni slikovnih metoda u bolesnika s kri&#x017E;oboljom. (<xref ref-type="bibr" rid="r91"><italic>91</italic></xref>)</p>
<p>Kada govorimo o korelaciji nalaza MR-a s klini&#x010D;kim obilje&#x017E;jima (prvenstveno vezanima za bol) u bolesnika s kri&#x017E;oboljom jedan je sistematski pregled &#x010D;lanaka pokazao da je rani MR bez &#x201E;crvenih zastava&#x201C; bila povezana s produljenom duljinom nesposobnosti, definiranom kao broj dana nesposobnosti (odsutnost s posla). (<xref ref-type="bibr" rid="r92"><italic>92</italic></xref>) Neki su izvje&#x0161;taji pokazali da postoji korelacija izme&#x0111;u zone visokog intenziteta MR-a lumbalnog diska i degeneracije diska, kao i postojane boli kod diskogene kri&#x017E;obolje. (<xref ref-type="bibr" rid="r93"><italic>93</italic></xref>) Sustavni pregled i metaanaliza Herlina i suradnika nisu identificirali sna&#x017E;nu povezanost izme&#x0111;u promjena na vertebralnoj plo&#x010D;i s nalazom MR-a s kroni&#x010D;nom kri&#x017E;oboljom u bolesnika s nesposobno&#x0161;&#x0107;u, iako postoji potreba za daljnjim istra&#x017E;ivanjem jer je ova studija pokazala zna&#x010D;ajnu heterogenost klini&#x010D;kih ishoda i objavljenih podataka. (<xref ref-type="bibr" rid="r94"><italic>94</italic></xref>) Me&#x0111;utim, ponovnom analizom literature koja se usredoto&#x010D;ila na homogenu populaciju bolesnika zaklju&#x010D;eno je da su dokazi jasniji, sugeriraju&#x0107;i da su Modic-promjene povezane s kroni&#x010D;nom boli i da bi promjene tipa 1 mogle biti povezane s vi&#x0161;im razinom boli od promjena tipa Modic 2. (<xref ref-type="bibr" rid="r95"><italic>95</italic></xref>) Nije jasno kakve bi to moglo imati implikacije u svakodnevnoj klini&#x010D;koj praksi. Naime, ovi nalazi nisu klju&#x010D;ni u postavljanju dijagnoze kri&#x017E;obolje te nemaju upori&#x0161;ta u medicinsko-ekonomskoj isplativosti identificiranja to&#x010D;nih uzroka boli i njihova odgovaraju&#x0107;eg lije&#x010D;enja; nije utvr&#x0111;eno bi li se time potencijalno mogli pobolj&#x0161;ati ishodi, u prvom redu nesposobnost u bolesnika s kri&#x017E;oboljom, te u kona&#x010D;nici smanjiti direktni i indirektni tro&#x0161;kovi. (<xref ref-type="bibr" rid="r96"><italic>96</italic></xref>)</p>
<p>Svi algoritmi, odnosno preporuke i smjernice za dijagnostiku i lije&#x010D;enje kri&#x017E;obolje na&#x010D;elno su protiv upotrebe slikovnih metoda za osobe s kri&#x017E;oboljom, uz neke stru&#x010D;no opravdane iznimke. Naime, nativnu radiografiju nema potrebe koristiti osim ako postoji sumnja na zna&#x010D;ajna o&#x0161;te&#x0107;enja ili strukturne promjene i nestabilnost kralje&#x017E;nice, MR je indiciran za identifikaciju izvora neurolo&#x0161;kih abnormalnosti (npr. hernija i. v. diska, sindrom kaude ekvine) i abnormalnosti mekog tkiva (npr. infekcija), dok je kompjutorizirana tomografija (CT) posebno korisna za ko&#x0161;tane promjene i preporu&#x010D;uje se ako je MR kontraindiciran. Tako&#x0111;er, smjernice nagla&#x0161;avaju da bolesnici trebaju biti odgovaraju&#x0107;e informirani kada su slikovne metode indicirane. (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>, <xref ref-type="bibr" rid="r97"><italic>97</italic></xref>-<xref ref-type="bibr" rid="r99"><italic>99</italic></xref>) Pritom je jedan od klju&#x010D;nih elemenata u obja&#x0161;njenju bolesnicima za&#x0161;to radiografsko snimanje nije potrebno zbog dobrobiti njih samih.</p>
<p>Tako&#x0111;er, nema razloga za ponavljanje snimanja ako nema promjena simptoma, dok se snimanje kralje&#x017E;nice mo&#x017E;e razmotriti u slu&#x010D;aju kroni&#x010D;ne i onesposobljavaju&#x0107;e kri&#x017E;obolje (nakon najmanje tri mjeseca trajanja).</p>
</sec>
<sec>
<title>Elektromiografija</title>
<p>Elektromiografija je indicirana kod akutne kri&#x017E;obolje. <italic>STUPANJ PREPORUKE: SNA&#x017D;NO SE NE PREPORU&#x010C;UJE.</italic></p>
<p>Elektromiografija je korisna u slu&#x010D;aju dugotrajne i izra&#x017E;ene subakutne/kroni&#x010D;ne kri&#x017E;obolje s radikulopatijom u svrhu procjene funkcionalnog statusa perifernoga &#x017E;iv&#x010D;anog sustava. <italic>STUPANJ PREPORUKE: SNA&#x017D;NO SE PREPORU&#x010C;UJE.</italic></p>
<p>Elektromiografija se mo&#x017E;e u&#x010D;initi u slu&#x010D;aju dugotrajne kroni&#x010D;ne kri&#x017E;obolje/radikulopatije bez pobolj&#x0161;anja. <italic>STUPANJ PREPORUKE: UVJETNO SE PREPORU&#x010C;UJE.</italic></p>
<p>Elektromiografija (EMG), elektrodijagnosti&#x010D;ki pregled u pravilu pomo&#x0107;u iglene elektrode, va&#x017E;na je dijagnosti&#x010D;ka metoda za bolesnike s radikulopatijom. EMG daje fiziolo&#x0161;ki dokaz denervacije mi&#x0161;i&#x0107;a koje inervira odre&#x0111;eni &#x017E;iv&#x010D;ani korijen. S EMG-om se rje&#x0161;avaju dijagnosti&#x010D;ke nedoumice bolesnikovih simptoma i znakovi gubitka osjeta i slabosti. Relevantnost EMG-a nogu u subakutnoj/kroni&#x010D;noj radikulopatiji procijenjena je na temelju stru&#x010D;nog mi&#x0161;ljenja &#x010D;lanova radne skupine, u smislu preporuka temeljenih na preglednom radu u dva dijela, jednoj mini-monografiji i jednom visokokvalitetnom znanstvenom radu. (<xref ref-type="bibr" rid="r100"><italic>100</italic></xref>-<xref ref-type="bibr" rid="r103"><italic>103</italic></xref>)</p>
<p>Utvr&#x0111;eno je da gubitak refleksa ili slabost zna&#x010D;ajno pove&#x0107;avaju vjerojatnost potvrde radikulopatije iglenim EMG-om. (<xref ref-type="bibr" rid="r103"><italic>103</italic></xref>) Tako&#x0111;er, potvrdom za postojanje radikulopatije smatra se ako se EMG-om prona&#x0111;u abnormalnosti u dva ili vi&#x0161;e mi&#x0161;i&#x0107;a inerviranih istim korijenom &#x017E;ivca i razli&#x010D;itim perifernim &#x017E;ivcima, dok su mi&#x0161;i&#x0107;i inervirani susjednim korijenima &#x017E;ivaca normalni. (<xref ref-type="bibr" rid="r102"><italic>102</italic></xref>) To pretpostavlja odsutnost drugih stanja, poput polineuropatije. EMG ima skromnu osjetljivost, ali visoku specifi&#x010D;nost u potvr&#x0111;ivanju radikularnog izvora boli, te je komplementaran sa slikovnim metodama dijagnostike kralje&#x017E;nice. (<xref ref-type="bibr" rid="r100"><italic>100</italic></xref>) Me&#x0111;utim, treba imati na umu da kod nekih bolesnika upu&#x0107;enih na EMG anamneza i klini&#x010D;ki pregled ne mogu predvidjeti rezultate pretrage, jer oko 15&#x2013;18% bolesnika bez karakteristi&#x010D;nih simptoma i s urednim klini&#x010D;kim pregledom ima abnormalan nalaz EMG-a. (<xref ref-type="bibr" rid="r103"><italic>103</italic></xref>) Lumbosakralna radikulopatija potvr&#x0111;ena EMG-om povezana je s boljim klini&#x010D;kim ishodima ako su bolesnici podvrgnuti intervencijskom ili kirur&#x0161;kom lije&#x010D;enju, poput epiduralnih injekcija glukokortikoida ili otvorene operacije kralje&#x017E;nice. (<xref ref-type="bibr" rid="r100"><italic>100</italic></xref>)</p>
</sec>
</sec>
<sec sec-type="other5">
<title>Mjere ishoda</title>
<p>Mjere ishoda, a posebno ishodi o kojima izvje&#x0161;tavaju bolesnici, trebaju biti standardna klini&#x010D;ka praksa u lije&#x010D;enju bolesnika s kri&#x017E;oboljom. <italic>STUPANJ PREPORUKE: SNA&#x017D;NO SE PREPORU&#x010C;UJE.</italic></p>
<p>Kod razmatranja mjera ishoda pa&#x017E;nju treba posebno obratiti na njihova svojstva i izvedivost u kontekstu svakodnevne klini&#x010D;ke prakse, vode&#x0107;i ra&#x010D;una npr. o optere&#x0107;enju osoblja i bolesnika, utro&#x0161;enom vremenu i drugome. Naime, razvijeni su mnogobrojni ishodi i koriste se kod bolesnika s kri&#x017E;oboljom, ali je njihova uporaba naj&#x010D;e&#x0161;&#x0107;e ograni&#x010D;ena na klini&#x010D;ke studije.</p>
<p>Prema me&#x0111;unarodnoj klasifikaciji funkcioniranja, nesposobnosti i zdravlja (skr. ICF) sr&#x017E;ne mjere ishoda kri&#x017E;obolje (engl. <italic>core set of outcome measures</italic>) uklju&#x010D;uju: specifi&#x010D;nost funkcije slabinske kralje&#x017E;nice, op&#x0107;e zdravstveno stanje pojedinca, bol, radnu sposobnost i bolesnikovo zadovoljstvo. (<xref ref-type="bibr" rid="r104"><italic>104</italic></xref>)</p>
<p>Radna skupina analizirala je dva reprezentativna sustavna pregleda i preporuke, kao i temeljne izvore u vezi s naj&#x010D;e&#x0161;&#x0107;e kori&#x0161;tenim ishodima kod bolesnika s kri&#x017E;oboljom, s posebnim naglaskom na ishode koje su prijavili bolesnici (engl. <italic>patient&#x2013;reported outcomes, skr. PROs</italic>) za koje vjerujemo da su od najve&#x0107;eg interesa.</p>
<p>U sustavnom pregledu Chapman i suradnici su identificirali, opisali i evaluirali naj&#x010D;e&#x0161;&#x0107;e kori&#x0161;tene mjere ishoda u bolesnika s kroni&#x010D;nom kri&#x017E;oboljom. (<xref ref-type="bibr" rid="r105"><italic>105</italic></xref>) Zaklju&#x010D;ili su da su domene od najve&#x0107;e va&#x017E;nosti: vizualna analogna ljestvica (engl. v<italic>isual analogue scale</italic>, skr. VAS) i numeri&#x010D;ka ljestvica ocjene boli (engl. <italic>numerical rating scale</italic>, skr. NRS) za bol, Oswestryjev indeks invaliditeta (engl. <italic>Oswestry Disability Index,</italic> skr. ODI) i Roland-Morrisov upitnik nesposobnosti (engl. <italic>Roland-Morris Disability Questionnaire</italic>, skr. RMDQ) za funkciju, te <italic>EurQoL-5D</italic> (skr. EQ-5D) i <italic>Short-Form-6D</italic> (skr. SF-6D) za kvalitetu &#x017E;ivota. Dodatne tri domene tako&#x0111;er su odabrane kao &#x010D;esto kori&#x0161;tene i va&#x017E;ne za ishode prou&#x010D;avanja kod bolesnika s degenerativnim bolestima lumbalne kralje&#x017E;nice, a to su: radni status, komplikacije lije&#x010D;enja i lijekovi. Carter Clement i suradnici op&#x0107;enito su slijedili sugestije iz rada Chapmana i suradnika, te su analizirali i predlo&#x017E;ili svoj skup alata kako bi pobolj&#x0161;ali standardizaciju u izvje&#x0161;&#x0107;ivanju o ishodima u lije&#x010D;enju kri&#x017E;obolje. (<xref ref-type="bibr" rid="r106"><italic>106</italic></xref>) Oni su predlo&#x017E;ili sljede&#x0107;e parametre: NRS, ODI, EQ-5D-3L i EQ-VAS, kao i pitanja vezana za radni status i uporabu analgetika.</p>
<sec>
<title>Bol</title>
<p>Vizualna analogna ljestvica (VAS) i numeri&#x010D;ka ljestvica boli (NRS) preporu&#x010D;eni su instrumenti za procjenu intenziteta boli u le&#x0111;ima i, ako je primjenjivo, boli u nozi kod bolesnika s kri&#x017E;oboljom. <italic>PREPORUKA: SNA&#x017D;NO SE PREPORU&#x010C;UJE.</italic></p>
<p>Bol je kardinalno obilje&#x017E;je i njegovo uklanjanje je prioritet za bolesnike s kri&#x017E;oboljom. Kvalitativna studija Boutevillain i suradnika potvrdila je kako bol predstavlja relevantan klini&#x010D;ki simptom koji stvara prepreke u sudjelovanju u aktivnostima kod osoba s kri&#x017E;oboljom. (<xref ref-type="bibr" rid="r107"><italic>107</italic></xref>) Osim toga, bol je po&#x017E;eljno smanjiti i zbog negativnih u&#x010D;inaka periferne i centralne senzitizacije, odnosno njezinog prelaska u kroni&#x010D;no bolno stanje. (<xref ref-type="bibr" rid="r108"><italic>108</italic></xref>)</p>
<p>Procjena boli mo&#x017E;e uklju&#x010D;ivati jednodimenzionalne ili vi&#x0161;edimenzionalne ljestvice, koje mogu biti u obliku samoprocjene ili opservacije. (<xref ref-type="bibr" rid="r109"><italic>109</italic></xref>) Multidimenzionalne ljestvice (npr. <italic>Brief Pain Inventory</italic> ili upitnik boli McGill) uklju&#x010D;uju brojne aspekte boli. Naime, bol ima osjetno-diskriminativnu dimenziju koja uklju&#x010D;uje primanje, prijenos i centralno procesuiranje &#x0161;tetnih podra&#x017E;aja, kognitivno-evaluativnu dimenziju koja se odnosi na percepciju u tijeku i shva&#x0107;anje zna&#x010D;enja onoga &#x0161;to se doga&#x0111;a, te afektivno-motivacijsku dimenziju, &#x0161;to je u biti &#x017E;elja da se izbjegne &#x0161;teta ili posljedice &#x0161;tete. Iako korisni u evaluaciji boli, multidimenzionalni upitnici su zahtjevni ili njihovo ispunjavanje traje dulje pa, op&#x0107;enito, nisu pogodni za prakti&#x010D;ni klini&#x010D;ki rad. (<xref ref-type="bibr" rid="r110"><italic>110</italic></xref>)</p>
<p>Ne postoji zlatni standard u pogledu jednodimenzionalnih alata za mjerenje intenziteta boli, ali naj&#x010D;e&#x0161;&#x0107;i su i dobro validirani vizualna analogna ljestvica (VAS) i numeri&#x010D;ka ljestvica ocjenjivanja (NRS). U sustavnom pregledu ljestvica boli Karcioglua i suradnici analizirali su VAS, verbalnu ljestvicu ocjenjivanja (VRS) i NRS, te su zaklju&#x010D;ili da su sve tri valjane, pouzdane i prikladne za kori&#x0161;tenje u klini&#x010D;koj praksi, iako VAS ima ne&#x0161;to vi&#x0161;e pote&#x0161;ko&#x0107;a od ostalih dvaju instrumenta. (<xref ref-type="bibr" rid="r111"><italic>111</italic></xref>)</p>
<p>VAS je u svojoj uobi&#x010D;ajenoj verziji vodoravno postavljena du&#x017E;ina od 100 mm, s oznakama krajnje lijevo, 0 &#x2013; bez boli i krajnje desno, 100 &#x2013; najgora zamisliva bol, pri &#x010D;emu bolesnik na toj du&#x017E;ini ozna&#x010D;i prosje&#x010D;ni intenzitet boli tijekom pro&#x0161;log tjedna. VAS je valjan i pouzdan alat koji omogu&#x0107;uje adekvatno mjerenje specifi&#x010D;nih odgovora kod bolesnika s boli koja proizlazi iz kralje&#x017E;nice. (<xref ref-type="bibr" rid="r112"><italic>112</italic></xref>, <xref ref-type="bibr" rid="r113"><italic>113</italic></xref>) NRS, u rasponu od 0 do 10 (0 &#x2013; nema boli; 10 &#x2013; najgora mogu&#x0107;a bol), jednostavan je alat, ne zahtijeva dodatno obja&#x0161;njenje, odnosno mo&#x017E;e se izvesti verbalno. Tako&#x0111;er, ne zahtijeva prilagodbu za eventualno vi&#x0161;ekratno tiskanje ili prikaz na monitoru. (<xref ref-type="bibr" rid="r112"><italic>112</italic></xref>&#x2013;<xref ref-type="bibr" rid="r114"><italic>114</italic></xref>)</p>
<p>Identificiranje neuropatske komponente boli u kri&#x017E;obolji korisno je u dijagnosti&#x010D;ke i terapijske svrhe. Ono se temelji prvenstveno na anamnezi i klini&#x010D;kom pregledu, dok se u tom pogledu ne mo&#x017E;e preporu&#x010D;iti ni jedan upitnik za probir. <italic>STUPANJ PREPORUKE: UVJETNO SE PREPORU&#x010C;UJE.</italic></p>
<p>Posljednjih se desetlje&#x0107;a sve vi&#x0161;e pozornosti pridaje neuropatskoj komponenti kri&#x017E;obolje, nu&#x017E;nosti njezine procjene te, sukladno tomu, odgovaraju&#x0107;em lije&#x010D;enju. Postoji nekoliko klini&#x010D;kih testova probira koji se mogu koristiti, a primjeri nekih od njih su: <italic>Leeds Assessment of Neuropathic Symptoms and Signs</italic> (LANSS), <italic>Neuropathic Pain Questionnaire</italic> (NPQ), <italic>painDETECT</italic>, <italic>ID-Pain</italic>, <italic>Douleur Neuropathique en 4 questions</italic> (DN4). Povezanost izme&#x0111;u neuropatske boli i kri&#x017E;obolje dokazana je kori&#x0161;tenjem razli&#x010D;itih testova probira, uglavnom kod mla&#x0111;e populacije, te je prisutna u 20&#x2013;55% bolesnika. (<xref ref-type="bibr" rid="r115"><italic>115</italic></xref>-<xref ref-type="bibr" rid="r117"><italic>117</italic></xref>) U sustavnom pregledu s metaanalizom koja je uklju&#x010D;ivala 20 studija s ukupno 14.269 bolesnika s kri&#x017E;oboljom, od kojih je 55,8% identificirano da ima neuropatsku bol, utvr&#x0111;ene su ve&#x0107;e PR vrijednosti neuropatske boli u kri&#x017E;obolji s koegszistiraju&#x0107;om boli u nozi u odnosu na kri&#x017E;obolju bez boli u nozi. (<xref ref-type="bibr" rid="r118"><italic>118</italic></xref>) Budu&#x0107;i da je bol subjektivan fenomen i ne postoji zlatni standard za klini&#x010D;ki utemeljenu dijagnosti&#x010D;ku metodu za neuropatsku bol, radna skupina se slo&#x017E;ila da dijagnoza neuropatske boli uglavnom ovisi o anamnezi i klini&#x010D;kom pregledu.</p>
</sec>
<sec>
<title>Funkcija</title>
<p>Oswestryjev indeks nesposobnosti (ODI) i <italic>Roland-Morris Disability Questionnaire</italic> (RMDQ) su upitnici koji se preporu&#x010D;uju za ocjenu funkcionalne sposobnosti u bolesnika s kri&#x017E;oboljom, a bez preferencije za jedan od njih. <italic>STUPANJ PREPORUKE: UVJETNO SE PREPORU&#x010C;UJE.</italic></p>
<p>&#x0160;to se ti&#x010D;e funkcije povezane s kri&#x017E;oboljom, prou&#x010D;avano je i predlo&#x017E;eno nekoliko alata kao &#x0161;to su to u svojim preglednim radovima izlo&#x017E;ili Longo i suradnici, Chapman i suradnici i Carter Clement i suradnici. (<xref ref-type="bibr" rid="r105"><italic>105</italic></xref>, <xref ref-type="bibr" rid="r106"><italic>106</italic></xref>, <xref ref-type="bibr" rid="r119"><italic>119</italic></xref>) Naj&#x010D;e&#x0161;&#x0107;e kori&#x0161;teni i citirani alati u tom smislu su ODI i RMDQ. (<xref ref-type="bibr" rid="r120"><italic>120</italic></xref>, <xref ref-type="bibr" rid="r121"><italic>121</italic></xref>) Ta su dva upitnika preporu&#x010D;ena i od strane prethodno spomenute skupine stru&#x010D;njaka. (<xref ref-type="bibr" rid="r106"><italic>106</italic></xref>, <xref ref-type="bibr" rid="r107"><italic>107</italic></xref>) Iako su predlo&#x017E;ene razli&#x010D;ite verzije ovih dvaju upitnika, preporuka je koristiti ODI verziju 2.1a (0&#x2013;100) i originalnu verziju RMDQ (0&#x2013;24). (<xref ref-type="bibr" rid="r122"><italic>122</italic></xref>) Oba su se upitnika pokazala valjanima, pouzdanima i odgovaraju&#x0107;ima u populaciji bolesnika s kri&#x017E;oboljom. U sustavnom pregledu literature sa svrhom evaluacije sadr&#x017E;aja i psihometrijskih svojstava upitnika za procjenu tjelesne funkcije u osoba s kri&#x017E;oboljom u ve&#x0107;ini je evaluacija ODI (uz <italic>Quebec Back Pain Disability Scale</italic>) pokazao odgovaraju&#x0107;a psihometrijska svojstva. (<xref ref-type="bibr" rid="r123"><italic>123</italic></xref>) U detaljnijoj usporedbi nema &#x010D;vrstog razloga za preferiranje jednog upitnika nad drugim u procjeni fizi&#x010D;ke funkcije kod pacijenata s nespecifi&#x010D;nim kri&#x017E;oboljom. Iako, na&#x0111;ene su neke razlike u smislu da ODI pokazuje bolju test-retest podudarnost, manju pogre&#x0161;ku mjerenja, dok RMDQ ima bolju konstruktivnu valjanost kao mjeru fizi&#x010D;kog funkcioniranja. (<xref ref-type="bibr" rid="r124"><italic>124</italic></xref>) Sveukupno, radna skupina smatra da su ODI i RMDQ najizvedljiviji za implementaciju kao upitnici ocjene funkcionalne sposobnosti u bolesnika s kri&#x017E;oboljom, pru&#x017E;aju&#x0107;i optimalnu klini&#x010D;ku interpretaciju.</p>
</sec>
<sec>
<title>Kvaliteta &#x017E;ivota povezana sa zdravljem (HR-QoL)</title>
<p><italic>EuroQol</italic> &#x2013; 5-dimenzijski test (EQ-5D-3L) i <italic>Euro-Qol</italic> VAS ljestvica samoocjene zdravlja (EQ-VAS) mjere su koje se preporu&#x010D;uju za ocjenu kvalitete &#x017E;ivota povezane sa zdravljem (HR-QoL). <italic>STUPANJ PREPORUKE: UVJETNO SE PREPORU&#x010C;UJE.</italic></p>
<p>Kao i kod ocjene funkcionalne sposobnosti, u bolesnika s kri&#x017E;oboljom postoji vi&#x0161;e alata za ocjenu kvalitete &#x017E;ivota povezane sa zdravljem (engl. <italic>health-related quality of life</italic>, skr. HR-QoL). Naj&#x010D;e&#x0161;&#x0107;e kori&#x0161;teni i prou&#x010D;avani upitnici jesu <italic>Short Form</italic> &#x2013; <italic>36</italic> (SF-36), <italic>EuroQol</italic> &#x2013; 5-dimenzijski test (skr. EQ-5D) i s njim povezana <italic>Euro-Qol</italic> VAS ljestvica samoocjene zdravlja (skr. EQ-VAS), <italic>Nottingham health profile</italic> (NHP) i SF-12, kao skra&#x0107;ena verzija prethodno navedenog upitnika. (<xref ref-type="bibr" rid="r107"><italic>107</italic></xref>) NHP i SF-12 pokazali su se valjanima i pouzdanima, dok se SF-36 pokazao valjanim, pouzdanim i osjetljivim u populaciji bolesnika s kri&#x017E;oboljom. (<xref ref-type="bibr" rid="r105"><italic>105</italic></xref>) EQ-5D upitnik je &#x0161;iroko primjenjivan kako u op&#x0107;oj populaciji tako i u razli&#x010D;itim bolestima i stanjima. (<xref ref-type="bibr" rid="r125"><italic>125</italic></xref>, <xref ref-type="bibr" rid="r126"><italic>126</italic></xref>) U svom su radu Garratt i suradnici procijenili verzije EQ-5D-3L i EQ-5D-5L kod bolesnika s kri&#x017E;oboljom i zaklju&#x010D;ili da EQ-5D-5L ima prednost u odnosu na EQ-5D-3L. (<xref ref-type="bibr" rid="r127"><italic>127</italic></xref>) Osim toga, EQ-5D dobro korelira s upitnikom ODI u bolesnika s kri&#x017E;oboljom. (<xref ref-type="bibr" rid="r128"><italic>128</italic></xref>) U usporedbi s drugim alatima za procjenu kvalitete &#x017E;ivota EQ-5D i EQ-VAS imaju prednost &#x0161;to su relativno jednostavni, imaju uspostavljena psihometrijska svojstva u najve&#x0107;em broju jezika, u pogledu njihove upotrebe i &#x0161;irenja te velik broj citata koji su u brzom porastu. (<xref ref-type="bibr" rid="r105"><italic>105</italic></xref>)</p>
<p>Va&#x017E;no je napomenuti da svi navedeni alati u domenama boli, funkcije i HR-QoL imaju dokazanu valjanost i pouzdanost te da se radi o&#x010D;uvanja njihovih psihometrijskih funkcija preporu&#x010D;uje da se koriste u izvornom formatu. Glede grani&#x010D;nih vrijednosti odabranih alata u smislu minimalno va&#x017E;ne promjene (engl. <italic>minimally important difference</italic>, skr. MID) za bol na VAS i NRS, upitniku ODI i EQ-5D, radna skupina je prihvatila prijedlog NICE-a, koji se temelji na postoje&#x0107;oj literaturi ili konsenzusu o nepostojanju objavljenog MID-a u literaturi. (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>) Tako je MID za bol mjerenu na VAS 10 (0 &#x2013; 100), za bol na NSR 1 (0 &#x2013; 10), za ODI je 10 (0 &#x2013; 100), za RMDQ je 2 (0 &#x2013; 24), a za EQ-5D je 0,03. Tako&#x0111;er, &#x0161;to se ti&#x010D;e stanja podno&#x0161;ljivosti simptoma za bolesnika (engl. <italic>patient accepteble-symptoms state</italic>, skr. PASS), Daste i suradnici su u&#x010D;inili procjenu za naj&#x010D;e&#x0161;&#x0107;e ishode o kojima izvje&#x0161;tavaju bolesnici s kroni&#x010D;nom nespecifi&#x010D;nom kri&#x017E;oboljom, te su tako vrijednosti 47,5 (95% CI 40,0 &#x2013; 50,0)/100 za bol u kri&#x017E;ima (na ljestvici 0 &#x2013; 100) i 30,5 (95% CI 30,0 &#x2013; 40,0)/100 za radikularnu bol. (<xref ref-type="bibr" rid="r129"><italic>129</italic></xref>)</p>
<p>Radni status i uporaba analgetika navedeni su kao bitni ishodi u dvama klju&#x010D;nim pregledima. (<xref ref-type="bibr" rid="r105"><italic>105</italic></xref>, <xref ref-type="bibr" rid="r106"><italic>106</italic></xref>) Me&#x0111;utim, radna skupina je zauzela stajali&#x0161;te da, iako su na&#x010D;elno korisni, na povratak na posao i uporabu analgetika kao mjere ishoda utje&#x010D;u brojni intrenzi&#x010D;ki i ekstrinzi&#x010D;ki &#x010D;imbenici i stoga ti ishodi nisu odgovaraju&#x0107;e validirani u na&#x0161;im uvjetima pa se ne mogu preporu&#x010D;iti za klini&#x010D;ku praksu u Hrvatskoj.</p>
</sec>
<sec>
<title>Fizi&#x010D;ka (tjelesna) funkcija</title>
<p>Vremenski test &#x201E;uspravi se-i-kreni&#x201C; (TUGT) i test s pet ponavljanja &#x201E;sjedni-ustani&#x201C; (5StS) preporu&#x010D;uju se kao mjere fizi&#x010D;ke (tjelesne) funkcije, tj. zadatci fizi&#x010D;kog kapaciteta kod bolesnika s kri&#x017E;oboljom. <italic>STUPANJ PREPORUKE: UVJETNO SE PREPORU&#x010C;UJE.</italic></p>
<p>Mjere fizi&#x010D;ke (tjelesne) funkcije u bolesnika s kri&#x017E;oboljom zna&#x010D;ajno se razlikuju unutar literature. Radi se o zadatcima fizi&#x010D;ke sposobnosti, standardiziranoj aktivnosti koju izvodi bolesnik, a promatra i mjeri ispitiva&#x010D;, te su Stienen i suradnici napravili sustavni pregled literature i pregled dostupnih objektivnih mjera funkcije za bolesnike s degenerativnim bolestima lumbalne kralje&#x017E;nice, uz naglasak na njihovu pojavnost u dostupnoj literaturi. (<xref ref-type="bibr" rid="r130"><italic>130</italic></xref>) Autori su zaklju&#x010D;ili da je vremenski test &#x201E;uspravi se-i-kreni&#x201C; (engl. <italic>Timed &#x201C;Up-and-Go&#x201D; test</italic>, skr. TUGT) naj&#x010D;e&#x0161;&#x0107;e kori&#x0161;tena mjera, a slijede ga test s motoriziranom trakom za tr&#x010D;anje, test s pet ponavljanja &#x201E;sjedni-ustani&#x201C; (engl. <italic>5 Sit-to-Stand</italic>) i test analiza akcelerometrije. Jacobsson i suradnici su tako&#x0111;er napravili sustavni pregled s ciljem procjene razine dokaza za podudarnost, valjanost i odzivnost zadataka fizi&#x010D;kog kapaciteta, koriste&#x0107;i standarde COSMIN. Test pet ponavljanja &#x201E;sjedni-ustani&#x201C;, petminutnog hoda, test 50 stopa (&#x223C;15,3 m) hoda, test procjene progresivnoga izoinercijalnog podizanja (engl. <italic>Progressive Isoinertial Lifting Evaluation</italic>) i TUGT su testovi s umjerenim do sna&#x017E;nim pozitivnim obilje&#x017E;jima pouzdanosti i konstruktne valjanosti. Jednominutni test hoda uza stube, test pet ponavljanja &#x201E;sjedni-ustani&#x201C;, test &#x201E;<italic>shuttle</italic>&#x201C; hodanja i TUGT, iako obe&#x0107;avaju&#x0107;i, pokazali su u tom smislu ograni&#x010D;enu razinu dokaza. (<xref ref-type="bibr" rid="r131"><italic>131</italic></xref>)</p>
<p>Radna skupina je odabrala one testove fizi&#x010D;ke (tjelesne) funkcije koji se naj&#x010D;e&#x0161;&#x0107;e koriste, s najboljim dostupnim psihometrijskim zna&#x010D;ajkama, a uzimaju&#x0107;i u obzir prakti&#x010D;nost njihove uporabe.</p>
</sec>
</sec>
<sec sec-type="other6">
<title>Primjena umjetne inteligencije i strojnog u&#x010D;enja u dijagnosticiranju bolesnika s kri&#x017E;oboljom</title>
<p>Umjetna inteligencija i strojno u&#x010D;enje poma&#x017E;u u dijagnosticiranju bolesnika s kri&#x017E;oboljom. <italic>SNAGA PREPORUKE: UVJETNO SE PREPORU&#x010C;UJE.</italic></p>
<p>Donosimo kratki osvrt i na strojno u&#x010D;enje, odnosno ulogu sve prisutnije umjetne inteligencije i ra&#x010D;unalno potpomognutih alata u postavljanju dijagnoze, ali sve vi&#x0161;e i u lije&#x010D;enju/skrbi za bolesnike s kri&#x017E;oboljom. Duboko u&#x010D;enje je tehnika strojnog u&#x010D;enja koja koristi algoritme i ra&#x010D;unalne jedinice ili neurone u umjetnoj neuralnoj mre&#x017E;i koja opona&#x0161;a ljudski mozak; strojno u&#x010D;enje se odnosi na analizu ra&#x010D;unalnog sustava koji se prema prethodnom iskustvu automatski u&#x010D;i i prilago&#x0111;ava, a bez posebnoga prethodnog programiranja, dok umjetna inteligencija koristi ra&#x010D;unalnu znanost i podatke da se problem rije&#x0161;i pomo&#x0107;u stroja. Dakle, u &#x0161;irem smislu, duboko u&#x010D;enje je dio strojnog u&#x010D;enja, koje je dio umjetne inteligencije kao &#x0161;ireg pojma, &#x0161;to se sveukupno mo&#x017E;e promatrati u koncentri&#x010D;nim krugovima. (<xref ref-type="bibr" rid="r132"><italic>132</italic></xref>) U sistematskom pregledu D&#x2019;Antonija i suradnika glavna primjena dijagnoze pomo&#x0107;u ra&#x010D;unala kod kri&#x017E;obolje jest u klasifikaciji i regresiji. Klasifikacija se koristi za identifikaciju ili kategorizaciju kri&#x017E;obolje, dok se regresija koristi za numeri&#x010D;ke rezultate kao kvantitativne procjene nekih mjera. Sustavi s najboljim rezultatima razvijeni su za dijagnosticiranje degenerativnih promjena kralje&#x017E;nice na temelju slikovnih podataka, s prosje&#x010D;nim stopama to&#x010D;nosti &gt;80%. Zabilje&#x017E;eni su zna&#x010D;ajni rezultati i za ra&#x010D;unalno podr&#x017E;ane alate koji izvr&#x0161;avaju razli&#x010D;ite zadatke uklju&#x010D;uju&#x0107;i analizu klini&#x010D;kih, biomehani&#x010D;kih, elektrofiziolo&#x0161;kih i funkcionalnih slikovnih podataka. Tako&#x0111;er, potrebne su daljnje studije kako bi se bolje definirala uloga tih alata u skrbi bolesnika s kri&#x017E;oboljom. (<xref ref-type="bibr" rid="r133"><italic>133</italic></xref>) U recentnom okvirnom pregledu i budu&#x0107;im smjernicama o strojnom u&#x010D;enju u postavljanju dijagnoze lije&#x010D;enja i skrbi bolesnika s kri&#x017E;oboljom Seas i suradnici su prona&#x0161;li 223 istra&#x017E;ivanja objavljena izme&#x0111;u 1988. i 2023. godine, a ne&#x0161;to vi&#x0161;e od 50% njih usmjereno je na dijagnosticiranje kri&#x017E;obolje. Uobi&#x010D;ajeni unosi uklju&#x010D;ivali su anamnezu, demografske podatke i laboratorijske nalaze, dok su radovi objavljeni nakon 2010. tako&#x0111;er &#x010D;esto uklju&#x010D;ivali slikovne podatke u svoje modele (41,7% &#x010D;lanaka). Od svih radova samo osam je uklju&#x010D;ivalo vanjsku provjeru valjanosti, a devet ih je imalo javno dostupan kod. Autori su zaklju&#x010D;ili da unato&#x010D; brzoj primjeni strojnog u&#x010D;enja u podru&#x010D;ju kri&#x017E;obolje ve&#x0107;ina &#x010D;lanaka ne slijedi standardne najbolje prakse, vi&#x0161;e od 95% radova ne mo&#x017E;e se reproducirati ili provjeriti, pa je potrebna poja&#x010D;ana suradnja i dijeljenje koda kako bi se podr&#x017E;ao budu&#x0107;i rast i implementacija strojnog u&#x010D;enja u skrbi bolesnika s kri&#x017E;oboljom. (<xref ref-type="bibr" rid="r134"><italic>134</italic></xref>)</p>
</sec>
<sec sec-type="other7">
<title>Snaga i ograni&#x010D;enja smjernica</title>
<p>Snaga smjernica se o&#x010D;ituje prvenstveno u detaljnom sistematskom pregledu literature koji je osim probira stru&#x010D;nih osoba &#x2013; knji&#x017E;ni&#x010D;ara uklju&#x010D;io nekoliko krugova probira literature, pri &#x010D;emu su u obzir uzeti prvenstveno hijerarhijski najvi&#x0161;i izvori (sistematski pregledi/metaanalize). Preporuke, sukladne metodi GRADE, rezultat su dokaza iz literature, pri &#x010D;emu smo se usredoto&#x010D;ili na najkvalitetnije i najjasnije dokaze, a nakon rasprave, glasanja i u kona&#x010D;nici konsenzusa stru&#x010D;njaka razli&#x010D;itih specijalnosti.</p>
<p>Osnovno ograni&#x010D;enje ovih smjernica jest da nisu namijenjene bolesnicima.</p>
</sec>
<sec sec-type="other8">
<title>Zaklju&#x010D;ak</title>
<p>U ovom radu prikazali smo nove hrvatske smjernice za definiciju i terminologiju kri&#x017E;obolje, klini&#x010D;ku evaluaciju tih bolesnika, njihovu klasifikaciju, s posebnim naglaskom na ocjenu rizika za kroni&#x010D;nost, dijagnosti&#x010D;ku va&#x017E;nost laboratorijskih nalaza, slikovnih metoda i EMG-a, bitne mjere ishoda, ocjenu fizi&#x010D;ke funkcije te op&#x0107;i dijagnosti&#x010D;ki put bolesnika s kri&#x017E;oboljom (s radikulopatijom ili bez nje). Uslijedit &#x0107;e smjernice za konzervativno i intervencijsko/kirur&#x0161;ko lije&#x010D;enje.</p>
<p>U sredi&#x0161;tu na&#x0161;ih napora jest bolesnik. Ove a&#x017E;urirane smjernice nakon vi&#x0161;e od deset godina od objave prethodnih smjernica predstavljaju temelj za klini&#x010D;ku praksu i korak su prema ustanovljenju zajednice lije&#x010D;nika koji &#x0107;e svoje djelovanje uskladiti prema najboljim dokazima. Smjernice imaju zna&#x010D;ajan potencijal za pobolj&#x0161;anje kvalitete &#x017E;ivota bolesnika s kri&#x017E;oboljom te za smanjenje direktnih i indirektnih tro&#x0161;kova. Daljnja primjena i validacija smjernica sigurno &#x0107;e zahtijevati dodatni napor svih lije&#x010D;nika uklju&#x010D;enih u lije&#x010D;enje bolesnika s kri&#x017E;oboljom u svakodnevnoj klini&#x010D;koj praksi, pogotovo prilagodbe prema smjernicama, &#x0161;to je, dakako, izazov za budu&#x0107;nost. To uklju&#x010D;uje svijest o tome &#x0161;to se mora raditi druga&#x010D;ije nego ranije, identifikaciju olak&#x0161;avaju&#x0107;ih &#x010D;imbenika i barijere za primjenu smjernica, promjene pona&#x0161;anja da bi se osna&#x017E;ili olak&#x0161;avaju&#x0107;i &#x010D;imbenici, a prevladale prepreke, te mjerenje ishoda promijenjenih praksa.</p>
<p>Kao i svake druge smjernice, i ove &#x0107;e biti podvrgnute kriti&#x010D;koj analizi i novim spoznajama te &#x0107;e biti dopunjene, odnosno nove vezije napisane u pretpostavljenom razdoblju od osam do deset godina.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p content-type="fn-title">INFORMACIJE O SUKOBU INTERESA</p>
<p>Autori nisu deklarirali sukob interesa relevantan za ovaj rad.</p>
</fn>
<fn fn-type="financial-disclosure">
<p content-type="fn-title">INFORMACIJA O FINANCIRANJU</p>
<p>Za ovaj &#x010D;lanak nisu primljena financijska sredstva.</p>
</fn>
</fn-group>
<ref-list>
<title>LITERATURA</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Tao</surname><given-names>C</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name><etal/></person-group> <article-title>Global, regional and national burden of low back pain 1990&#x2013;2019: A systematic analysis of the Global Burden of Disease study 2019.</article-title> <source>J Orthop Translat</source>. <year>2021</year>;<volume>32</volume>:<fpage>49</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.jot.2021.07.005</pub-id><pub-id pub-id-type="pmid">34934626</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>GBD 2017 Disease and injury incidence and prevalence collaborators</collab></person-group>. <article-title>Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990&#x2013;2017: a systematic analysis for the Global Burden of Disease Study 2017.</article-title> <source>Lancet</source>. <year>2018</year>;<volume>392</volume>:<fpage>1789</fpage>&#x2013;<lpage>858</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(18)32279-7</pub-id><pub-id pub-id-type="pmid">30496104</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melman</surname><given-names>A</given-names></name><name><surname>Lord</surname><given-names>HJ</given-names></name><name><surname>Coombs</surname><given-names>D</given-names></name><name><surname>Zadro</surname><given-names>J</given-names></name><name><surname>Maher</surname><given-names>CG</given-names></name><name><surname>Machado</surname><given-names>GC</given-names></name></person-group>. <article-title>Global prevalence of hospital admissions for low back pain: A systematic review with meta-analysis.</article-title> <source>BMJ Open</source>. <year>2023</year>;<volume>13</volume>(<issue>4</issue>):<elocation-id>e069517</elocation-id>. <pub-id pub-id-type="doi">10.1136/bmjopen-2022-069517</pub-id><pub-id pub-id-type="pmid">37085316</pub-id></mixed-citation></ref>
<ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>CB</given-names></name><name><surname>Hamilton</surname><given-names>M</given-names></name><name><surname>Traeger</surname><given-names>A</given-names></name><name><surname>Buchbinder</surname><given-names>R</given-names></name><name><surname>Richards</surname><given-names>B</given-names></name><name><surname>Rogan</surname><given-names>E</given-names></name><etal/></person-group> <article-title>Do patients with acute low back pain in emergency departments have more severe symptoms than those in general practice? A systematic review with meta-analysis.</article-title> <source>Pain Med</source>. <year>2022</year>;<volume>23</volume>(<issue>4</issue>):<fpage>614</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1093/pm/pnab260</pub-id><pub-id pub-id-type="pmid">34480571</pub-id></mixed-citation></ref>
<ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grazio</surname><given-names>S</given-names></name><name><surname>&#x0106;urkovi&#x0107;</surname><given-names>B</given-names></name><name><surname>Vlak</surname><given-names>T</given-names></name><name><surname>Ba&#x0161;i&#x0107; Kes</surname><given-names>V</given-names></name><name><surname>Jeli&#x0107;</surname><given-names>M</given-names></name><name><surname>Buljan</surname><given-names>D</given-names></name><etal/></person-group> <article-title>u ime Hrvatskoga vertebrolo&#x0161;kog dru&#x0161;tva. Dijagnostika i konzervativno lije&#x010D;enje kri&#x017E;obolje: pregled i smjernice Hrvatskog vertebrolo&#x0161;kog dru&#x0161;tva.</article-title> <source>Acta Med Croatica</source>. <year>2012</year>;<volume>66</volume>:<fpage>259</fpage>&#x2013;<lpage>94</lpage>.<pub-id pub-id-type="pmid">23814971</pub-id></mixed-citation></ref>
<ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kova&#x010D;</surname><given-names>D</given-names></name><name><surname>Rotim</surname><given-names>K</given-names></name><name><surname>Bo&#x017E;i&#x0107;</surname><given-names>B</given-names></name><name><surname>Sajko</surname><given-names>T</given-names></name><name><surname>Kejla</surname><given-names>Z</given-names></name><name><surname>Perovi&#x0107;</surname><given-names>D</given-names></name><etal/></person-group> <article-title>u ime Hrvatskoga vertebrolo&#x0161;kog dru&#x0161;tva. Smjernice za intervencijske i invazivne postupke u bolesnika s mehani&#x010D;kom kri&#x017E;oboljom.</article-title> <source>Acta Med Croatica</source>. <year>2013</year>;<volume>67</volume>:<fpage>225</fpage>&#x2013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">25007432</pub-id></mixed-citation></ref>
<ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailly</surname><given-names>F</given-names></name><name><surname>Trouvin</surname><given-names>AP</given-names></name><name><surname>Bercier</surname><given-names>S</given-names></name><name><surname>Dadoun</surname><given-names>S</given-names></name><name><surname>Deneuville</surname><given-names>JP</given-names></name><name><surname>Faguer</surname><given-names>R</given-names></name><etal/></person-group> <article-title>Clinical guidelines and care pathway for management of low back pain with or without radicular pain.</article-title> <source>Joint Bone Spine</source>. <year>2021</year>;<volume>88</volume>(<issue>6</issue>):<elocation-id>105227</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.jbspin.2021.105227</pub-id><pub-id pub-id-type="pmid">34051387</pub-id></mixed-citation></ref>
<ref id="r8"><label>8</label><mixed-citation publication-type="web">NICE. National Institute for Health and Care Excellence. Low back pain and sciatica in over 16s: assessment and management. NICE guideline [NG59]. 2016. Dostupno na: htps://<ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.nice.org.uk/guidance/ng59">www.nice.org.uk/guidance/ng59</ext-link> [Pristupljeno 1. listopada 2023.].</mixed-citation></ref>
<ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huygen</surname><given-names>F</given-names></name><name><surname>Kallewaard</surname><given-names>JW</given-names></name><name><surname>van Tulder</surname><given-names>M</given-names></name><name><surname>Van Boxem</surname><given-names>K</given-names></name><name><surname>Vissers</surname><given-names>K</given-names></name><name><surname>van Kleef</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Evidence&#x2010;based interventional pain medicine according to clinical diagnoses: Update 2018.</article-title> <source>Pain Pract</source>. <year>2019</year>;<volume>19</volume>:<fpage>664</fpage>&#x2013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1111/papr.12786</pub-id><pub-id pub-id-type="pmid">30957944</pub-id></mixed-citation></ref>
<ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>MJ</given-names></name><name><surname>McKenzie</surname><given-names>JE</given-names></name><name><surname>Bossuyt</surname><given-names>PM</given-names></name><name><surname>Boutron</surname><given-names>I</given-names></name><name><surname>Hoffmann</surname><given-names>TC</given-names></name><name><surname>Mulrow</surname><given-names>CD</given-names></name><etal/></person-group> <article-title>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.</article-title> <source>BMJ</source>. <year>2021</year>;<volume>372</volume>(<issue>71</issue>): <pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmid">33782057</pub-id></mixed-citation></ref>
<ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guyatt</surname><given-names>G</given-names></name><name><surname>Oxman</surname><given-names>AD</given-names></name><name><surname>Akl</surname><given-names>EA</given-names></name><name><surname>Kunz</surname><given-names>R</given-names></name><name><surname>Vist</surname><given-names>G</given-names></name><name><surname>Brozek</surname><given-names>J</given-names></name><etal/></person-group> <article-title>GRADE guidelines: 1. Introduction &#x2013; GRADE evidence profiles and summary of findings tables.</article-title> <source>J Clin Epidemiol</source>. <year>2011</year>;<volume>64</volume>:<fpage>383</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.jclinepi.2010.04.026</pub-id><pub-id pub-id-type="pmid">21195583</pub-id></mixed-citation></ref>
<ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Airaksinen</surname><given-names>O</given-names></name><name><surname>Brox</surname><given-names>JI</given-names></name><name><surname>Cedraschi</surname><given-names>C</given-names></name><name><surname>Hildebrandt</surname><given-names>J</given-names></name><name><surname>Klaber-Moffett</surname><given-names>J</given-names></name><name><surname>Konacs</surname><given-names>F</given-names></name><etal/></person-group> <article-title>On behalf of the COST B13 Working Group on Guidelines for Chronic Low Back Pain.</article-title> <source>Eur Spine J</source>. <year>2006</year>;<volume>15</volume> <supplement>Suppl 2</supplement>:<fpage>S192</fpage>&#x2013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1007/s00586-006-1072-1</pub-id><pub-id pub-id-type="pmid">16550448</pub-id></mixed-citation></ref>
<ref id="r13"><label>13</label><mixed-citation publication-type="book">Kinkade S. Evaluation and treatment of acute low back pain. Am Ac Fam Phys. 2007:1182&#x2013;8.</mixed-citation></ref>
<ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Von Korff</surname><given-names>M</given-names></name></person-group>. <article-title>Studying the natural history of back pain.</article-title> <source>Spine</source>. <year>1994</year>;<volume>19</volume>(<issue>18</issue>) <supplement>Suppl</supplement>:<fpage>2041S</fpage>&#x2013;<lpage>6S</lpage>. <pub-id pub-id-type="doi">10.1097/00007632-199409151-00005</pub-id><pub-id pub-id-type="pmid">7801181</pub-id></mixed-citation></ref>
<ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koes</surname><given-names>BW</given-names></name><name><surname>van Tulder</surname><given-names>MW</given-names></name><name><surname>Thomas</surname><given-names>S</given-names></name></person-group>. <article-title>Diagnosis and treatment of low back pain.</article-title> <source>BMJ</source>. <year>2006</year>;<volume>332</volume>(<issue>7555</issue>):<fpage>1430</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.332.7555.1430</pub-id><pub-id pub-id-type="pmid">16777886</pub-id></mixed-citation></ref>
<ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pengel</surname><given-names>LHM</given-names></name><name><surname>Herbert</surname><given-names>RD</given-names></name><name><surname>Maher</surname><given-names>CG</given-names></name><name><surname>Refshauge</surname><given-names>KM</given-names></name></person-group>. <article-title>Acute low back pain: systematic review of its prognosis.</article-title> <source>BMJ</source>. <year>2003</year>;<volume>327</volume>(<issue>7410</issue>):<fpage>323</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.327.7410.323</pub-id><pub-id pub-id-type="pmid">12907487</pub-id></mixed-citation></ref>
<ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva</surname><given-names>T</given-names></name><name><surname>Mills</surname><given-names>K</given-names></name><name><surname>Brown</surname><given-names>BT</given-names></name><name><surname>Pocovi</surname><given-names>N</given-names></name><name><surname>de Campos</surname><given-names>T</given-names></name><name><surname>Maher</surname><given-names>C</given-names></name><etal/></person-group> <article-title>Recurrence of low back pain is common: a prospective inception cohort study.</article-title> <source>J Physiother</source>. <year>2019</year>;<volume>65</volume>:<fpage>159</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.jphys.2019.04.010</pub-id><pub-id pub-id-type="pmid">31208917</pub-id></mixed-citation></ref>
<ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Depreitere</surname><given-names>B</given-names></name><name><surname>Jonckheer</surname><given-names>P</given-names></name><name><surname>Coeckelberghs</surname><given-names>E</given-names></name><name><surname>Desomer</surname><given-names>A</given-names></name><name><surname>van Wambeke</surname><given-names>P</given-names></name></person-group>. <article-title>The pivotal role for the multidisciplinary approach at all phases and at all levels in the national pathway for the management of low back pain and radicular pain in Belgium.</article-title> <source>Eur J Phys Rehabil Med</source>. <year>2020</year>;<volume>56</volume>:<fpage>228</fpage>&#x2013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.23736/S1973-9087.19.05984-7</pub-id><pub-id pub-id-type="pmid">31556511</pub-id></mixed-citation></ref>
<ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>R</given-names></name><name><surname>Qaseem</surname><given-names>A</given-names></name><name><surname>Snow</surname><given-names>V</given-names></name><name><surname>Casey</surname><given-names>D</given-names></name><name><surname>Cross</surname><given-names>TJ</given-names></name><name><surname>Shekelle</surname><given-names>P</given-names></name><etal/></person-group> <article-title>Diagnosis and treatment of low back pain: A joint clinical practice guideline from the American College of Physicians and the American Pain Society.</article-title> <source>Ann Intern Med</source>. <year>2007</year>;<volume>147</volume>:<fpage>478</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-147-7-200710020-00006</pub-id><pub-id pub-id-type="pmid">17909209</pub-id></mixed-citation></ref>
<ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manchikanti</surname><given-names>L</given-names></name><name><surname>Boswell</surname><given-names>MV</given-names></name><name><surname>Singh</surname><given-names>V</given-names></name><name><surname>Benyamin</surname><given-names>RM</given-names></name><name><surname>Fellows</surname><given-names>B</given-names></name><name><surname>Abdi</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Comprehensive evidence-based guidelines for interventional techniques in the management of chronic spinal pain.</article-title> <source>Pain Physician</source>. <year>2009</year>;<volume>12</volume>:<fpage>699</fpage>&#x2013;<lpage>802</lpage>. <pub-id pub-id-type="doi">10.36076/ppj.2009/12/699</pub-id><pub-id pub-id-type="pmid">19644537</pub-id></mixed-citation></ref>
<ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>KM</given-names></name><name><surname>Hestbaek</surname><given-names>L</given-names></name><name><surname>Cassidy</surname><given-names>JD</given-names></name></person-group>. <article-title>Low back pain across the life course.</article-title> <source>Best Pract Res Clin Rheumatol</source>. <year>2013</year>;<volume>27</volume>(<issue>5</issue>):<fpage>591</fpage>&#x2013;<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1016/j.berh.2013.09.007</pub-id><pub-id pub-id-type="pmid">24315141</pub-id></mixed-citation></ref>
<ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicol</surname><given-names>V</given-names></name><name><surname>Verdaguer</surname><given-names>C</given-names></name><name><surname>Daste</surname><given-names>C</given-names></name><name><surname>Bisseriex</surname><given-names>H</given-names></name><name><surname>Lapeyre</surname><given-names>E</given-names></name><name><surname>Lfevre-Colau</surname><given-names>MM</given-names></name><etal/></person-group> <article-title>Chronic low back pain: A narrative review of recent international guidelines for diagnosis and conservative treatment.</article-title> <source>J Clin Med</source>. <year>2023</year>;<volume>12</volume>(<issue>4</issue>):<fpage>1685</fpage>. <pub-id pub-id-type="doi">10.3390/jcm12041685</pub-id><pub-id pub-id-type="pmid">36836220</pub-id></mixed-citation></ref>
<ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallwork</surname><given-names>SB</given-names></name><name><surname>Braithwaite</surname><given-names>FA</given-names></name><name><surname>O&#x2019;Keeffe</surname><given-names>M</given-names></name><name><surname>Travers</surname><given-names>MJ</given-names></name><name><surname>Summers</surname><given-names>SJ</given-names></name><name><surname>Lange</surname><given-names>B</given-names></name><etal/></person-group> <article-title>The clinical course of acute, subacute and persistent low back pain: a systematic review and meta-analysis.</article-title> <source>CMAJ</source>. <year>2024</year>;<volume>196</volume>(<issue>2</issue>):<fpage>E29</fpage>&#x2013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1503/cmaj.230542</pub-id><pub-id pub-id-type="pmid">38253366</pub-id></mixed-citation></ref>
<ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dillane</surname><given-names>JB</given-names></name><name><surname>Fry</surname><given-names>J</given-names></name><name><surname>Kalton</surname><given-names>G</given-names></name></person-group>. <article-title>Acute back syndrome: A study from general practice.</article-title> <source>BMJ</source>. <year>1966</year>;<volume>2</volume>:<fpage>82</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.2.5505.82</pub-id><pub-id pub-id-type="pmid">20791052</pub-id></mixed-citation></ref>
<ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balagu&#x00E9;</surname><given-names>F</given-names></name><name><surname>Mannion</surname><given-names>AF</given-names></name><name><surname>Pellis&#x00E9;</surname><given-names>F</given-names></name><name><surname>Cedraschi</surname><given-names>C</given-names></name></person-group>. <article-title>Non-specific low back pain.</article-title> <source>Lancet</source>. <year>2012</year>;<volume>379</volume>(<issue>9814</issue>):<fpage>482</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(11)60610-7</pub-id><pub-id pub-id-type="pmid">21982256</pub-id></mixed-citation></ref>
<ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bardin</surname><given-names>LD</given-names></name><name><surname>King</surname><given-names>P</given-names></name><name><surname>Maher</surname><given-names>CG</given-names></name></person-group>. <article-title>Diagnostic triage for low back pain: a practical approach for primary care.</article-title> <source>Med J Aust</source>. <year>2017</year>;<volume>206</volume>(<issue>6</issue>):<fpage>268</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.5694/mja16.00828</pub-id><pub-id pub-id-type="pmid">28359011</pub-id></mixed-citation></ref>
<ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borenstein</surname><given-names>D</given-names></name></person-group>. <article-title>Mechanical low back pain &#x2013; a rheumatologist&#x2019;s view.</article-title> <source>Nat Rev Rheumatol</source>. <year>2013</year>;<volume>9</volume>(<issue>11</issue>):<fpage>643</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1038/nrrheum.2013.133</pub-id><pub-id pub-id-type="pmid">24018549</pub-id></mixed-citation></ref>
<ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Will</surname><given-names>JS</given-names></name><name><surname>Bury</surname><given-names>DC</given-names></name><name><surname>Miller</surname><given-names>JA</given-names></name></person-group>. <article-title>Mechanical Low Back Pain.</article-title> <source>Am Fam Physician</source>. <year>2018</year>;<volume>98</volume>(<issue>7</issue>):<fpage>421</fpage>&#x2013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">30252425</pub-id></mixed-citation></ref>
<ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiarotto</surname><given-names>A</given-names></name><name><surname>Koes</surname><given-names>BW</given-names></name></person-group>. <article-title>Nonspecific low back pain.</article-title> <source>N Engl J Med</source>. <year>2022</year>;<volume>386</volume>(<issue>18</issue>):<fpage>1732</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMcp2032396</pub-id><pub-id pub-id-type="pmid">35507483</pub-id></mixed-citation></ref>
<ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tagliaferri</surname><given-names>SD</given-names></name><name><surname>Ng</surname><given-names>SK</given-names></name><name><surname>Fitzgibbon</surname><given-names>BM</given-names></name><name><surname>Owen</surname><given-names>PJ</given-names></name><name><surname>Miller</surname><given-names>CT</given-names></name><name><surname>Bowe</surname><given-names>SJ</given-names></name><etal/></person-group> <article-title>Relative contributions of the nervous system, spinal tissue and psychosocial health to non-specific low back pain: Multivariate meta-analysis.</article-title> <source>Eur J Pain</source>. <year>2022</year>;<volume>26</volume>(<issue>3</issue>):<fpage>578</fpage>&#x2013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1002/ejp.1883</pub-id><pub-id pub-id-type="pmid">34748265</pub-id></mixed-citation></ref>
<ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>YZ</given-names></name><name><surname>Chou</surname><given-names>L</given-names></name><name><surname>Au</surname><given-names>RT</given-names></name><name><surname>Seneviwickrama</surname><given-names>KMD</given-names></name><name><surname>Cicuttini</surname><given-names>FM</given-names></name><name><surname>Briggs</surname><given-names>AM</given-names></name><etal/></person-group> <article-title>People with low back pain want clear, consistent and personalised information on prognosis, treatment options and self-management strategies: a systematic review.</article-title> <source>J Physiother</source>. <year>2019</year>;<volume>65</volume>:<fpage>124</fpage>&#x2013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.jphys.2019.05.010</pub-id><pub-id pub-id-type="pmid">31227280</pub-id></mixed-citation></ref>
<ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deyo</surname><given-names>RA</given-names></name><name><surname>Mirza</surname><given-names>SK</given-names></name></person-group>. <article-title>Herniated lumbar intervertebral disk.</article-title> <source>N Engl J Med</source>. <year>2016</year>;<volume>374</volume>(<issue>18</issue>):<fpage>1763</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMcp1512658</pub-id><pub-id pub-id-type="pmid">27144851</pub-id></mixed-citation></ref>
<ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>JB</given-names></name><name><surname>Goode</surname><given-names>AP</given-names></name><name><surname>George</surname><given-names>SZ</given-names></name><name><surname>Cook</surname><given-names>CE</given-names></name></person-group>. <article-title>Incidence and risk factors for first-time incident low back pain: a systematic review and meta-analysis.</article-title> <source>Spine J</source>. <year>2014</year>;<volume>14</volume>(<issue>10</issue>):<fpage>2299</fpage>&#x2013;<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1016/j.spinee.2014.01.026</pub-id><pub-id pub-id-type="pmid">24462537</pub-id></mixed-citation></ref>
<ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigos</surname><given-names>SJ</given-names></name><name><surname>Holland</surname><given-names>J</given-names></name><name><surname>Holland</surname><given-names>C</given-names></name><name><surname>Webster</surname><given-names>JS</given-names></name><name><surname>Battie</surname><given-names>M</given-names></name><name><surname>Malmgren</surname><given-names>JA</given-names></name></person-group>. <article-title>High-quality controlled trials on preventing episodes of back problems: systematic literature review in working-age adults.</article-title> <source>Spine J</source>. <year>2009</year>;<volume>9</volume>:<fpage>147</fpage>&#x2013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.spinee.2008.11.001</pub-id><pub-id pub-id-type="pmid">19185272</pub-id></mixed-citation></ref>
<ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>JQ</given-names></name><name><surname>Kwong</surname><given-names>WH</given-names></name><name><surname>Chan</surname><given-names>YL</given-names></name><name><surname>Kawabata</surname><given-names>M</given-names></name></person-group>. <article-title>Comparison of in vivo intradiscal pressure between sitting and standing in human lumbar spine: a systematic review and meta-analysis.</article-title> <source>Life (Basel)</source>. <year>2022</year>;<volume>12</volume>(<issue>3</issue>):<fpage>457</fpage>. <pub-id pub-id-type="doi">10.3390/life12030457</pub-id><pub-id pub-id-type="pmid">35330208</pub-id></mixed-citation></ref>
<ref id="r36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohlmann</surname><given-names>A</given-names></name><name><surname>Zander</surname><given-names>T</given-names></name><name><surname>Graichen</surname><given-names>F</given-names></name><name><surname>Bergmann</surname><given-names>G</given-names></name></person-group>. <article-title>Lifting up and laying down a weight causes high spinal loads.</article-title> <source>J Biomech</source>. <year>2013</year>;<volume>46</volume>:<fpage>511</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiomech.2012.10.022</pub-id><pub-id pub-id-type="pmid">23141957</pub-id></mixed-citation></ref>
<ref id="r37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Zeng</surname><given-names>R</given-names></name></person-group>. <article-title>Temporal trends in the disease burden of osteoarthritis from 1990 to 2019, and projections until 2030.</article-title> <source>PLoS One</source>. <year>2023</year>;<volume>18</volume>:<elocation-id>e0288561</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0288561</pub-id><pub-id pub-id-type="pmid">37486949</pub-id></mixed-citation></ref>
<ref id="r38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manchikanti</surname><given-names>L</given-names></name><name><surname>Singh</surname><given-names>V</given-names></name><name><surname>Pampati</surname><given-names>V</given-names></name><name><surname>Damron</surname><given-names>KS</given-names></name><name><surname>Barnhill</surname><given-names>RC</given-names></name><name><surname>Beyer</surname><given-names>C</given-names></name><etal/></person-group> <article-title>Evaluation of the relative contributions of various structures in chronic low back pain.</article-title> <source>Pain Physician</source>. <year>2001</year>;<volume>4</volume>:<fpage>308</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.36076/ppj.2001/4/308</pub-id><pub-id pub-id-type="pmid">16902676</pub-id></mixed-citation></ref>
<ref id="r39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbs</surname><given-names>D</given-names></name><name><surname>McGahan</surname><given-names>BG</given-names></name><name><surname>Ropper</surname><given-names>AE</given-names></name><name><surname>Xu</surname><given-names>DS</given-names></name></person-group>. <article-title>Back pain: Differential diagnosis and management.</article-title> <source>Neurol Clin</source>. <year>2023</year>;<volume>41</volume>(<issue>1</issue>):<fpage>61</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/j.ncl.2022.07.002</pub-id><pub-id pub-id-type="pmid">36400559</pub-id></mixed-citation></ref>
<ref id="r40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carman</surname><given-names>MJCE</given-names></name></person-group>. <article-title>Assessing back pain in patients presenting to the ED.</article-title> <source>Am J Nurs</source>. <year>2021</year>;<volume>121</volume>(<issue>7</issue>):<fpage>26</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1097/01.NAJ.0000756520.85864.c0</pub-id><pub-id pub-id-type="pmid">34117133</pub-id></mixed-citation></ref>
<ref id="r41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koumtouzoua</surname><given-names>S</given-names></name><name><surname>Higgins</surname><given-names>S</given-names></name></person-group>. <article-title>Evaluating and managing the patient with back pain.</article-title> <source>Med Clin North Am</source>. <year>2021</year>;<volume>105</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcna.2020.08.014</pub-id><pub-id pub-id-type="pmid">33246512</pub-id></mixed-citation></ref>
<ref id="r42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ropper</surname><given-names>AH</given-names></name><name><surname>Zafonte</surname><given-names>RD</given-names></name></person-group>. <article-title>Sciatica.</article-title> <source>N Engl J Med</source>. <year>2015</year>;<volume>372</volume>(<issue>13</issue>):<fpage>1240</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra1410151</pub-id><pub-id pub-id-type="pmid">25806916</pub-id></mixed-citation></ref>
<ref id="r43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Windt</surname><given-names>DA</given-names></name><name><surname>Simons</surname><given-names>E</given-names></name><name><surname>Riphagen</surname><given-names>II</given-names></name><name><surname>Ammendolia</surname><given-names>C</given-names></name><name><surname>Verhagen</surname><given-names>AP</given-names></name><name><surname>Laslett</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Physical examination for lumbar radiculopathy due to disc herniation in patients with low-back pain.</article-title> <source>Cochrane Database Syst Rev</source>. <year>2010</year>; (<issue>2</issue>):<elocation-id>CD007431</elocation-id>. <pub-id pub-id-type="doi">10.1002/14651858.CD007431.pub2</pub-id><pub-id pub-id-type="pmid">20166095</pub-id></mixed-citation></ref>
<ref id="r44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekedahl</surname><given-names>H</given-names></name><name><surname>J&#x00F6;nsson</surname><given-names>B</given-names></name><name><surname>Annertz</surname><given-names>M</given-names></name><name><surname>Frobell</surname><given-names>RB</given-names></name></person-group>. <article-title>Accuracy of clinical tests in detecting disk herniation and nerve root compression in subjects with lumbar radicular symptoms.</article-title> <source>Arch Phys Med Rehabil</source>. <year>2018</year>;<volume>99</volume>(<issue>4</issue>):<fpage>726</fpage>&#x2013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.apmr.2017.11.006</pub-id><pub-id pub-id-type="pmid">29253501</pub-id></mixed-citation></ref>
<ref id="r45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nee</surname><given-names>RJ</given-names></name><name><surname>Coppieters</surname><given-names>MW</given-names></name><name><surname>Boyd</surname><given-names>BS</given-names></name></person-group>. <article-title>Reliability of the straight leg raise test for suspected lumbar radicular pain: A systematic review with meta-analysis.</article-title> <source>Musculoskelet Sci Pract</source>. <year>2022</year>;<volume>59</volume>:<elocation-id>102529</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.msksp.2022.102529</pub-id><pub-id pub-id-type="pmid">35245880</pub-id></mixed-citation></ref>
<ref id="r46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pesonen</surname><given-names>J</given-names></name><name><surname>Shacklock</surname><given-names>M</given-names></name><name><surname>Rantanen</surname><given-names>P</given-names></name><name><surname>M&#x00E4;ki</surname><given-names>J</given-names></name><name><surname>Karttunen</surname><given-names>L</given-names></name><name><surname>Kankaanp&#x00E4;&#x00E4;</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Extending the straight leg raise test for improved clinical evaluation of sciatica: reliability of hip internal rotation or ankle dorsiflexion.</article-title> <source>BMC Musculoskelet Disord</source>. <year>2021</year>;<volume>22</volume>(<issue>1</issue>):<fpage>303</fpage>. <pub-id pub-id-type="doi">10.1186/s12891-021-04159-y</pub-id><pub-id pub-id-type="pmid">33761924</pub-id></mixed-citation></ref>
<ref id="r47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsubaie</surname><given-names>AM</given-names></name><name><surname>Mazaheri</surname><given-names>M</given-names></name><name><surname>Martinez-Valdes</surname><given-names>E</given-names></name><name><surname>Falla</surname><given-names>D</given-names></name></person-group>. <article-title>Is movement variability altered in people with chronic non-specific low back pain? A systematic review.</article-title> <source>PLoS One</source>. <year>2023</year>;<volume>18</volume>(<issue>6</issue>):<elocation-id>e0287029</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0287029</pub-id><pub-id pub-id-type="pmid">37315096</pub-id></mixed-citation></ref>
<ref id="r48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>JJ</given-names></name><name><surname>Furukawa</surname><given-names>M</given-names></name></person-group>. <article-title>Evaluation of the patient with hip pain.</article-title> <source>Am Fam Physician</source>. <year>2014</year>;<volume>89</volume>(<issue>1</issue>):<fpage>27</fpage>&#x2013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">24444505</pub-id></mixed-citation></ref>
<ref id="r49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poddubnyy</surname><given-names>D</given-names></name><name><surname>van Tubergen</surname><given-names>A</given-names></name><name><surname>Landew&#x00E9;</surname><given-names>R</given-names></name><name><surname>Sieper</surname><given-names>J</given-names></name><name><surname>van der Heijde</surname><given-names>D</given-names></name></person-group>. <article-title>Assessment of SpondyloArthritis international Society (ASAS). Development of an ASAS-endorsed recommendation for the early referral of patients with a suspicion of axial spondyloarthritis.</article-title> <source>Ann Rheum Dis</source>. <year>2015</year>;<volume>74</volume>(<issue>8</issue>):<fpage>1483</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2014-207151</pub-id><pub-id pub-id-type="pmid">25990288</pub-id></mixed-citation></ref>
<ref id="r50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudwaleit</surname><given-names>M</given-names></name><name><surname>Sieper</surname><given-names>J</given-names></name></person-group>. <article-title>Referral strategies for early diagnosis of axial spondyloarthritis.</article-title> <source>Nat Rev Rheumatol</source>. <year>2012</year>;<volume>8</volume>:<fpage>262</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/nrrheum.2012.39</pub-id><pub-id pub-id-type="pmid">22487797</pub-id></mixed-citation></ref>
<ref id="r51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telli</surname><given-names>H</given-names></name><name><surname>Telli</surname><given-names>S</given-names></name><name><surname>Topal</surname><given-names>M</given-names></name></person-group>. <article-title>The validity and reliability of provocation test in the diagnosis of sacroiliac joint dysfunction.</article-title> <source>Pain Physician</source>. <year>2018</year>;<volume>21</volume>:<elocation-id>E367</elocation-id>. <pub-id pub-id-type="doi">10.36076/ppj.2018.4.E367</pub-id><pub-id pub-id-type="pmid">30045603</pub-id></mixed-citation></ref>
<ref id="r52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>BJ</given-names></name><name><surname>Ehsanian</surname><given-names>R</given-names></name><name><surname>Rosati</surname><given-names>R</given-names></name><name><surname>Huynh</surname><given-names>L</given-names></name><name><surname>Levin</surname><given-names>J</given-names></name><name><surname>Kennedy</surname><given-names>DJ</given-names></name></person-group>. <article-title>Validity of physical exam maneuvers in the diagnosis of sacroiliac joint pathology.</article-title> <source>Pain Med</source>. <year>2020</year>;<volume>21</volume>:<fpage>255</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1093/pm/pnz183</pub-id><pub-id pub-id-type="pmid">31393577</pub-id></mixed-citation></ref>
<ref id="r53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saueressig</surname><given-names>T</given-names></name><name><surname>Owen</surname><given-names>PJ</given-names></name><name><surname>Diemer</surname><given-names>F</given-names></name><name><surname>Zebisch</surname><given-names>J</given-names></name><name><surname>Belavy</surname><given-names>DL</given-names></name></person-group>. <article-title>Diagnostic Accuracy of Clusters of Pain Provocation Tests for Detecting Sacroiliac Joint Pain: Systematic Review with Meta-analysis.</article-title> <source>J Orthop Sports Phys Ther</source>. <year>2021</year>;<volume>51</volume>:<fpage>422</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.2519/jospt.2021.10469</pub-id><pub-id pub-id-type="pmid">34210160</pub-id></mixed-citation></ref>
<ref id="r54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casazza</surname><given-names>BA</given-names></name></person-group>. <article-title>Diagnosis and treatment of acute low back pai.</article-title> <source>Am Fam Physician</source>. <year>2012</year>;<volume>85</volume>(<issue>4</issue>):<fpage>343</fpage>&#x2013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">22335313</pub-id></mixed-citation></ref>
<ref id="r55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verhagen</surname><given-names>AP</given-names></name><name><surname>Downie</surname><given-names>A</given-names></name><name><surname>Popal</surname><given-names>N</given-names></name><name><surname>Maher</surname><given-names>C</given-names></name><name><surname>Koes</surname><given-names>BW</given-names></name></person-group>. <article-title>Red flags presented in current low back pain guidelines: A review.</article-title> <source>Eur Spine J</source>. <year>2016</year>;<volume>25</volume>:<fpage>2788</fpage>&#x2013;<lpage>802</lpage>. <pub-id pub-id-type="doi">10.1007/s00586-016-4684-0</pub-id><pub-id pub-id-type="pmid">27376890</pub-id></mixed-citation></ref>
<ref id="r56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreoletti</surname><given-names>F</given-names></name><name><surname>Maselli</surname><given-names>F</given-names></name><name><surname>Storari</surname><given-names>L</given-names></name><name><surname>Vongher</surname><given-names>A</given-names></name><name><surname>Erbesato</surname><given-names>M</given-names></name><name><surname>Testa</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Screening for referral of serious pathology by physical examination tests in patients with back or chest pain: a systematic review.</article-title> <source>Int J Environ Res Public Health</source>. <year>2022</year>;<volume>19</volume>(<issue>24</issue>):<fpage>16418</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph192416418</pub-id><pub-id pub-id-type="pmid">36554298</pub-id></mixed-citation></ref>
<ref id="r57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>CM</given-names></name><name><surname>Henschke</surname><given-names>N</given-names></name><name><surname>Maher</surname><given-names>CG</given-names></name><name><surname>van Tulder</surname><given-names>MW</given-names></name><name><surname>Koes</surname><given-names>BW</given-names></name><name><surname>Macaskill</surname><given-names>P</given-names></name><etal/></person-group> <article-title>Red flags to screen for vertebral fracture in patients presenting with low-back pain.</article-title> <source>Cochrane Database Syst Rev</source>. <year>2023</year>;<volume>11</volume>(<issue>11</issue>):<elocation-id>CD008643</elocation-id>. <pub-id pub-id-type="doi">10.1002/14651858.CD008643.pub3</pub-id><pub-id pub-id-type="pmid">38014846</pub-id></mixed-citation></ref>
<ref id="r58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verhagen</surname><given-names>AP</given-names></name><name><surname>Downie</surname><given-names>A</given-names></name><name><surname>Maher</surname><given-names>CG</given-names></name><name><surname>Koes</surname><given-names>BW</given-names></name></person-group>. <article-title>Most red flags for malignancy in low back pain guidelines lack empirical support: a systematic review.</article-title> <source>Pain</source>. <year>2017</year>;<volume>158</volume>(<issue>10</issue>):<fpage>1860</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1097/j.pain.0000000000000998</pub-id><pub-id pub-id-type="pmid">28708761</pub-id></mixed-citation></ref>
<ref id="r59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knoop</surname><given-names>J</given-names></name><name><surname>Rutten</surname><given-names>G</given-names></name><name><surname>Lever</surname><given-names>C</given-names></name><name><surname>Leemeijer</surname><given-names>J</given-names></name><name><surname>de Jong</surname><given-names>LJ</given-names></name><name><surname>Verhagen</surname><given-names>AP</given-names></name><etal/></person-group> <article-title>Lack of Consensus Across Clinical Guidelines Regarding the Role of Psychosocial Factors Within Low Back Pain Care: A Systematic Review.</article-title> <source>J Pain</source>. <year>2021</year>;<volume>22</volume>:<fpage>1545</fpage>&#x2013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpain.2021.04.013</pub-id><pub-id pub-id-type="pmid">34033963</pub-id></mixed-citation></ref>
<ref id="r60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galliker</surname><given-names>G</given-names></name><name><surname>Scherer</surname><given-names>DE</given-names></name><name><surname>Trippolini</surname><given-names>MA</given-names></name><name><surname>Rasmussen-Barr</surname><given-names>E</given-names></name><name><surname>LoMartire</surname><given-names>R</given-names></name><name><surname>Wertli</surname><given-names>MM</given-names></name></person-group>. <article-title>Low back pain in the emergency department: prevalence of serious spinal pathologies and diagnostic accuracy of red flags.</article-title> <source>Am J Med</source>. <year>2020</year>;<volume>133</volume>(<issue>1</issue>):<fpage>60</fpage>&#x2013;<lpage>72.e14</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjmed.2019.06.005</pub-id><pub-id pub-id-type="pmid">31278933</pub-id></mixed-citation></ref>
<ref id="r61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieminen</surname><given-names>LK</given-names></name><name><surname>Pyysalo</surname><given-names>LM</given-names></name><name><surname>Kankaanp&#x00E4;&#x00E4;</surname><given-names>MJ</given-names></name></person-group>. <article-title>Prognostic factors for pain chronicity in low back pain: a systematic review.</article-title> <source>Pain Rep</source>. <year>2021</year>;<volume>6</volume>(<issue>1</issue>):<elocation-id>e919</elocation-id>. <pub-id pub-id-type="doi">10.1097/PR9.0000000000000919</pub-id><pub-id pub-id-type="pmid">33981936</pub-id></mixed-citation></ref>
<ref id="r62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manderlier</surname><given-names>A</given-names></name><name><surname>de Fooz</surname><given-names>M</given-names></name><name><surname>Patris</surname><given-names>S</given-names></name><name><surname>Berquin</surname><given-names>A</given-names></name></person-group>. <article-title>Modifiable lifestyle-related prognostic factors for the onset of chronic spinal pain: A systematic review of longitudinal studies.</article-title> <source>Ann Phys Rehabil Med</source>. <year>2022</year>;<volume>65</volume>(<issue>6</issue>):<elocation-id>101660</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.rehab.2022.101660</pub-id><pub-id pub-id-type="pmid">35351652</pub-id></mixed-citation></ref>
<ref id="r63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansell</surname><given-names>G</given-names></name><name><surname>Corp</surname><given-names>N</given-names></name><name><surname>Wynne-Jones</surname><given-names>G</given-names></name><name><surname>Hill</surname><given-names>J</given-names></name><name><surname>Stynes</surname><given-names>S</given-names></name><name><surname>van der Windt</surname><given-names>D</given-names></name></person-group>. <article-title>Self-reported prognostic factors in adults reporting neck or low back pain: An umbrella review.</article-title> <source>Eur J Pain</source>. <year>2021</year>;<volume>25</volume>(<issue>8</issue>):<fpage>1627</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1002/ejp.1782</pub-id><pub-id pub-id-type="pmid">33864327</pub-id></mixed-citation></ref>
<ref id="r64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname><given-names>EB</given-names></name><name><surname>Canhao</surname><given-names>H</given-names></name><name><surname>Fernandes</surname><given-names>R</given-names></name><name><surname>Caeiro</surname><given-names>C</given-names></name><name><surname>Branco</surname><given-names>JC</given-names></name><name><surname>Rodrigues</surname><given-names>AM</given-names></name><etal/></person-group> <article-title>Prognostic indicators for poor outcomes in low back pain patients consulted in primary care.</article-title> <source>PLoS One</source>. <year>2020</year>;<volume>15</volume>(<issue>3</issue>):<elocation-id>e0229265</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0229265</pub-id><pub-id pub-id-type="pmid">32218561</pub-id></mixed-citation></ref>
<ref id="r65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmer</surname><given-names>JM</given-names></name><name><surname>Fauser</surname><given-names>D</given-names></name><name><surname>Golla</surname><given-names>A</given-names></name><name><surname>Bethge</surname><given-names>M</given-names></name><name><surname>Mau</surname><given-names>W</given-names></name></person-group>. <article-title>Contextual factors in persistent severe back pain: A longitudinal analysis among German employees.</article-title> <source>Eur J Pain</source>. <year>2024</year>;<volume>28</volume>:<fpage>649</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1002/ejp.2209</pub-id><pub-id pub-id-type="pmid">37994204</pub-id></mixed-citation></ref>
<ref id="r66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>AM</given-names></name><name><surname>Kamper</surname><given-names>SJ</given-names></name><name><surname>Maher</surname><given-names>CG</given-names></name><name><surname>Latimer</surname><given-names>J</given-names></name><name><surname>Ferreira</surname><given-names>ML</given-names></name><name><surname>Nicholas</surname><given-names>MK</given-names></name></person-group>. <article-title>Symptoms of depression and stress mediate the effect of pain on disability.</article-title> <source>Pain</source>. <year>2011</year>;<volume>152</volume>:<fpage>1044</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2011.01.014</pub-id><pub-id pub-id-type="pmid">21306826</pub-id></mixed-citation></ref>
<ref id="r67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bezzina</surname><given-names>A</given-names></name><name><surname>Austin</surname><given-names>E</given-names></name><name><surname>Nguyen</surname><given-names>H</given-names></name><name><surname>James</surname><given-names>C</given-names></name></person-group>. <article-title>Workplace psychosocial factors and their association with musculoskeletal disorders: a systematic review of longitudinal studies.</article-title> <source>Workplace Health Saf</source>. <year>2023</year>;<volume>71</volume>(<issue>12</issue>):<fpage>578</fpage>&#x2013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1177/21650799231193578</pub-id><pub-id pub-id-type="pmid">37698343</pub-id></mixed-citation></ref>
<ref id="r68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Froud</surname><given-names>R</given-names></name><name><surname>Patterson</surname><given-names>S</given-names></name><name><surname>Eldridge</surname><given-names>S</given-names></name><name><surname>Seale</surname><given-names>C</given-names></name><name><surname>Pincus</surname><given-names>T</given-names></name><name><surname>Rajendran</surname><given-names>D</given-names></name><etal/></person-group> <article-title>A systematic review and meta-synthesis of the impact of low back pain on people&#x2019;s lives.</article-title> <source>BMC Musculoskelet Disord</source>. <year>2014</year>;<volume>15</volume>:<fpage>50</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2474-15-50</pub-id><pub-id pub-id-type="pmid">24559519</pub-id></mixed-citation></ref>
<ref id="r69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glocker</surname><given-names>C</given-names></name><name><surname>Kirchberger</surname><given-names>I</given-names></name><name><surname>Gl&#x00E4;&#x00DF;el</surname><given-names>A</given-names></name><name><surname>Fincziczki</surname><given-names>A</given-names></name><name><surname>Stucki</surname><given-names>G</given-names></name><name><surname>Cieza</surname><given-names>A</given-names></name></person-group>. <article-title>Content validity of the comprehensive international classification of functioning, disability and health (ICF) core set for low back pain from the perspective of physicians: a Delphi survey.</article-title> <source>Chronic Illn</source>. <year>2013</year>;<volume>9</volume>(<issue>1</issue>):<fpage>57</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1177/1742395312451280</pub-id><pub-id pub-id-type="pmid">22689356</pub-id></mixed-citation></ref>
<ref id="r70"><label>70</label><mixed-citation publication-type="web">KCE. <italic>Belgian Health Knowledge Center.</italic> Clinical Practice Guide for Low Back and Radicular Pain. Published in 2017. Dostupno na: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://kce.fgov.be/sites/default/files/2021-11/KCE_287C_Low_back_pain_Summary.pdfhttps://kce.fgov.be/en/publications/all-reports/low-back-pain-and-radicular-pain-development-of-a-clinical-pathway">https://kce.fgov.be/sites/default/files/2021-11/KCE_287C_Low_back_pain_Summary.pdf https://kce.fgov.be/en/publications/all-reports/low-back-pain-and-radicular-pain-development-of-a-clinical-pathway</ext-link>. [Pristupljeno 15. listopada 2024.]</mixed-citation></ref>
<ref id="r71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Feller</surname><given-names>D</given-names></name><name><surname>Koes</surname><given-names>B</given-names></name><name><surname>Chiarotto</surname><given-names>A</given-names></name></person-group>. <article-title>Prognostic models for chronic low back pain outcomes in primary care are at high risk of bias and lack validation-high-quality studies are needed: A systematic review.</article-title> <source>J Orthop Sports Phys Ther</source>. <year>2024</year>;<volume>54</volume>(<issue>5</issue>):<fpage>302</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.2519/jospt.2024.12081</pub-id><pub-id pub-id-type="pmid">38356405</pub-id></mixed-citation></ref>
<ref id="r72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lheureux</surname><given-names>A</given-names></name><name><surname>Berquin</surname><given-names>A</given-names></name></person-group>. <article-title>Comparison between the STarT Back Screening Tool and the Orebro Musculoskeletal Pain Screening Questionnaire: Which tool for what purpose? A semi-systematic review.</article-title> <source>Ann Phys Rehabil Med</source>. <year>2019</year>;<volume>62</volume>(<issue>3</issue>):<fpage>178</fpage>&#x2013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/j.rehab.2018.09.007</pub-id><pub-id pub-id-type="pmid">30342997</pub-id></mixed-citation></ref>
<ref id="r73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>JC</given-names></name><name><surname>Dunn</surname><given-names>KM</given-names></name><name><surname>Lewis</surname><given-names>M</given-names></name><name><surname>Mullis</surname><given-names>R</given-names></name><name><surname>Main</surname><given-names>CJ</given-names></name><name><surname>Foster</surname><given-names>NE</given-names></name><etal/></person-group> <article-title>A primary care back pain screening tool: identifying patient subgroups for initial treatment.</article-title> <source>Arthritis Rheum</source>. <year>2008</year>;<volume>59</volume>:<fpage>632</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1002/art.23563</pub-id><pub-id pub-id-type="pmid">18438893</pub-id></mixed-citation></ref>
<ref id="r74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linton</surname><given-names>SJ</given-names></name><name><surname>Nicholas</surname><given-names>M</given-names></name><name><surname>MacDonald</surname><given-names>S</given-names></name></person-group>. <article-title>Development of a short form of the &#x00D6;rebro Musculoskeletal Pain Screening Questionnaire.</article-title> <source>Spine</source>. <year>2011</year>;<volume>36</volume>:<fpage>1891</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1097/BRS.0b013e3181f8f775</pub-id><pub-id pub-id-type="pmid">21192286</pub-id></mixed-citation></ref>
<ref id="r75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastos</surname><given-names>RM</given-names></name><name><surname>Moya</surname><given-names>CR</given-names></name><name><surname>de Vasconcelos</surname><given-names>RA</given-names></name><name><surname>Costa</surname><given-names>LOP</given-names></name></person-group>. <article-title>Treatment-based classification for low back pain: systematic review with meta-analysis.</article-title> <source>J Man Manip Ther</source>. <year>2022</year>;<volume>30</volume>(<issue>4</issue>):<fpage>207</fpage>&#x2013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1080/10669817.2021.2024677</pub-id><pub-id pub-id-type="pmid">35067217</pub-id></mixed-citation></ref>
<ref id="r76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tagliaferri</surname><given-names>SD</given-names></name><name><surname>Mitchell</surname><given-names>UH</given-names></name><name><surname>Saueressig</surname><given-names>T</given-names></name><name><surname>Owen</surname><given-names>PJ</given-names></name><name><surname>Miller</surname><given-names>CT</given-names></name><name><surname>Belavy</surname><given-names>DL</given-names></name></person-group>. <article-title>Classification approaches for treating low back pain have small effects that are not clinically meaningful: A systematic review with meta-analysis.</article-title> <source>J Orthop Sports Phys Ther</source>. <year>2022</year>;<volume>52</volume>(<issue>2</issue>):<fpage>67</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.2519/jospt.2022.10761</pub-id><pub-id pub-id-type="pmid">34775831</pub-id></mixed-citation></ref>
<ref id="r77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiodo</surname><given-names>AF</given-names></name><name><surname>Haley</surname><given-names>M</given-names></name></person-group>. <article-title>Does risk stratification with a matched treatment pathway improve clinical outcomes for adults with acute back pain? A systematic review and meta-analysis.</article-title> <source>Braz J Phys Ther</source>. <year>2024</year>;<volume>28</volume>(<issue>5</issue>):<elocation-id>101116</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.bjpt.2024.101116</pub-id><pub-id pub-id-type="pmid">39270550</pub-id></mixed-citation></ref>
<ref id="r78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>EM</given-names></name><name><surname>Neves</surname><given-names>JR</given-names></name><name><surname>Laranjeira</surname><given-names>M</given-names></name><name><surname>Reis</surname><given-names>J</given-names></name></person-group>. <article-title>The importance of inflammatory biomarkers in non-specific acute and chronic low back pain: a systematic review.</article-title> <source>Eur Spine J</source>. <year>2023</year>;<volume>32</volume>(<issue>9</issue>):<fpage>3230</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1007/s00586-023-07717-1</pub-id><pub-id pub-id-type="pmid">37195364</pub-id></mixed-citation></ref>
<ref id="r79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saravanan</surname><given-names>A</given-names></name><name><surname>Bai</surname><given-names>J</given-names></name><name><surname>Bajaj</surname><given-names>P</given-names></name><name><surname>Sterner</surname><given-names>E</given-names></name><name><surname>Rajagopal</surname><given-names>M</given-names></name><name><surname>Sanders</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Composite biomarkers, behavioral symptoms, and comorbidities in axial low back pain: a systematic review.</article-title> <source>Biol Res Nurs</source>. <year>2023</year>;<volume>25</volume>(<issue>4</issue>):<fpage>571</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1177/10998004231171146</pub-id><pub-id pub-id-type="pmid">37139992</pub-id></mixed-citation></ref>
<ref id="r80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname><given-names>EL</given-names></name><name><surname>Ihleb&#x00E6;k</surname><given-names>C</given-names></name></person-group>. <article-title>Primary care doctors&#x2019; management of low back pain patients--ten years after.</article-title> <source>Tidsskr Nor Laegeforen</source>. <year>2012</year>;<volume>132</volume>:<fpage>2388</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.4045/tidsskr.12.0395</pub-id><pub-id pub-id-type="pmid">23160588</pub-id></mixed-citation></ref>
<ref id="r81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzardo</surname><given-names>A</given-names></name><name><surname>Miceli</surname><given-names>L</given-names></name><name><surname>Bednarova</surname><given-names>R</given-names></name><name><surname>Guadagnin</surname><given-names>GM</given-names></name><name><surname>Sbrojavacca</surname><given-names>R</given-names></name><name><surname>Della Rocca</surname><given-names>G</given-names></name></person-group>. <article-title>Low-back pain at the emergency department: still not being managed?</article-title> <source>Ther Clin Risk Manag</source>. <year>2016</year>;<volume>12</volume>:<fpage>183</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">26929631</pub-id></mixed-citation></ref>
<ref id="r82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brinjikji</surname><given-names>W</given-names></name><name><surname>Luetmer</surname><given-names>PH</given-names></name><name><surname>Comstock</surname><given-names>B</given-names></name><name><surname>Bresnahan</surname><given-names>BW</given-names></name><name><surname>Chen</surname><given-names>LE</given-names></name><name><surname>Deyo</surname><given-names>RA</given-names></name><etal/></person-group> <article-title>Systematic literature review of imaging features of spinal degeneration in asymptomatic populations.</article-title> <source>AJNR Am J Neuroradiol</source>. <year>2015</year>;<volume>36</volume>(<issue>4</issue>):<fpage>811</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.3174/ajnr.A4173</pub-id><pub-id pub-id-type="pmid">25430861</pub-id></mixed-citation></ref>
<ref id="r83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steffens</surname><given-names>D</given-names></name><name><surname>Hancock</surname><given-names>MJ</given-names></name><name><surname>Maher</surname><given-names>CG</given-names></name><name><surname>Williams</surname><given-names>C</given-names></name><name><surname>Jensen</surname><given-names>TS</given-names></name><name><surname>Latimer</surname><given-names>J</given-names></name></person-group>. <article-title>Does magnetic resonance imaging predict future low back pain? A systematic review.</article-title> <source>Eur J Pain</source>. <year>2014</year>;<volume>18</volume>(<issue>6</issue>):<fpage>755</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1002/j.1532-2149.2013.00427.x</pub-id><pub-id pub-id-type="pmid">24276945</pub-id></mixed-citation></ref>
<ref id="r84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>A</given-names></name><name><surname>Agiro</surname><given-names>A</given-names></name><name><surname>Gottlieb</surname><given-names>M</given-names></name><name><surname>Barron</surname><given-names>J</given-names></name><name><surname>Brady</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group> <article-title>Early Trends Among Seven Recommendations From the Choosing Wisely Campaign.</article-title> <source>JAMA Intern Med</source>. <year>2015</year>;<volume>175</volume>:<fpage>1913</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1001/jamainternmed.2015.5441</pub-id><pub-id pub-id-type="pmid">26457643</pub-id></mixed-citation></ref>
<ref id="r85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Downie</surname><given-names>A</given-names></name><name><surname>Hancock</surname><given-names>M</given-names></name><name><surname>Jenkins</surname><given-names>H</given-names></name><name><surname>Buchbinder</surname><given-names>R</given-names></name><name><surname>Harris</surname><given-names>I</given-names></name><name><surname>Underwood</surname></name><etal/></person-group>. <article-title>How common is imaging for low back pain in primary and emergency care? Systematic review and meta-analysis of over 4 million imaging requests across 21 years.</article-title> <source>Br J Sports Med</source>. <year>2020</year>;<volume>54</volume>(<issue>11</issue>):<fpage>642</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1136/bjsports-2018-100087</pub-id><pub-id pub-id-type="pmid">30760458</pub-id></mixed-citation></ref>
<ref id="r86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemmers</surname><given-names>GPG</given-names></name><name><surname>van Lankveld</surname><given-names>W</given-names></name><name><surname>Westert</surname><given-names>GP</given-names></name><name><surname>van der Wees</surname><given-names>PJ</given-names></name><name><surname>Staal</surname><given-names>JB</given-names></name></person-group>. <article-title>Imaging versus no imaging for low back pain: a systematic review, measuring costs, healthcare utilization and absence from work.</article-title> <source>Eur Spine J</source>. <year>2019</year>;<volume>28</volume>(<issue>5</issue>):<fpage>937</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1007/s00586-019-05918-1</pub-id><pub-id pub-id-type="pmid">30796513</pub-id></mixed-citation></ref>
<ref id="r87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>SA</given-names></name><name><surname>Rampersaud</surname><given-names>YR</given-names></name></person-group>. <article-title>The importance of identifying and modifying unemployment predictor variables in the evolution of a novel model of care for low back pain in the general population.</article-title> <source>Spine J</source>. <year>2016</year>;<volume>16</volume>(<issue>1</issue>):<fpage>16</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.spinee.2015.09.034</pub-id><pub-id pub-id-type="pmid">26409414</pub-id></mixed-citation></ref>
<ref id="r88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blank</surname><given-names>L</given-names></name><name><surname>Baxter</surname><given-names>S</given-names></name><name><surname>Woods</surname><given-names>HB</given-names></name><name><surname>Goyder</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><name><surname>Payne</surname><given-names>N</given-names></name></person-group>. <article-title>What is the evidence on interventions to manage referral from primary to specialist non-emergency care? A systematic review and logic model synthesis.</article-title> <source>Health Services and Delivery Research</source>. <year>2015</year>;<volume>3</volume>:<fpage>1</fpage>&#x2013;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.3310/hsdr03240</pub-id><pub-id pub-id-type="pmid">25996020</pub-id></mixed-citation></ref>
<ref id="r89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verbeek</surname><given-names>J</given-names></name><name><surname>Sengers</surname><given-names>MJ</given-names></name><name><surname>Riemens</surname><given-names>L</given-names></name><name><surname>Haafkens</surname><given-names>J</given-names></name></person-group>. <article-title>Patient expectations of treatment for back pain: a systematic review of qualitative and quantitative studies.</article-title> <source>Spine</source>. <year>2004</year>;<volume>29</volume>:<fpage>2309</fpage>&#x2013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1097/01.brs.0000142007.38256.7f</pub-id><pub-id pub-id-type="pmid">15480147</pub-id></mixed-citation></ref>
<ref id="r90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blank</surname><given-names>L</given-names></name><name><surname>Baxter</surname><given-names>S</given-names></name><name><surname>Woods</surname><given-names>HB</given-names></name><name><surname>Goyder</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><name><surname>Payne</surname><given-names>N</given-names></name><etal/></person-group> <article-title>Referral interventions from primary to specialist care: a systematic review of international evidence.</article-title> <source>Br J Gen Pract</source>. <year>2014</year>;<volume>64</volume>:<fpage>e765</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.3399/bjgp14X682837</pub-id><pub-id pub-id-type="pmid">25452541</pub-id></mixed-citation></ref>
<ref id="r91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanner</surname><given-names>L</given-names></name><name><surname>Saywell</surname><given-names>NL</given-names></name><name><surname>Adams</surname><given-names>T</given-names></name><name><surname>Niazi</surname><given-names>IK</given-names></name><name><surname>Hill</surname><given-names>J</given-names></name></person-group>. <article-title>Factors influencing imaging clinical decision-making in low back pain management. A scoping review.</article-title> <source>Musculoskeletal Care</source>. <year>2024</year>;<volume>22</volume>(<issue>2</issue>):<elocation-id>e1898</elocation-id>. <pub-id pub-id-type="doi">10.1002/msc.1898</pub-id><pub-id pub-id-type="pmid">38862275</pub-id></mixed-citation></ref>
<ref id="r92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shraim</surname><given-names>BA</given-names></name><name><surname>Shraim</surname><given-names>MA</given-names></name><name><surname>Ibrahim</surname><given-names>AR</given-names></name><name><surname>Elgamal</surname><given-names>ME</given-names></name><name><surname>Al-Omari</surname><given-names>B</given-names></name><name><surname>Shraim</surname><given-names>M</given-names></name></person-group>. <article-title>The association between early MRI and length of disability in acute lower back pain: a systematic review and narrative synthesis.</article-title> <source>BMC Musculoskelet Disord</source>. <year>2021</year>;<volume>22</volume>(<issue>1</issue>):<fpage>983</fpage>. <pub-id pub-id-type="doi">10.1186/s12891-021-04863-9</pub-id><pub-id pub-id-type="pmid">34819061</pub-id></mixed-citation></ref>
<ref id="r93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name></person-group>. <article-title>The correlation between the lumbar disc MRI high-intensity zone and discogenic low back pain: a systematic review and meta-analysis.</article-title> <source>J Orthop Surg Res</source>. <year>2023</year>;<volume>18</volume>(<issue>1</issue>):<fpage>758</fpage>. <pub-id pub-id-type="doi">10.1186/s13018-023-04187-5</pub-id><pub-id pub-id-type="pmid">37805519</pub-id></mixed-citation></ref>
<ref id="r94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herlin</surname><given-names>C</given-names></name><name><surname>Kjaer</surname><given-names>P</given-names></name><name><surname>Espeland</surname><given-names>A</given-names></name><name><surname>Skouen</surname><given-names>JS</given-names></name><name><surname>Leboeuf-Yde</surname><given-names>C</given-names></name><name><surname>Karppinen</surname><given-names>J</given-names></name><etal/></person-group> <article-title>Modic changes &#x2013; Their associations with low back pain and activity limitation: A systematic literature review and meta-analysis.</article-title> <source>PLoS One</source>. <year>2018</year>;<volume>13</volume>(<issue>8</issue>):<elocation-id>e0200677</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0200677</pub-id><pub-id pub-id-type="pmid">30067777</pub-id></mixed-citation></ref>
<ref id="r95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czaplewski</surname><given-names>LG</given-names></name><name><surname>Rimmer</surname><given-names>O</given-names></name><name><surname>McHale</surname><given-names>D</given-names></name><name><surname>Laslett</surname><given-names>M</given-names></name></person-group>. <article-title>Modic changes as seen on MRI are associated with nonspecific chronic lower back pain and disability.</article-title> <source>J Orthop Surg Res</source>. <year>2023</year>;<volume>18</volume>:<fpage>351</fpage>. <pub-id pub-id-type="doi">10.1186/s13018-023-03839-w</pub-id><pub-id pub-id-type="pmid">37170132</pub-id></mixed-citation></ref>
<ref id="r96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paskowski</surname><given-names>I</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Stevans</surname><given-names>J</given-names></name><name><surname>Ventura</surname><given-names>JM</given-names></name><name><surname>Justice</surname><given-names>BD</given-names></name></person-group>. <article-title>A hospital-based standardized spine care pathway: report of a multidisciplinary, evidence-based process.</article-title> <source>J Manipulative Physiol Ther</source>. <year>2011</year>;<volume>34</volume>(<issue>2</issue>):<fpage>98</fpage>&#x2013;<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmpt.2010.12.004</pub-id><pub-id pub-id-type="pmid">21334541</pub-id></mixed-citation></ref>
<ref id="r97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>JJ</given-names></name><name><surname>C&#x00F4;t&#x00E9;</surname><given-names>P</given-names></name><name><surname>Sutton</surname><given-names>DA</given-names></name><name><surname>Randhawa</surname><given-names>K</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Varatharajan</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Clinical practice guidelines for the noninvasive management of low back pain: a systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration.</article-title> <source>Eur J Pain</source>. <year>2017</year>;<volume>21</volume>:<fpage>201</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1002/ejp.931</pub-id><pub-id pub-id-type="pmid">27712027</pub-id></mixed-citation></ref>
<ref id="r98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernstein</surname><given-names>IA</given-names></name><name><surname>Malik</surname><given-names>Q</given-names></name><name><surname>Carville</surname><given-names>S</given-names></name><name><surname>Ward</surname><given-names>S</given-names></name></person-group>. <article-title>Low back pain and sciatica: summary of NICE guidance.</article-title> <source>BMJ</source>. <year>2017</year>;<volume>356</volume>:<fpage>i6748</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.i6748</pub-id><pub-id pub-id-type="pmid">28062522</pub-id></mixed-citation></ref>
<ref id="r99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qaseem</surname><given-names>A</given-names></name><name><surname>Wilt</surname><given-names>TJ</given-names></name><name><surname>McLean</surname><given-names>RM</given-names></name><name><surname>Forciea</surname><given-names>MA</given-names></name></person-group>. <article-title>Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians.</article-title> <source>Ann Intern Med</source>. <year>2017</year>;<volume>166</volume>:<fpage>514</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.7326/M16-2367</pub-id><pub-id pub-id-type="pmid">28192789</pub-id></mixed-citation></ref>
<ref id="r100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dillingham</surname><given-names>TR</given-names></name><name><surname>Annaswamy</surname><given-names>TM</given-names></name><name><surname>Plastaras</surname><given-names>CT</given-names></name></person-group>. <article-title>Evaluation of persons with suspected lumbosacral and cervical radiculopathy: Electrodiagnostic assessment and implications for treatment and outcomes (Part I).</article-title> <source>Muscle Nerve</source>. <year>2020</year>;<volume>62</volume>:<fpage>462</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1002/mus.26997</pub-id><pub-id pub-id-type="pmid">32557709</pub-id></mixed-citation></ref>
<ref id="r101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dillingham</surname><given-names>TR</given-names></name><name><surname>Annaswamy</surname><given-names>TM</given-names></name><name><surname>Plastaras</surname><given-names>CT</given-names></name></person-group>. <article-title>Evaluation of persons with suspected lumbosacral and cervical radiculopathy: Electrodiagnostic assessment and implications for treatment and outcomes (Part II).</article-title> <source>Muscle Nerve</source>. <year>2020</year>;<volume>62</volume>:<fpage>474</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1002/mus.27008</pub-id><pub-id pub-id-type="pmid">32564381</pub-id></mixed-citation></ref>
<ref id="r102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilbourn</surname><given-names>AJ</given-names></name><name><surname>Aminoff</surname><given-names>MJ</given-names></name></person-group>. <article-title>AAEM minimonography 32: the electrodiagnostic examination in patients with radiculopathies. American Association of Electrodiagnostic Medicine.</article-title> <source>Muscle Nerve</source>. <year>1998</year>;<volume>21</volume>:<fpage>1612</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1097-4598(199812)21:12&lt;1612::AID-MUS2&gt;3.0.CO;2-0</pub-id><pub-id pub-id-type="pmid">9843062</pub-id></mixed-citation></ref>
<ref id="r103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauder</surname><given-names>TD</given-names></name><name><surname>Dillingham</surname><given-names>TR</given-names></name><name><surname>Andary</surname><given-names>M</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Pezzin</surname><given-names>LE</given-names></name><name><surname>Stephens</surname><given-names>RT</given-names></name><etal/></person-group> <article-title>Effect of history and exam in predicting electrodiagnostic outcome among patients with suspected lumbosacral radiculopathy.</article-title> <source>Am J Phys Med Rehabil</source>. <year>2000</year>;<volume>79</volume>:<fpage>60</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1097/00002060-200001000-00013</pub-id><pub-id pub-id-type="pmid">10678605</pub-id></mixed-citation></ref>
<ref id="r104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullis</surname><given-names>R</given-names></name><name><surname>Barber</surname><given-names>J</given-names></name><name><surname>Lewis</surname><given-names>M</given-names></name><name><surname>Hay</surname><given-names>E</given-names></name></person-group>. <article-title>ICF Core sets for low back pain: do they include what matters to patients?</article-title> <source>J Rehabil Med</source>. <year>2007</year>;<volume>39</volume>:<fpage>353</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.2340/16501977-0059</pub-id><pub-id pub-id-type="pmid">17549324</pub-id></mixed-citation></ref>
<ref id="r105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>JR</given-names></name><name><surname>Norvell</surname><given-names>DC</given-names></name><name><surname>Hermsmeryer</surname><given-names>JT</given-names></name><name><surname>Bransford</surname><given-names>RJ</given-names></name><name><surname>DeVine</surname><given-names>J</given-names></name><name><surname>McGirt</surname><given-names>MJ</given-names></name><etal/></person-group> <article-title>Evaluating common outcomes for measuring treatment success for chronic low back pain.</article-title> <source>Spine</source>. <year>2011</year>;<volume>36</volume>(<issue>21</issue>) <supplement>Suppl</supplement>:<fpage>S54</fpage>&#x2013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1097/BRS.0b013e31822ef74d</pub-id><pub-id pub-id-type="pmid">21952190</pub-id></mixed-citation></ref>
<ref id="r106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clement</surname><given-names>RC</given-names></name><name><surname>Welander</surname><given-names>A</given-names></name><name><surname>Stowell</surname><given-names>C</given-names></name><name><surname>Cha</surname><given-names>TD</given-names></name><name><surname>Chen</surname><given-names>JL</given-names></name><name><surname>Davies</surname><given-names>M</given-names></name><etal/></person-group> <article-title>A proposed set of metrics for standardized outcome reporting in the management of low back pain.</article-title> <source>Acta Orthop</source>. <year>2015</year>;<volume>86</volume>(<issue>5</issue>):<fpage>523</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.3109/17453674.2015.1036696</pub-id><pub-id pub-id-type="pmid">25828191</pub-id></mixed-citation></ref>
<ref id="r107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boutevillain</surname><given-names>L</given-names></name><name><surname>Dupeyron</surname><given-names>A</given-names></name><name><surname>Rouch</surname><given-names>C</given-names></name><name><surname>Richard</surname><given-names>E</given-names></name><name><surname>Coudeyre</surname><given-names>E</given-names></name></person-group>. <article-title>Facilitators and barriers to physical activity in people with chronic low back pain: A qualitative study.</article-title> <source>PLoS One</source>. <year>2017</year>;<volume>12</volume>(<issue>7</issue>):<elocation-id>e0179826</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0179826</pub-id><pub-id pub-id-type="pmid">28742820</pub-id></mixed-citation></ref>
<ref id="r108"><label>108</label><mixed-citation publication-type="other">Grazio S. Principi lije&#x010D;enja bolesnika s kri&#x017E;oboljom. U: Grazio S, Buljan D, ur. Kri&#x017E;obolja. Jastrebarsko: Naklada Slap; 2009, str. 265&#x2013;76.</mixed-citation></ref>
<ref id="r109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breivik</surname><given-names>H</given-names></name><name><surname>Borchgrevink</surname><given-names>PC</given-names></name><name><surname>Allen</surname><given-names>SM</given-names></name><name><surname>Rosseland</surname><given-names>LA</given-names></name><name><surname>Romundstad</surname><given-names>L</given-names></name><name><surname>Breivik Hals</surname><given-names>EK</given-names></name><etal/></person-group> <article-title>Assessment of pain.</article-title> <source>Br J Anaesth</source>. <year>2008</year>;<volume>101</volume>(<issue>1</issue>):<fpage>17</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1093/bja/aen103</pub-id><pub-id pub-id-type="pmid">18487245</pub-id></mixed-citation></ref>
<ref id="r110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crisman</surname><given-names>E</given-names></name><name><surname>Appenzeller-Herzog</surname><given-names>C</given-names></name><name><surname>Tabakovic</surname><given-names>S</given-names></name><name><surname>Nickel</surname><given-names>CH</given-names></name><name><surname>Minotti</surname><given-names>B</given-names></name></person-group>. <article-title>Multidimensional versus unidimensional pain scales for the assessment of analgesic requirement in the emergency department: a systematic review.</article-title> <source>Intern Emerg Med</source>. <year>2024</year>;<volume>19</volume>:<fpage>1463</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1007/s11739-024-03608-5</pub-id><pub-id pub-id-type="pmid">38664325</pub-id></mixed-citation></ref>
<ref id="r111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karcioglu</surname><given-names>O</given-names></name><name><surname>Topacoglu</surname><given-names>H</given-names></name><name><surname>Dikme</surname><given-names>O</given-names></name><name><surname>Dikme</surname><given-names>O</given-names></name></person-group>. <article-title>A systematic review of the pain scales in adults: Which to use?</article-title> <source>Am J Emerg Med</source>. <year>2018</year>;<volume>36</volume>(<issue>4</issue>):<fpage>707</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajem.2018.01.008</pub-id><pub-id pub-id-type="pmid">29321111</pub-id></mixed-citation></ref>
<ref id="r112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamison</surname><given-names>RN</given-names></name><name><surname>Raymond</surname><given-names>SA</given-names></name><name><surname>Slawsby</surname><given-names>EA</given-names></name><name><surname>McHugo</surname><given-names>GJ</given-names></name><name><surname>Baird</surname><given-names>JC</given-names></name></person-group>. <article-title>Pain assessment in patients with low back pain: comparison of weekly recall and momentary electronic data.</article-title> <source>J Pain</source>. <year>2006</year>;<volume>7</volume>(<issue>3</issue>):<fpage>192</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpain.2005.10.006</pub-id><pub-id pub-id-type="pmid">16516825</pub-id></mixed-citation></ref>
<ref id="r113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolton</surname><given-names>JE</given-names></name><name><surname>Humphreys</surname><given-names>BK</given-names></name><name><surname>van Hedel</surname><given-names>HJA</given-names></name></person-group>. <article-title>Validity of weekly recall ratings of average pain intensity in neck pain patients.</article-title> <source>J Manipulative Physiol Ther</source>. <year>2010</year>;<volume>33</volume>(<issue>8</issue>):<fpage>612</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmpt.2010.08.009</pub-id><pub-id pub-id-type="pmid">21036283</pub-id></mixed-citation></ref>
<ref id="r114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>MP</given-names></name><name><surname>Mardekian</surname><given-names>J</given-names></name><name><surname>Lakshminarayanan</surname><given-names>M</given-names></name><name><surname>Boye</surname><given-names>ME</given-names></name></person-group>. <article-title>Validity of 24-h recall ratings of pain severity: biasing effects of &#x201C;Peak&#x201D; and &#x201C;End&#x201D; pain.</article-title> <source>Pain</source>. <year>2008</year>;<volume>137</volume>(<issue>2</issue>):<fpage>422</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2007.10.006</pub-id><pub-id pub-id-type="pmid">18035495</pub-id></mixed-citation></ref>
<ref id="r115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>S</given-names></name></person-group>. <article-title>Development of new screening questionnaire to identify neuropathic components in Japanese patients with chronic pain.</article-title> <source>Pain Clin</source>. <year>2010</year>;<volume>31</volume>:<fpage>1187</fpage>&#x2013;<lpage>94</lpage>.</mixed-citation></ref>
<ref id="r116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freynhagen</surname><given-names>R</given-names></name><name><surname>Baron</surname><given-names>R</given-names></name><name><surname>Gockel</surname><given-names>U</given-names></name><name><surname>T&#x00F6;lle</surname><given-names>TR</given-names></name></person-group>. <article-title>Pain DETECT: a new screening questionnaire to identify neuropathic components in patients with back pain.</article-title> <source>Curr Med Res Opin</source>. <year>2006</year>;<volume>22</volume>:<fpage>1911</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1185/030079906X132488</pub-id><pub-id pub-id-type="pmid">17022849</pub-id></mixed-citation></ref>
<ref id="r117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>Y</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Hida</surname><given-names>T</given-names></name><name><surname>Ito</surname><given-names>S</given-names></name><name><surname>Harada</surname><given-names>A</given-names></name></person-group>. <article-title>Neuropathic pain in elderly patients with chronic low back pain and effects of pregabalin: A preliminary study.</article-title> <source>Asian Spine J</source>. <year>2015</year>;<volume>9</volume>(<issue>2</issue>):<fpage>254</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.4184/asj.2015.9.2.254</pub-id><pub-id pub-id-type="pmid">25901238</pub-id></mixed-citation></ref>
<ref id="r118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gudala</surname><given-names>K</given-names></name><name><surname>Bansal</surname><given-names>D</given-names></name><name><surname>Vatte</surname><given-names>R</given-names></name><name><surname>Ghai</surname><given-names>B</given-names></name><name><surname>Schifano</surname><given-names>F</given-names></name><name><surname>Boya</surname><given-names>C</given-names></name></person-group>. <article-title>High prevalence of neuropathic pain component in patients with low back pain: Evidence from meta-analysis.</article-title> <source>Pain Physician</source>. <year>2017</year>;<volume>20</volume>(<issue>5</issue>):<fpage>343</fpage>&#x2013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">28727698</pub-id></mixed-citation></ref>
<ref id="r119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longo</surname><given-names>UG</given-names></name><name><surname>Loppini</surname><given-names>M</given-names></name><name><surname>Denaro</surname><given-names>L</given-names></name><name><surname>Maffulli</surname><given-names>N</given-names></name><name><surname>Denaro</surname><given-names>V</given-names></name></person-group>. <article-title>Rating scales for low back pain.</article-title> <source>Br Med Bull</source>. <year>2010</year>;<volume>94</volume>(<issue>1</issue>):<fpage>81</fpage>&#x2013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1093/bmb/ldp052</pub-id><pub-id pub-id-type="pmid">20064820</pub-id></mixed-citation></ref>
<ref id="r120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fairbank</surname><given-names>JC</given-names></name><name><surname>Couper</surname><given-names>J</given-names></name><name><surname>Davies</surname><given-names>JB</given-names></name><name><surname>O&#x2019;Brien</surname><given-names>JP</given-names></name></person-group>. <article-title>The Oswestry low back pain disability questionnaire.</article-title> <source>Physiotherapy</source>. <year>1980</year>;<volume>66</volume>(<issue>8</issue>):<fpage>271</fpage>&#x2013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">6450426</pub-id></mixed-citation></ref>
<ref id="r121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roland</surname><given-names>M</given-names></name><name><surname>Morris</surname><given-names>R</given-names></name></person-group>. <article-title>A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain.</article-title> <source>Spine</source>. <year>1983</year>;<volume>8</volume>(<issue>2</issue>):<fpage>141</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1097/00007632-198303000-00004</pub-id><pub-id pub-id-type="pmid">6222486</pub-id></mixed-citation></ref>
<ref id="r122"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roland</surname><given-names>M</given-names></name><name><surname>Fairbank</surname><given-names>J.</given-names></name></person-group> <article-title>The Roland&#x2013;Morris Disability Questionnaire and the Oswestry Disability Questionnaire.</article-title> <source>Spine (Phila Pa 1976)</source>. <year>2000</year>;<volume>25</volume>:<fpage>3115</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1097/00007632-200012150-00006</pub-id><pub-id pub-id-type="pmid">11124727</pub-id></mixed-citation></ref>
<ref id="r123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiitavaara</surname><given-names>B</given-names></name><name><surname>Heiden</surname><given-names>M</given-names></name></person-group>. <article-title>Content and psychometric evaluations of questionnaires for assessing physical function in people with low back disorders. A systematic review of the literature.</article-title> <source>Disabil Rehabil</source>. <year>2020</year>;<volume>42</volume>(<issue>2</issue>):<fpage>163</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1080/09638288.2018.1495274</pub-id><pub-id pub-id-type="pmid">30324809</pub-id></mixed-citation></ref>
<ref id="r124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiarotto</surname><given-names>A</given-names></name><name><surname>Maxwell</surname><given-names>LJ</given-names></name><name><surname>Terwee</surname><given-names>CB</given-names></name><name><surname>Wells</surname><given-names>GA</given-names></name><name><surname>Tugwell</surname><given-names>P</given-names></name><name><surname>Ostelo</surname><given-names>RW</given-names></name></person-group>. <article-title>Roland-Morris Disability Questionnaire and Oswestry Disability Index: which has better measurement properties for measuring physical functioning in nonspecific low back pain? Systematic review and meta-analysis.</article-title> <source>Phys Ther</source>. <year>2016</year>;<volume>96</volume>:<fpage>1620</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.2522/ptj.20150420</pub-id><pub-id pub-id-type="pmid">27081203</pub-id></mixed-citation></ref>
<ref id="r125"><label>125</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinz</surname><given-names>A</given-names></name><name><surname>Kohlmann</surname><given-names>T</given-names></name><name><surname>St&#x00F6;bel-Richter</surname><given-names>Y</given-names></name><name><surname>Zenger</surname><given-names>M</given-names></name><name><surname>Br&#x00E4;hler</surname><given-names>E</given-names></name></person-group>. <article-title>The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population.</article-title> <source>Qual Life Res</source>. <year>2014</year>;<volume>23</volume>(<issue>2</issue>):<fpage>443</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1007/s11136-013-0498-2</pub-id><pub-id pub-id-type="pmid">23921597</pub-id></mixed-citation></ref>
<ref id="r126"><label>126</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>TH</given-names></name><name><surname>Jo</surname><given-names>MW</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Chung</surname><given-names>SM</given-names></name></person-group>. <article-title>Psychometric properties of the EQ-5D-5L in the general population of South Korea.</article-title> <source>Qual Life Res</source>. <year>2013</year>;<volume>22</volume>(<issue>8</issue>):<fpage>2245</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1007/s11136-012-0331-3</pub-id><pub-id pub-id-type="pmid">23224560</pub-id></mixed-citation></ref>
<ref id="r127"><label>127</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garratt</surname><given-names>AM</given-names></name><name><surname>Furunes</surname><given-names>H</given-names></name><name><surname>Hellum</surname><given-names>C</given-names></name><name><surname>Solberg</surname><given-names>T</given-names></name><name><surname>Brox</surname><given-names>JI</given-names></name><name><surname>Storheim</surname><given-names>K</given-names></name><etal/></person-group> <article-title>Evaluation of the EQ-5D-3L and 5L versions in low back pain patients.</article-title> <source>Health Qual Life Outcomes</source>. <year>2021</year>;<volume>19</volume>(<issue>1</issue>):<fpage>155</fpage>. <pub-id pub-id-type="doi">10.1186/s12955-021-01792-y</pub-id><pub-id pub-id-type="pmid">34049574</pub-id></mixed-citation></ref>
<ref id="r128"><label>128</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>B</given-names></name><name><surname>Carreon</surname><given-names>LY</given-names></name><name><surname>Glassman</surname><given-names>SD</given-names></name></person-group>. <article-title>Comparison of the EuroQOL-5D with the Oswestry disability index, back and leg pain scores in patients with degenerative lumbar spine pathology.</article-title> <source>Spine</source>. <year>2013</year>;<volume>38</volume>(<issue>9</issue>):<fpage>757</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1097/BRS.0b013e31827ab803</pub-id><pub-id pub-id-type="pmid">23124265</pub-id></mixed-citation></ref>
<ref id="r129"><label>129</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daste</surname><given-names>C</given-names></name><name><surname>Abdoul</surname><given-names>H</given-names></name><name><surname>Foissac</surname><given-names>F</given-names></name><name><surname>Lef&#x00E8;vre-Colau</surname><given-names>M-M</given-names></name><name><surname>Poiraudeau</surname><given-names>S</given-names></name><name><surname>Rannou</surname><given-names>F</given-names></name><etal/></person-group> <article-title>Patient acceptable symptom state for patient-reported outcomes in people with non-specific chronic low back pain.</article-title> <source>Ann Phys Rehabil Med</source>. <year>2022</year>;<volume>65</volume>(<issue>1</issue>):<elocation-id>101451</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.rehab.2020.10.005</pub-id><pub-id pub-id-type="pmid">33152522</pub-id></mixed-citation></ref>
<ref id="r130"><label>130</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stienen</surname><given-names>MN</given-names></name><name><surname>Ho</surname><given-names>AL</given-names></name><name><surname>Staartjes</surname><given-names>VE</given-names></name><name><surname>Maldaner</surname><given-names>N</given-names></name><name><surname>Veeravagu</surname><given-names>A</given-names></name><name><surname>Desai</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Objective measures of functional impairment for degenerative diseases of the lumbar spine: a systematic review of the literature.</article-title> <source>Spine J</source>. <year>2019</year>;<volume>19</volume>(<issue>7</issue>):<fpage>1276</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.spinee.2019.02.014</pub-id><pub-id pub-id-type="pmid">30831316</pub-id></mixed-citation></ref>
<ref id="r131"><label>131</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakobsson</surname><given-names>M</given-names></name><name><surname>Gutke</surname><given-names>A</given-names></name><name><surname>Mokkink</surname><given-names>LB</given-names></name><name><surname>Smeets</surname><given-names>R</given-names></name><name><surname>Lundberg</surname><given-names>M</given-names></name></person-group>. <article-title>Level of evidence for reliability, validity, and responsiveness of physical capacity tasks designed to assess functioning in patients with low back pain: A Systematic review using the COSMIN standards.</article-title> <source>Phys Ther</source>. <year>2019</year>;<volume>99</volume>(<issue>4</issue>):<fpage>457</fpage>&#x2013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1093/ptj/pzy159</pub-id><pub-id pub-id-type="pmid">30566577</pub-id></mixed-citation></ref>
<ref id="r132"><label>132</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>RY</given-names></name><name><surname>Coyner</surname><given-names>AS</given-names></name><name><surname>Kalpathy-Cramer</surname><given-names>J</given-names></name><name><surname>Chiang</surname><given-names>MF</given-names></name><name><surname>Campbell</surname><given-names>JP</given-names></name></person-group>. <article-title>Introduction to machine learning, neural networks, and deep learning.</article-title> <source>Transl Vis Sci Technol</source>. <year>2020</year>;<volume>9</volume>(<issue>2</issue>):<fpage>14</fpage>.<pub-id pub-id-type="pmid">32704420</pub-id></mixed-citation></ref>
<ref id="r133"><label>133</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x2019;Antoni</surname><given-names>F</given-names></name><name><surname>Russo</surname><given-names>F</given-names></name><name><surname>Ambrosio</surname><given-names>L</given-names></name><name><surname>Bacco</surname><given-names>L</given-names></name><name><surname>Vollero</surname><given-names>L</given-names></name><name><surname>Vadala</surname><given-names>G</given-names></name><etal/></person-group> <article-title>Artificial intelligence and computer aided diagnosis in chronic low back pain: a systematic review.</article-title> <source>Int J Environ Res Public Health</source>. <year>2022</year>;<volume>19</volume>(<issue>10</issue>):<fpage>5971</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph19105971</pub-id><pub-id pub-id-type="pmid">35627508</pub-id></mixed-citation></ref>
<ref id="r134"><label>134</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seas</surname><given-names>A</given-names></name><name><surname>Zachem</surname><given-names>TJ</given-names></name><name><surname>Valan</surname><given-names>B</given-names></name><name><surname>Goertz</surname><given-names>C</given-names></name><name><surname>Nischal</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>SF</given-names></name><etal/></person-group> <article-title>Machine learning in the diagnosis, management, and care of patients with low back pain: a scoping review of the literature and future directions.</article-title> <source>Spine J</source>. <year>2025</year>;<volume>25</volume>(<issue>1</issue>):<fpage>18</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.spinee.2024.09.010</pub-id><pub-id pub-id-type="pmid">39332687</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
